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One of the ambitious goals of synthetic biology is to produce biologically compatible 
catalysts that are cheap, robust, and sustainable. Tailor-made synthetic proteins that can 
mimic the highly specific and efficient catalysis of natural proteins are key to realising this 
goal for industrial biotechnology [1]. Oxidoreductases are a diverse class of enzymes that 
catalyse a similarly diverse array of redox reactions, everything from electron transfer in 
photosynthesis to site-specific hydrocarbon oxidation in the mammalian liver [2]. 
Sophisticated oxidoreductase functionality has long been the goal of the maquette protein 
design approach [3, 4]. The maquette approach aims to understand the necessary sequence 
structure relationship of these enzymes by iteratively designing in functionality into a non-
functional de novo scaffold. This bottom up approach to enzyme design aims to produce 
biocompatible catalysts, desired by the biotechnology industry, whilst simultaneously 
providing an acid test for our understanding of oxidoreductase enzymology, by building an 
oxidoreductase from scratch.  
This project focuses on c-type heme binding maquettes that have been designed to mimic 
the functionality of peroxidases en route to the more commercially interesting oxygenase or 
peroxygenase chemistry. These c-type heme binding maquettes have a de novo protein 
sequence which only contains the essential information for folding into a four-helix bundle 
that can covalently bind c-type heme. This project describes the last design iteration in 
producing a mono-histidine heme ligation in a c-type heme maquette known as C45. C45 
functions as a catalytically efficient peroxidase and represents a resounding success of the 
maquette design principles.  Chapter 2 is concerned with the biophysical and kinetic 
characterisation of the peroxidase activity of C45. Alongside the extensive experimental 
characterisation this chapter also used computational modelling in the form of: molecular 
dynamics, small molecule binding screens and ab initio protein structure prediction to 
complement the experimental results. The results of this chapter are an important 
contribution to our understanding of what the minimal structural requirements to produce 
native-like peroxidase activity are.  
Chapter 3 looks in detail at the reactive intermediates generated during the peroxidase 
cycle of C45. In particular, the presence of a tryptophan protein radical and its effect on the 
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functionality of the peroxidase. To do this, a number of tryptophan mutants of C45 were 
constructed and characterised. The results of this chapter will contribute to future designs of 
de novo proteins that are able to access the reactive heme intermediates of the heme peroxidase 
and oxygenase reactive cycles.  
The fourth chapter compliments the bottom up approach to studying peroxidase activity 
by using high level computational modelling to study the reactive intermediates of natural 
peroxidases (CcP and AXP). The dual purpose of these calculations is to both shed light on a 
contentious issue in the natural peroxidase mechanism and to investigate computational 
techniques that could be used in the future to inform the design of de novo heme protein 
maquettes. The effect of the distal histidine protonation state on the stability and hydrogen 
bonding network in the peroxidase active site is the focus of the calculations on the natural 
peroxidases. These calculations were performed in light of the publication of neutron cryo-
crystallography structures that challenged the accepted histidine protonation states of the 
peroxidase compound I and subsequently the mechanism of proton delivery [5, 6].  
This work is evidence of the effectiveness of the bottom up maquette design approach. 
The minimalist design of the de novo peroxidase produces activity that rivals the catalytic 
efficacy of natural peroxidases. This project also shows the benefit of integrating 
computational modelling on the de novo system to inform the design and characterisation 
process, as well as the potential to use higher-level calculations of the electronic environment 
in future de novo proteins.  
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1 Introduction  
The defining test of our understanding of any natural system is our ability to recreate 
it. As famously noted by Richard Feynman, “What I cannot create, I do not understand” [7]. 
To this end, the field of de novo enzyme design seeks to understand the relationship between 
protein sequence, structure and function in enzymatic catalysis by recreating it. Proteins are 
the functional molecules of life and perform an astonishing array of chemical processes, highly 
specifically and generally in ambient conditions. Proteins as nanoscale machines facilitate 
everything from the capture of solar energy and storage in various forms, to carefully curating, 
reading and replicating DNA. The potential uses for protein-based materials, systems and 
therapies to address many fundamental challenges facing mankind is immense.  
This project aims to better understand the necessary components needed to produce 
sophisticated oxidoreductase activity in a de novo protein. This will be primarily achieved using 
the bottom-up maquette design approach. Computational modelling on natural peroxidases 
will also be performed to further our understanding of the peroxidase reactive mechanism 
and to set the context for using same modelling techniques in the de novo system in the future.  
1.1 Protein Folding 
Our understanding of protein folding is founded on the success of structural biology 
in producing atomic resolution structures of proteins in native-like conformations. The first 
structure of a globular protein in 1958 set in motion the huge biophysical conundrum that is 
the protein folding problem [8]. The level of complexity and lack of symmetry which 
astounded Kendrew et al. with their initial structure of myoglobin has been observed again 
and again with successive protein structures solved. Currently there are over 60 thousand 
unique atomistic protein structures solved but work on a solution of the protein folding 
problem is still very much in progress [9]. The protein folding problem has often been 
described by two key questions [10]. First, what is the physical code, what physical and 
chemical processes allow the three-dimensional structure of a protein to be fully expressed 
from its one-dimensional sequence? Second, what is the folding mechanism that reduces the 
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terrifyingly vast number of possible conformations even a short protein can adopt, and how 
does this process occur so quickly? The famous calculation by Cyrus Levinthal showed that 
this clearly could not be a random process of sampling all possible conformations [11]. To 
illustrate the point, we can construct a model protein and vastly restrict its conformational 
flexibility to just 10 possible values of the φ and ψ angles in the backbone, and allow each 
conformation to be sampled as fast as a single bond rotation (10-13 s) [12]. Under these 
conditions a protein of just 32 amino acids would take 31 billion years to sample all possible 
conformations, which is universally agreed to be too long.  
1.1.1 Physical code for folding  
The driving force for protein folding is a combination of physicochemical factors. 
Hydrogen bonds play a key role, which was first shown in the stabilization of secondary 
structure and predicted to be a key interaction in helix promotion as far back as 1951 [13]. 
Van der Waals and electrostatic interactions clearly play an important role in such tightly 
packed molecules. The protein backbone angle preferences add an additional restriction to 
folding. However, hydrophobic/hydrophilic interactions between the protein and solvent 
seem to be the largest driving force of protein folding [14].  
1.1.2 Mechanism of folding  
In terms of a mechanism, protein folding is now understood as a landscape, which for 
natural proteins is shaped like a funnel. This funnel consists of many higher-energy unfolded 
conformations at the upper edges. As the protein folds into lower-energy conformations there 
are fewer and fewer possible globular structures at the center of the funnel [10]. In this funnel, 
adding an energy bias to correct folding on the order of just 2kT (where k is Boltzmann's 
constant and T the temperature) can reduce the time of a random folding search of a protein 
to the order of seconds [15]. At the bottom of this funnel is the native state of a protein, 
which is described as the global minimum Gibbs free energy conformation formalized in 1973 
with Anfinsen’s “thermodynamic hypothesis” [16]. The description of a protein folding 
landscape does not give a mechanistic description of how the protein will fold, only why it 
does from a thermodynamic perspective. Many different folding mechanisms have been 
postulated. The Nucleation-growth mechanism was one of the first to be rejected. It 
hypothesizes that tertiary structure propagates out rapidly from a nucleus of secondary 
1.1. Protein Folding 
  21 
structure without any folding intermediates. The isolation and study of protein folding 
intermediates in the 1970’s made this hypothesis unpopular [17].  
Two other proposed mechanisms were the framework mechanism and hydrophobic 
collapse (see Figure 1.1.1) [18, 19]. The framework mechanism sees the secondary structure 
fold, first with the tertiary structure, then buildup by the docking of completed secondary 
elements. This mechanism was born out of studies on small stable helical peptides that 
refolded rapidly after denaturation [19]. These secondary structural elements, that were 
stable in solution, were then thought to form a framework that the tertiary structure was built 
around. However, it is relatively rare to find such strong structural preferences in normal 
protein sequences. Additionally, the majority of peptides that make up secondary structure 
are disordered when taken out of context [20]. Long range interactions between residues 
sequentially far apart, were also seen to be important in producing and stabilizing secondary 
structure [21]. All three observations are in contradiction to a purely framework mechanism.  
In the hydrophobic collapse model, folding is initiated by coalescing of the 
hydrophobic residues and the expulsion of water from the core [18]. In this smaller volume, 
proteins would then have a confined conformational search for the native structure. Early 
support came from studies showing that hydrophobic interactions were the major contributor 
to protein stability for most proteins [22]. But, questions were raised over if it would be 
possible to overcome the reorganizational energy needed from secondary structure within a 
nonspecific hydrophobic globule.  
1.1.3 Nucleation-condensation mechanism 
It is now thought likely that most proteins do not fold by either extreme (framework 
or hydrophobic collapse) but through some sort of hybrid. This middle ground is sometimes 
termed the Nucleation-condensation mechanism. Fink et al. analyzed structural properties of 
41 native and partially-folded (occupying a stable intermediate) proteins trying to address 
what they term the “chicken-egg scenario” of condensation and secondary structure formation 
[23]. They observed a good correlation between secondary structure formation alongside 
deceasing hydrodynamic volume. The discovery of proteins like chymotrypsin inhibitor (CI2) 
that fold with two-state kinetics without accumulating folding intermediates allude to the 
possibility of the Nucleation-growth mechanism [24]. Φ-value analysis of CI2 indicated the 
secondary and tertiary structure formation occur in parallel with hydrophobic collapse [25]. 
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Φ-value analysis uses point mutations to probe different amino acids’ contribution to the 
native folding kinetics. These techniques have allowed the following general principles from 
small globular protein folding to be proposed, and could be abstracted to most proteins. First, 
folding is initiated by the formation of a nucleus. This nucleus is made up of consolidation of 
the hydrophobic core concurrent with secondary and tertiary structure formation. This folding 
nucleus often contains a high proportion of secondary structure. Second, the formation of the 
nucleus involves a condensation of the molecule that is largely driven by hydrophobic effects. 
Third, early folding stages can involve multiple pathways but the latter stages are more unified 
in the conformational path taken to the native structure [26].  
 
Figure 1.1.1 Protein folding mechanisms. The yellow spheres represent hydrophobic residues and coils 
represent secondary structure.  
1.1.4 Protein structure prediction 
With developments in genomics, the thousand-fold gap between the number of protein 
sequences we know and the number of structures available is growing [27]. This problem is 
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partially addressed by methods of homology modeling which can predict the structure of 
homologous proteins that have high sequence identity. Where this is not the case, other 
computational methods are needed. Critical Assessment of Structure Prediction (CASP) 
meetings were setup to experimentally test these methods of protein structure prediction and 
their results demonstrate gradual improvements every two years since its start in 1994 [28]. 
CASP tests structure prediction algorithms on sequences that have not yet been made publicly 
available, allowing the predictions to be scored against the experimental structure. All the 
successful algorithms rely heavily on the PDB as they assume that similar sequences will have 
similar structures. HHpred is an interactive server for protein homology detection and 
structure prediction that consistently performs well in CASP. It is purely a fragment-based 
method [29].  
Rosetta is another protein structure prediction software that is leading the field in ab 
initio structure prediction or free modeling, where no high identity homology structure for the 
target exists [30]. Rosetta is a hybrid approach that combines small fragments of structural 
homology derived from the PDB (either three or nine amino acids long) and all-atom 
structural refinements. In general, Rosetta ab initio protocols first fit the short fragments on 
to the sequence. Then using a Monte Carlo search protocol, perturbations are made to the 
proteins with the side chains represented as centroids. A scoring function composed of terms 
representing close range physical interactions (hydrogen bonding, hydrophobic burial and 
electrostatics) and sequence dependent terms (assembly of α and β structure) selects for 
folded results. A second all-atom refinement step then takes place using the Rosetta full-atom 
force field. In CASP10 around 10% of targets were predicted accurately enough to guide 
biochemical, industrial study or be used as an experimental native structure could [10, 28]. 
An additional challenge is that intrinsically disordered proteins may account for a large 
fraction of the eukaryotic proteome, with over 30% of human proteins predicted to be fully 
or partially disordered [31]. To predict the dynamics and structures of these proteins, more 
work on understanding and modeling the fundamental physical force driving folding is 
required. This will build a more general, physical description of folding and reduce our 
reliance on existing protein structural databases that are missing these types of proteins. 
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1.2 Protein design  
For many groups in more recent history, protein structure prediction algorithms and 
protein design have gone hand in hand. This is most clearly seen in the use of Rosetta to 
remodel and produce new protein structures and even enzymes. The most notable result in 
this case was the design of a protein fold that had not been found in nature, Top7 [32]. The 
design process used a de novo backbone sketch as a starting structure to fit PDB fragments to, 
creating a large backbone ensemble. This ensemble then went through rounds of sequence 
optimization and backbone refinement scored with the Rosetta force field. 
A step change in the utility of this software was its use in designing Kemp elimination 
functionality in to an existing protein scaffold [33]. Here Rosetta’s packing and scoring 
algorithms were utilized to redesign an existing natural protein structure to bind and stabilize 
a theoretical transition state of a chemical reaction. The initial result from the computational 
library (WT) had modest activity that was improved 200-fold after 7 rounds of directed 
evolution (R7). The catalytic efficiency (kcat/KM) of the WT was 12 M-1s-1and after directed 
evolution R7 had a kcat/KM of 2590 M-1s-1. This Rosetta design process was also able to produce 
enzymes that catalyse retro-aldol and Diels–Alder reactions with both initial structures also 
greatly improved though directed evolution [34, 35]. Whilst this constitutes a watershed 
moment for computational design it is not the start of de novo protein design. In fact some of 
the early protein designers (DeGrado et al.) were able to produce a Kemp eliminase with 
activity comparable to that of the initial Rosetta design before directed evolution, just using 
their chemical intuition [36].  
1.2.1 De novo design  
Current computational methods rely heavily on the PDB with the results of these 
methods biased towards looking like other experimentally determined structures. A greater 
challenge is to use a fully de novo protein scaffold as a starting point for designing activity. But 
why would anyone punish themselves in this way? There are several good reasons. Natural 
enzymes are the result of a complex mix of evolutionary pressures through time. Many of 
these selective pressures have little to do with the primary enzymatic activity and more to do 
with the protein existing in a dense soup of cellular interactions. From an explorative 
viewpoint, studying the fundamental principles that drive activity in a system this free from 
evolutionary complexity gives a unique and invaluable perspective. 
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Figure 1.2.1 Comparison of new folds and protein structures over time. The blue line and left axis 
show the number of new basic protein folds added to the CATH database per year. The red and right y axis 
show the number of protein structures deposited on the PDB per year. 
 
Another good reason is that nature only uses a very small area of protein sequence 
space, and the trend of discovery of new protein folds suggests that the same seems to be true 
for protein structure space. There have been no new basic folds listed in the CATH database 
(cathdb.info CATH v4.0) since 2012, while the number of new proteins structures deposited 
on the PDB has been steadily increasing per year from 7261 in 2010 to 10334 in 2017 [9]. De 
novo protein design could then be the only way to discover new and perhaps better protein 
structures.  
A third reason for de novo design is to more easily create proteins and enzymes 
orthogonal to natural pathways when used or expressed in vivo. These components designed 
to have few or no interactions with natural proteins could play an important role in 
constructing and understanding synthetic genetic circuits and other synthetic pathways. One 
final advantage of de novo proteins and enzymes is to construct proteins robust enough to cope 
with the difficult conditions needed for industrial use. Large free energies of folding are 
unlikely to have been a strong driving force in natural protein evolution as a free energy of 
folding of 8 kcal.mol-1 corresponds to having over 99.999% of the population folded [37]. 
Through designing and understanding optimal protein folding it will be possible to make 
proteins more stable than is required by nature.  
1.2.2 Basic principles  
Some of the very first de novo proteins were designed in the late 80’s. Both DeGrado et 
al. and Hecht et al. separately produced de novo four-helical bundle proteins by using the 
general principles of protein folding understood at the time. Hecht et al. aimed at building a 
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native like sequence using almost the full complement of amino acids [38]. DeGrado et al. 
aimed to understand the minimal sequence requirements for producing this tertiary structure 
so used as few amino acids as possible [39, 40]. This early work coevolved with an increasing 
number of studies aiming to understand the thermodynamic contributions of different amino 
acids to produce α-helical and β-strand structures [41, 42]. The design process took an 
iterative approach, testing the effect of each change on the structure. The designed proteins 
were built with hydrophobic interactions as the driving force for folding. This was achieved 
by using binary patterning of hydrophobic (H: Ala, Phe, Ile, Leu, Met, Val, Trp, and Tyr) and 
polar (P: Asp, Glu, His, Lys, Asn, Gln, Arg, Ser, and Thr) residues to build up a core and 
surface, burying H and exposing P sidechains [43]. The most naive patterning would comprise 
an alternating repeat (HPHP…) along the polypeptide chain. This type of repeat lends itself 
to forming β-structure. In a β-sheet alternate sidechains point in opposite directions allowing 
two or more stands to pack together, burying the hydrophobic sidechains [12].  
α-helical structure corresponds to right-handed helices where backbone carboxyl 
groups (residue n) hydrogen bonds along the helical axis of the amino group of the residue 
four along (n+4). Each turn of an α-helix has a pitch (the rise along the helical axis) of 5.4 Å 
and is made up of 3.6 residues. In most proteins α-helices are on average 12 residues or 18 Å 
long [13]. The residue sidechains point outward from the helix and can be represented on 
helical wheel diagrams (Figure 1.2.2). These diagrams can be used to aid protein design. The 
position hydrophobic residues along one face of the helix can produce a core when one or 
more amphipathic helices combine, as seen in Figure 1.2.2.B and C. 
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Figure 1.2.2 Helical Wheel diagram.  
(A) Shows a right hander α-helical heptad repeat. The letters a to g are given to the positions of the 
heptad. The direction of the oval at each position show the direction the side chain protrudes out of the 
helix. (B) Shows the binary patterning of a coiled-coil. “h” are hydrophobic residues and “p” are polar 
residues. (C) Shows a helical wheel representation of the protein sequence of the first maquette four-
helical bundle (see Figure 1.4.1.1). 
1.2.3 Coiled-coils 
This hydrophobic patterning and core packing have been well studied in natural and 
de novo coiled-coils. Canonical coiled-coils have a tandem heptad repeat that form amphipathic 
α-helices which assemble into helical bundles with left handed supercoils [44]. The heptad 
repeat in its binary form is generally HPPHPPP and is given the notation abcdefg for the 7 
positions around the helix where a and d are hydrophobic (Figure 1.2.2.B). Since 7 residues 
are not quite 2 turns (3.6 × 2 = 7.2) an imperfect hydrophobic interface is created, resulting 
in supercoiling. The core packing in coiled-coils is stricter than in non-coiled-coil 4 α-helical 
bundles; they obey knobs-in-holes packing first predicted by Crick in 1953 [45]. Differing a 
and d hydrophobic residues will have preferred packing arrangements. Changing between 
leucine isoleucine and valine (L, I and V) in these positions produces different oligomerisation 
states. The a and d position of dimers are generally V/I and L or , trimers I and I and tetramers 
L and I [46]. Positions e and g, that often make up the interface are between oligomers, are 
important in producing polar interactions that enhance the specificity for particular 
oligomerisation states. This parameterisation of coiled-coil structure has allowed protein 
designers to produce an array of different complexes and barrels, many of which are not 
observed in nature [47]. 
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1.3 Maquette design approach  
A maquette is a term borrowed from sculpting and architecture. It is a small, cut-down 
model built before a full sculpture is created with the essential features of the design but in a 
simple form. Protein maquettes are small de novo protein scaffolds that are intended to aid our 
understanding of the minimal requirements of specific sequence-structure-function 
relationships. Generally, maquettes have been designed to have 4 α-helical bundle tertiary 
structure. 4 α-helical bundles are simple enough to be produced and studied as de novo 
proteins but robust enough to incorporate asymmetry and cofactor binding. These maquettes 
have their evolutionally roots back in the 1980’s with Degrado et al. [40]. Each iteration of 
design changes made to these proteins is tested by producing and biophysically characterising 
any variation from the previous generation.  
A theme of maquettes design is a drive for functionality over form (atomistic structural 
information). This thirst for useful activity has led to the incorporation of cofactors into 
maquettes. Particularly for redox chemistry, the incorporation and redox active cofactors is 
the best way to impart functionality. Then the exploration to find the minimal requirements 
need to produce a desired activity can be performed around the cofactor, the centre of and 
otherwise beige canvas [48]. This is a bottom-up approach to studying enzymology which 
complements classical studies on natural systems.  
1.3.1 Residue helical propensities 
Four helix bundles (4HB) are a relatively common and well-studied tertiary structure. 
Parameterisation of these structures has been led by insights from published experimental 
structures as well as studies on folding, stability of helix formation, topologies available and 
cofactor binding [49–51]. Deciding which residues to pattern the helices of the 4HB is made 
with attention to the individual amino acid’s particular propensity for forming alpha helices. 
Glycine, proline, serine, aspartic acid and asparagine have low α-helical propensity. Glycine is 
small and too flexible while the heterocyclic side chain of proline excludes the backbone 
angles needed for helix formation. Proline is therefore considered a helix breaking residue. 
Serine, aspartic acid and asparagine have short and polar side chains that can disrupt the 
backbone hydrogen bonding. Valine and isoleucine are also generally disfavoured for helix 
formation as they branch at the Cβ the first carbon of the side chain which hinders α-helix 
formation. The maquette sequence is therefore primarily comprised of amino acids that favour 
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helix formation: glutamate (E), alanine (A), leucine (L), glutamine (Q), lysine (K) and 
arginine (R) [52]. 
The net charge of most maquettes is around -20 (Figure 1.4.1-C45 is -18 in the ferrous 
form). This supercharged exterior serves to prevent oligomerisation and protect against 
aggregation. Studies comparing positive and negative supercharged Green fluorescent protein 
(GFP) with wtGFP, demonstrated that supercharging the protein decreased aggregation and 
a greater proportion of supercharged GFP retained its fluorescence characteristics after 
denaturation [53]. 
1.4 Maquette family history  
Maquettes have been designed to incorporate many natural cofactors including: heme, 
chlorins, flavins and quinones [54–58]. For more information on cofactors see Section 1.5. 
They have been used to study allosteric and charge activated conformational switching, 
cofactor binding, electron transfer and oxygen binding [59–62]. Heme A and B are the most 
common cofactors studied within 4HB maquettes. This section aims to chronicle the ancestry 
of a heme-peroxidase maquette which is the focus of this project. 
Hydrophobic collapse is considered to be the driving force for folding the 4HB in 
solution. Soluble maquettes use a heptad HPPHHPP binary pattern to form amphipathic 
helices that combine, forming a hydrophobic core. Unlike de novo coiled-coils the core packing 
interaction of 4HB are not specifically defined. The first generation maquettes were 
symmetrical helices that were synthesised by solid state peptide synthesis and oligomerised 
into a 4HB [39]. They were short, just two near-identical heptad repeats, and were composed 
of only three different amino acids (LEELLKKLEELLKL). To incorporate a cofactor, the short 
minimal sequence was lengthened to the size of a typical, natural 4HB. The result is a bundle 
where each helix is slightly more than three heptads long (27 residues) and can exist in a 
parallel or anti-parallel topology. The second generation added a N-terminal CGGG sequence 
which could restrict the topology to syn or anti through disulphide-mediated dimerization of 
the cysteine (C) side chains. One leucine on each helix was also replaced with a tryptophan 
(W) to improve optical detection of the peptides. The loop regions of maquettes are generally 
composed of glycine (G) and serine (S) as these residues have particularly low helical 
propensity and a high degree of conformational flexibility. 
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Figure 1.4.1 Maquette Family History.  
The shaded region in the helix highlights one heptad. Loop sequences are displayed in yellow. The red bold 
letters in the sequence have been altered since the previous iteration.  
 
A third generation incorporated heme B by mutating two of the core leucine residues 
to histidine (at position 10 and 24). Each pair of histidine residues were able to ligate the 
heme iron above and below the plane of the porphyrin ring, sequestering four heme cofactors 
to the interior of the protein [63]. In addition to this primary mutation, a leucine position 
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between the heme was changed to phenylalanine since they are commonly found near hemes 
in natural proteins. In order to distinguish the heme binding sites from one another an 
interior leucine was replaced with an arginine.  
The fourth generation was focused on simplifying and validating the tertiary structure 
of the maquettes. Two of the four heme binding sites were removed to simplify the maquette. 
A model of the apo structure showed a >50˚ rotation around the helical axis on removal of 
heme from the ligating histidines. Changes were made to the residues that had moved, 
making them more amenable to residing at the hydrophobic/hydrophilic interface. To restrict 
the conformational flexibility at these positions β-branched aromatic residues were 
introduced. These changes as well as the stabilising hydrogen bond between histidines in the 
apo form allowed the tertiary structure of the bundle to be seen by NMR and X-ray 
crystallography (Figure 1.4.1-4.1)[64, 65]. A deletion was introduced to better align the 
binary patterning of the core and results in a helix that is 26 residues long [66]. 
1.4.1 Oxygen binding maquette 
This generation contains glutamate at positions 11, 18 and 25 in order to try and 
weaken the histidine-iron ligation at the distal side of the heme. However, this helical strain 
was not enough to allow oxygen to bind stably at room temperature. Binding CO and 
illuminating at -15 ˚C showed that exchange to O2 was possible with 100% yield. This 
unstable binding of O2 at room temperature was thought to be a result of easy access to the 
heme face allowing protons and water to facilitate electron transfer to from ferrous heme to 
oxygen, a trend seen in natural globins [67]. The fifth generation of heme maquettes, focused 
on O2 binding, attempted to constrain the motion of the maquette to exclude water from the 
heme. The NMR result of maquette 4.3 (Figure 1.4.1) showed that the inter-helical interface 
of the third heptad where the second heme binding had been removed was the most motile 
section of the helix [62]. To remedy this, the helices were looped in together at the most 
mobile interface. Disulphide-mediated dimerization of the loops results in a full 4HB in a 
monomeric ‘candelabra’ topology [62]. NMR Deuterium exchange experiments showed that 
the exchange of core backbone residues had improved from around 15 min (Figure 1.4.1-4.2) 
to several hours (Figure 1.4.1-5). Crucially, O2 was now able to bind stably at room 
temperatures with exchange coefficients comparable to natural globins.  
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1.4.2 c-type heme maquettes 
The sixth generation of maquettes were first modified by looping all four helices 
together. Two helices are linked by two short loops and one long loop to facilitate the same 
helical topology as Figure 1.4.1-5. This sequence was transformed into a plasmid with an N-
terminal signal sequence to target it for periplasmic export, a hexahistidine tag for purification 
and a Tobacco Etch Virus protease (TEV) cleavage site to remove the hexahistidine tag 
(shown in Figure 1.4.3). The maquettes could now be expressed in vivo and purified. The next 
step was to further simplify the maquette by removing one of the heme B binding sites and 
replacing the other with a Heme C recognition sequence (CxxCH). This sequence is 
recognised by the endogenous Cytochrome c biogenesis system I (Ccm) in Escherichia coli (E. 
coli). The Ccm covalently attaches heme B to the cysteines of the recognition sequence with 
the histidine becoming the proximal ligand to the heme iron and the remaining histidine in 
the 4HB ligating the distal face of the heme. Proteins with a covalently bound heme B are 
then termed c-type cytochromes. The resulting maquette (Figure 1.4.1-C46) is a 4HB with a 
single c-type heme and is a c-type heme maquette (CHM).  
A covalently bound heme offers several advantages. The holo-protein can be full 
expressed in vivo, unlike the in vivo expressed heme B maquettes which needed to bind heme 
after purification in vitro. This has profound implications for developing the maquettes with 
techniques like directed evolution, or for use in synthetic pathways in vivo. The recognition 
sequence for c-type heme (CxxCH) makes three contacts with the heme. This directional 
binding is asymmetrical and constrains the orientation the heme can face. The most common 
rotamer for c-type heme proteins (m166) has the heme rotated 45˚ from perpendicular to the 
helix it is attached to [68]. From a design perspective incorporating a c-type heme allows the 
designer to control the position and orientation of the heme. Work preceding the design of 
C46 (in Figure 1.4.1) showed that the orientation of the heme propionates around the bundle 
significantly altered the stability and heme incorporation [69]. Orientations with the 
propionates facing into the bundle were less stable. Having the CxxCH motif on the forth 
helix was seen to be the most stable allowing the propionates to face the solvent rather than 
the core [69]. C46 is named so because it is a CHM, with the c-type binding motif on the 4th 
helix, and the heme iron is bis-histidine ligated resulting in all 6 of the octahedral ligand sites 
being filled by the porphyrin ring or protein.  
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Figure 1.4.2 Heme B and C comparison. (A) shows a skeletal representation of heme B. (B) shows a 
skeletal representation of c-type heme. The sulfurs and imidazole ring belong to cysteine and histidine 
protein side chains truncated at the Cβ carbon. (C) shows the structure of the most common c-type heme 
rotamer found on α-helical structure, m166 [68]. 
1.4.3 A penta-coordinate heme maquette 
The seventh generation of maquettes in this family tree was aimed at producing 
oxygenase activity. As discussed further in Section 1.7, natural heme-containing peroxidases 
and oxygenases generally have a penta-coordinate geometry around the heme iron leaving the 
distal side of the heme free to bind water in the resting state. Taking inspiration from these 
natural enzymes a single point mutation was made to remove the distal ligating histidine. 
This was only possible using a covalently bound c-type heme maquettes as removing the 
histidine from a heme B binding maquette eradicates stable binding. This penta-coordinate 
CHM, named C45, exhibits peroxidase activity and is the central subject of this thesis [70]. 
To complement the maquette design methodology this project utilizes computational 
modelling. Advances in computing power, quantum mechanical (QM) approaches and 
experimentally validated force fields makes computational modelling often the most useful 
and effective method of probing reactivity and protein dynamics. This project will utilise 
different computational methods to study structural dynamics and stability and possible 
binding of ligands. The inclusion of computational modelling to inform the design produces 
a workflow seen in Figure 1.4.3. The current CHM model is not directly based on an 
experimental structure, as there is not one available. The CHM model was made using a 
related maquette protein, crystallised in 2003 (Figure 1.4.1-4.2) [65]. 
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Figure 1.4.3 Maquette design cycle. 
Starting with rational design aided by computational simulation and moving clockwise around the cycle 
gives the maquettes design cycle. The image at “In vivo growth and expression” is a schematic of heme 
insertion by the Ccm. It is taken from Watkins et al 2012 [71]. 
1.4.3.1 Flexibility 
Like some natural proteins, heme binding in maquettes generally seems to increase 
protein rigidity. Cytochrome b562 is a 4HB thought to be involved in the bacterial electron 
transport chain [72]. It is considered molten globular in the Apo form [50]. A molecular 
dynamics study suggested that while NMR assignment was hindered due to high motility of 
the amino acid side chains, the overall protein structure was still highly ordered [50]. Binding 
heme B constrains the protein into its native structure. Equally, Apo-cytochrome c is 
considered molten globular and heme binding is required to attain the native structure [73]. 
Hp-1 is a homodimeric di-heme binding maquette shown in Figure 1.4.1 labelled 4.3. On 
binding heme 1D 1H NMR spectrum sharpen as the protein transitions from a molten globular 
structure to a more native-like conformation.  
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1.4.3.2 Redox properties 
The electrochemical properties of the heme in the maquettes can be adjusted by 
changing the environment around the heme. The electronic midpoint potential (Em) of most 
maquettes is negative [58]. The range in Em of heme-containing maquettes is between -290 
and 6 mV [58, 74]. Increasing the external charge of a maquette (by +29) has been seen to 
increase the Em by 100 mV [75]. Adding positive or negative residues near the heme has also 
been shown to have a more subtle effect in Em [75]. Figure 1.5.2 has more information about 
the redox properties of different proteins to put this information in context.  
1.5 Cofactors driving redox chemistry 
The functional groups of amino acid side chains are well suited to acid–base reactions, the 
formation of certain types of covalent bonds, and charge–charge interactions, but are less well 
equipped for the electronic requirements of redox chemistry. Consequently, redox enzymes 
tend to incorporate cofactors to impart function. Cofactors are non-proteinaceous molecules 
required by some enzymes for function. These can be metal ions (commonly iron, copper and 
zinc cations), metals within specialised coordination complex’s (hemes, and chlorophylls) or 
small organic molecules (such as NAD or flavins). Oxidoreductases are enzymes that catalyse 
the transfer of electrons from electron donor (reactant) to an electron acceptor (oxidant). 
There are many different types of Oxidoreductase; dehydrogenases, oxygenases, peroxidases 
and hydroxylases are some examples. Figure 1.5.1 gives some examples of different redox 
cofactors. Coenzymes are cofactors that are not bound for the whole reactive cycle of the 
enzyme. Nicotinamide adenine dinucleotide (NAD), which is used in metabolic cycles in all 
domains of life, is usually oxidised and replaced before the next catalytic cycle. When a 
cofactor is tightly associated with an enzyme, like the heme groups in cytochrome P450’s or 
the c-type cytochromes, it is known as a prosthetic group [12].  
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Figure 1.5.1 Redox cofactors. The redox cofactor represented in skeletal form have the redox-active 
part of the cofactor highlighted in orange. Heme B has 3 carbons of the porphyrin labelled that are the site 
of modification for Hemes A O and C (see Figure 1.4.2). Nicotinamide adenine dinucleotide (NAD) is 
shown in its oxidised form. Flavin group is shown in its reduced form. The R-group on the Flavin can 
represent either adenine mononucleotide (FMN) or adenine dinucleotide (FAD). Molybdopterin is a 
nitrate reductase associated cofactor [76]. The last row show redox active metal ion with their ligating 
protein side chains. The Copper and zinc protein shown is superoxide dismutase [77]. The 4Fe-4S cluster 
is the active site ferredoxin from Bacillus thermoproteolyticus [78]. The non-heme iron example a 
different  superoxide dismutase from Sulfolobus acidocaldarius [79]. 
 
1.5.1 Electron transfer 
 Generally, the distance between redox centres is calculated by the edge-to-edge distance 
of the conjugated system. The rate of electron transfer (ket) is exponentially related to the 
distance between the two redox centres (R). The Moser-Dutton equation (shown below) 
builds on the work of Marcus, Fermi and Hopfield, repurposing Marcus theory for electron 
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transfer for use within an insulating protein environment [80–82]. The driving force for 
electron transfer is the change in Gibbs free energy (ΔG in eV) and the reorganisation energy 
(λ). In this equation the packing density of the protein environment (vacuum-like or bond-
like) has been substituted for an average value in a normal protein (ρ = 0.76) and the 
remaining coefficients are tailored for exergonic electron transfer reactions at room 
temperature.  
!"#$%& = 13 − (1.2 − 0.80)(2 − 3.6) − 3.1(45 + 7)8/7   (1.1) 
Charge transfer from one redox centre to another changes the environment around each 
centre and typically requires the reorganisation of atoms near the redox centres, often the 
solvent. The energy associated with atomic movements to support the new electronic 
environment is the reorganisation energy (λ). In a polar environment the response to 
electronic changes is larger with a λ around 1-1.4 eV. In a non-polar environment the λ is 
reduced, taking a value between 0.2-0.7 eV [83]. An electron transfer to cofactors with a high 
charge density incurs a greater λ than to a cofactor with a large conjugated network and a low 
charge density. The exponential relationship between distance (R) and rate of transfer (ket) 
means that as the distance increase to 14 Å electron transfer reactions become so slow they 
are biologically irrelevant. Redox partners in nature are rarely found more than 12 Å apart 
[84].   
The midpoint potential (Em) of a redox centre is an experimentally derived value. It is 
quoted in Volts versus the Nernst hydrogen electrode (NHE), where an equimolar mixture 
of the reduced and oxidised states are found. The midpoint potential is related to the ΔG of 
electron transfer by the equation below. Where n is the number of electrons and F is the 
Faraday constant. As the difference in midpoint potential (ΔEm) between two redox centres 
increases so does ΔG. 
45 = 	−;<. 4=>          (1.2) 
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Figure 1.5.2 Redox midpoint potentials compared.  The potentials for non-heme redox cofactors 
shown are: 7Fe ferredoxin [85], phylloquinone [86], flavodoxin [87], plastoquinone [88], SOD [89], 
human ceruloplasmin [90], bc1 complex [91], bacteriochlorophyll [92], FAD choline oxidase [93], 
HiPIP [94], photosystem II [95], and chlorophyll [96]. The potentials for ferrous to ferric heme is show 
for the following proteins: HasA [97], horseradish peroxidase C [98], cytochrome P450cam [99], 
Cytochrome c peroxidase (CcP) [100],  CYP119 [99], Ascorbate peroxidase [101], neuroglobin [102], 
Lignin peroxidase (LiP) [103], myoglobin [104], dehaloperoxidase [105], yeast bc1 complex [106] and 
cytochrome c oxidase [107]. The potential for compound I to compound II (CPDI/CPDII) is shown 
highlighted in yellow for: C45 (maquette used this project), CcP [108], AXP [101],and P450’s [109]. 
The maquette redox potentials are highlighted in blue. -ve and +ve maquette are maquettes with high net 
surface charges [58]. HP7 Heme B maquette (figure 1.3.1.5) [110].  C2 is a heme B and C binding 
protein (both redox potentials are shown) [111]. AP1 is a lipophilic maquette [74]. H10H24 is a heme 
A binding maquette [54]. 
1.5.2 Heme  
Porphyrins are a class of cofactors used by a wide range of oxidoreductases, from 
mitochondrial proteins that take part in oxidative phosphorylation (complexes II, III and IV) 
to the reaction centre at the core of the photosynthetic apparatus. At the heart of all 
porphyrins is a tetrapyrrole conjugated system. Porphine is the simplest macrocyclic 
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porphyrin. Modifications of the porphine macrocycle, periphery and the metal ion, give rise 
to: hemes, chlorins (like chlorophyll a) and corrins (like cobalamin). These modifications 
explain the huge diversity in chemical properties of different natural porphyrins. The pyrrole 
nitrogens at the centre of the porphyrin can coordinate a number of metal ions, occupying the 
equatorial coordination sites of the metal. Different metals exhibit different the geometries 
around the axial ligands of the porphyrin. Palladium, zinc and iron porphyrins will present 
square planar, square pyramidal and octahedral geometries respectively [112].  
Nature can fine-tune the properties of porphyrins by changing the protein environment 
around the cofactor. The axial ligating protein residues generally have the greatest effect on 
the electronic properties but changes in the second shell around the cofactor can also produce 
a marked effect. Cysteine, histidine, tyrosine and methionine are all common axial ligands for 
oxygenase, peroxidase, catalases and electron transport proteins like Cytochrome c [102, 113–
115]. Natural iron protoporphyrins are known as hemes and all have two propionic acid 
groups attached at one edge of the macrocycle. At physiological pH’s these acid groups are 
deprotonated with an approximate pKa of 3. These charged groups are generally orientated 
towards the solvent in heme proteins with the macrocycle buried in the hydrophobic core of 
the protein. The electrostatic contacts made with the porphyrin propionates can also 
modulate the electronic properties of the heme as well as confer a better binding affinity of 
the heme [116]. The nomenclature around heme sees the letter of the heme capitalised when 
referred to outside of a protein, but is italicised in lowercase when as a prosthetic group, eg 
heme B inside the main subunit of complex III is known as cytochrome b. 
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Figure 1.5.3 Heme modifications. Heme B is shown in full. Heme A has the green modification to 
carbon C3. Heme O has both blue modifications to C3 and C18. Heme C has the red modifications shown 
for C3 and C8  
 
Heme A, B, C and O are all biologically common hemes that differ by the organic groups 
attached to sides of the macrocycle (not the side containing the propionates). Heme O and A 
differ only by the attachment of a methyl instead of a formyl group one carbon along from the 
second propionate attachment. This change confers a 180 mV decrease in midpoint potential 
between Heme O and A [116]. Heme C is a misnomer as it refers to heme B that has been 
covalently attached to a protein. Proteins with this modification are known as c-type 
cytochromes. The covalent thioester linkages are attached via the vinyl groups of heme B and 
only confer a modest change in redox properties [69]. As hemes are generally buried in the 
hydrophobic core of proteins it is common to see π-stacking of the heme with nearby 
phenylalanine residues. Heme B binding in myoglobin is dependent on π-stacking interactions 
between phenylalanine and the heme. Mutating phenylalanine 46 results in a greater than 10-
fold loss in heme binding [117]. In H-NOX (Heme Nitric oxide and/or Oxygen binding) 
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domains π-stacking has been seen to decrease the midpoint potential of the heme by 40 mV 
and increase the binding affinity of O2, CO and NO to the heme iron [118]. 
In mammals, the most abundant porphyrin is heme B (iron protoporphyrin IX). It is used 
to transport electrons around the respiratory transport chain, in haemoglobin and myoglobin 
to transport and store oxygen, and also has an enzymatic function [119]. Its role in enzymatic 
activity predates the understanding that the observed activity came from a heme containing 
enzyme. HRP was discovered in 1903 and CcP in 1940 [120, 121]. Owing to their relative 
ease of purification and HRP’s broad substrate reactivity they represent some of the best 
characterised enzymes. Heme containing oxygenases, liver cytochrome P450s, were first 
discovered in 1958 and later classified as heme proteins in 1964 [122–124]. The cytochrome 
P450 superfamily are of particular interest to the pharmaceutical industry due to their key 
roles in drug and xenobiotic metabolism. Natural oxygenases are able to break up molecular 
oxygen and insert it into an unreactive organic molecule in a tightly controlled reaction [125]. 
Globins in the resting state are typically in the ferrous (Fe2+) oxidation state but cytochromes 
P450 are in the ferric (Fe3+) oxidation state at rest and access reactive ferryl (Fe4+) 
intermediates during their reactive cycle. 
1.6 Heme oxidoreductases  
Heme peroxidases and oxygenases are both oxidoreductases. Peroxidases typically use 
peroxide (H2O2) to oxidise two equivalents of electron-donating substrate but do not usually 
catalyse oxygen-transfer reactions. Oxygenases use molecular oxygen (O2) as their oxidant, 
inserting one of the oxygen atoms into the substrate. Oxidation with O2 of most biological 
molecules is thermodynamically favourable. However, these oxidations do not occur as O2 is 
a paramagnetic molecule and biological molecules are spin paired making it a spin forbidden 
process. This places large kinetic barriers on these reactions forcing nature to incorporate 
transition metal cofactors to circumvent it [126].  
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1.6.1 P450’s 
P450’s monoxygenases come from the P450 superfamily of cysteine ligated heme B 
containing proteins. They are known as monoxygenases as only one of the oxygen atoms of 
molecular oxygen is used to oxygenate the other being reduced to water. P450’s were first 
shown to be enzymatically and physiologically important in 1963 where the 450 nm pigment 
protein in adrenal cortex microsomes was seen to catalyse C-21 hydroxylation of 17-
hydroxyprogesterone [127]. Since then P450’s have been seen to catalyse a diverse set of 
reactions on both endogenous physiological substrates but also drugs and chemicals foreign 
to the organism (xenobiotic). Almost all eukaryotic P450s are membrane associated, residing 
in the inner mitochondrial membrane or the endoplasmic reticulum. Over 450 different 
P450’s have been discovered and can be found in virtually all mammalian tissues. Liver 
microsomal P450s in mammals mediate membrane detoxification by oxygenating and 
partially solubilising toxic hydrophobic xenobiotics, allowing them to be excreted. P450 are 
blind to the knowledge that a particular xenobiotic may be a therapeutic molecule and can 
also convert these helpful compounds to toxic metabolites. Therefore, drug metabolism via 
cytochromes P450 has become a significant consideration for the pharmaceutical industry. 
Important for predicting drug interactions, toxicity and pharmacological lifetime [128, 129].  
P450’s are also of interest in biotechnology and synthetic biology as the ability to 
functionalise unactivated carbon-hydrogen bonds in a regio- and stereospecific manner is a 
challenging process. Natural P450’s catalyse a variety of interesting and intrinsically valuable 
reactions: hydroxylations, N- or O-dealkylations, epoxidations and Baeyer–Villiger oxidations 
[130]. These reactions could be exploited to provide a more environmentally friendly 
alternative to traditional chemical synthesis. P450’s have also been engineered to perform 
non-biological carbene and nitrene transfer reactions with superb stereoselectivity [131]. 
P450’s use a conserved cysteine residue for the proximal axial heme B ligand. Mutating 
cysteine to histidine results in an improved cyclopropanation activity in the synthesis of 
levomilnacipran [132]. P450’s designed and optimised by directed evolution can now be 
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bought as commercial products. Arnold et al. currently hold 57 patents for various P450’s 
showing a growing commercial appreciation for these enzymes [133]. 
1.6.2 Intermediates   
The catalytic cycle of both heme-containing oxygenases and peroxidases are very similar 
and access the same highly redox active intermediates. These similarities have allowed 
insights to be gained from the study of one heme oxidoreductases family to be transferred 
and compared to the others [119]. As seen in Figure 1.6.1, generally in the P450 superfamily, 
the water bound at the distal face of the heme is displaced by the binding of substrate. 
Increasing the midpoint potential (Em) of the ferric (Fe3+) heme by about 100 mV [134]. This 
change in electronic potential triggers the reduction of the ferric heme (Fe3+ to Fe2+) by 
NADPH. This reduction is facilitated reduction by cytochrome P450 reductase. These organic 
substrates tend to bind orientating the target C-H bond in close proximity to the heme [135]. 
P450cam was the first P450 to have its structure determined with its natural substrate 
camphor in the active site [136]. The structure showed that the reactive carbon of camphor 
is just 3.4 Å away from the heme [137]. Molecular oxygen can then bind and the complex is 
reduced a second time from an NADPH-derived electron passed from cytochrome P450 
reductase. This peroxyferric intermediate is known as compound 0. All heme-containing 
oxygenases progress through the peroxiferric species in their reactive cycle, and it is after this 
point that the difficult and interesting chemistry of oxygen bond cleavage takes place. If 
peroxide is bound instead of O2 P450s follow a mechanism known as the peroxide-shunt 
pathway that proceed similar to the peroxidase reactive cycle [138]. The activated oxygen, in 
the form of peroxide, is used to make compound 0 directly.  
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Figure 1.6.1 Reaction cycle of P450’s and peroxidases. (A) shows the reactive cycle of a typical 
P450. 1. The resting state Cys-Fe3+has water bond at the heme iron. 2. Substrate binding in the distal 
cavity displaces the water ligating the heme iron and produces a 100 mV increase in the heme midpoint 
potential (EM). 3. In humans this triggers the reduction to the ferrous iron oxidation state with NADPH 
mediated by cytochrome P450 reductase. 4. After binding to the heme, molecular oxygen is reduced by a 
second equivalent of NADPH, mediated by cytochrome P450 reductase. 5. Compound 0 is formed by the 
reduction and subsequent protonation of the bound oxygen. 6.Compound 0 is then protonated by a 
protein side chain in the active site and condenses. This produces the compound I porphyrin radical cation. 
7. Compound I oxidises the reactive group on the substrate producing compound II and a carbon radical 
cation. The carbon radical then immediately rebounds abstracting the hydroxyl group from the heme to 
form an alcohol [139]. Product exiting the active site returns the heme to the resting state. The Peroxide 
shunt pathways shows how the use of an activated oxygen, in the form of peroxide, is used to make 
compound 0 directly [138]. (B) shows a typical peroxidase reactive cycle. 1. Peroxidase have a ferric 
resting state with water bound. 2. Peroxide binding produces a peroxyferric complex that is then 
deprotonated. 3. This deprotonation forms compound 0. 4. Compound 0 is protonated, most likely by a 
water mediated mechanism involving the distal active site residues, and compound I is formed. Compound 
I is generally a porphyrin cation radical but protein radical cations have been observed in some 
peroxidases (see Section 1.8.4). 5. Compound I is reduced by an electron donating substrate to form 
compound II which is then reduce by a second electron donating substrate. The reductions are coupled to 
protonation of the ferryl oxygen in both cases.  
 
The P450 monogeneses strategy reductively activating molecular oxygen requires at least 
stoichiometric quantities of a reducing substrate [140]. Generally, compound I is regenerated 
using nicotinamide cofactors. Not only are these cofactors expensive to produce many 
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reducing equivalent are lost unproductive side reactions [141]. These side reactions most 
commonly feature O2 as an electron sink and subsequently produce reactive oxygen species 
(ROS). The peroxide-shunt pathway removes the problem of using reducing cofactors [138]. 
As a result, there is considerable interest in engineering P450 to become better peroxygenases 
as well as the prospect of using fungal heme-thiolate peroxidases which naturally exhibit 
peroxygenase [142, 143]. 
The O=O bond could be broken homolytically, generating two hydroxyl radicals, which 
would likely cause problems in any enzyme active site. Heterolytic cleavage is therefore 
selected for in nature. The products of lysis in this case effectively are a bare oxygen atom 
with only 6 valance electrons and water. The oxygen bound to the iron oxidises the heme 
producing a porphyrin radical cation intermediate known as compound I (Cys-
Fe4+=O:Porphyrin•+). Compound I is then able to abstract a hydrogen atom from the 
substrate C-H bond, reducing the compound I radical to compound II (Cys-Fe4+-OH) and 
producing a carbon radical on the substrate. Finally Compound II is reduced back to the 
resting state (Cys-Fe3+) as the hydroxyl group is transferred to the substrate producing a 
hydroxylated carbon [144]. Oxygen-activating maquettes could one day be included in a 
biocompatible system, offering new functionality in pathways to metabolise drug molecules.  
1.7 Heme peroxidases 
As previously mentioned, peroxidases were the first heme enzymes to be discovered. The 
X-ray structure of CcP was added to the protein data bank (PDB) in 1980 when there were 
only 57 other structures archived [145]. Myeloperoxidase, lignin peroxidase (LiP), ascorbate 
peroxidase (APX) and HRP followed [146–149]. At the time of writing (September 2018) 
there are now 705 heme peroxidase structures from over 200 different organisms [9]. In 
general, peroxidases catalyse the reduction of hydrogen peroxide to water coupled with two 
single electron oxidations of an electron donating substrate.  
?@@? + 2AB + 2?C 	
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L⎯⎯⎯⎯⎯⎯⎯N 2?8@     (1.3) 
Peroxidases are grouped in to three main classes. Class I are intracellular peroxidases 
such as CcP. Class II and III are extracellular plant and fungal peroxidases respectively. Heme 
peroxidases have a relatively well-conserved active site structure around the heme. On the 
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proximal face of the heme they are ligated by a histidine residue (pHIS) that forms a hydrogen 
bond with an aspartic acid residue (pASP), also on the proximal side of the heme. In CcP and 
AXP a proximal tryptophan residue (pTRP) also hydrogen bonds with the pASP and lies 
parallel to the dHIS very close to the heme edge. In CcP it is this pTRP that forms the protein 
radical cation compound I. Other peroxidases contain a phenylalanine residue in the place of 
the pTRP found in CcP and AXP. 
Peroxidases also have a conserved histidine (dHIS) and arginine (dARG) residue in 
the distal heme pocket. AXP and CcP also have another tryptophan on at the distal face of the 
heme (dTRP) but this position is normally filled by a phenylalanine in other peroxidases. The 
dARG (and dTRP in CcP and AXP) have been proposed to help stabilise the formation of 
compound I. dARG is seen in two different conformations, “in” and “out”. In the resting state 
it is “out” but in compound I structures it is “in”, close to the ferryl oxygen. The most 
kinetically important residue of the distal site is the dHIS. It is proposed to be involved in 
proton transfer at various stages of the catalytic cycle which will be discussed later in the 
chapter.  
All classical peroxidases exhibit a pentacoordinate geometry around the heme iron. 
Leading to water occupying the final ligation site on the distal heme face in the resting state. 
In the resting state the iron is in the Fe3+ oxidation state and is subtly bent out of plane 
towards the proximal ligand with respect to the heme. Like all classical peroxidases, HRP in 
the resting state exists as a mixture of spin states S=3/2 (low spin) and S=5/2 (high spin) 
[150].  
1.7.1 Substrate interactions 
Peroxidases will generally turn over a broad range of compounds, with phenolic substrates 
being the most commonly studied. HRP exemplifies the trend of substrate promiscuity in 
peroxidases. It has been characterised with many different electron donating substrates but 
its native substrate is still unknown. Differences between the reactivity of the ferryl heme 
(compound  I) and interactions with substrate control the diversity of functionality across the 
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heme peroxidase family [151]. Phenols and aromatic amines are the most common small 
molecule-reducing substrates. Hydrogen peroxide can also be replaced with peroxy acids with 
the general formula ROOH [152]. 
1992 saw the first crystal structure of CcP and Cytochrome c in complex and was the first 
structural characterisation of a peroxidase with its natural substrate [153]. This milestone 
added fuel to the fire of rigorous debate around the binding and inter-protein electron transfer 
between Cyt c and CcP [154]. Unlike HRP’s green compound I intermediate, CcP produces a 
red intermediate that has a characteristic g ≈ 2.0 EPR signal [155]. The signal has been 
identified as a tryptophan radical (TRP191•+) [156]. Electron transfer proceeds from the 
tryptophan radical along only a few peptide bonds to Cyt c. There is also on-going debate 
around the two binding sites identified for Cyt c on CcP, and to what extent they are 
physiologically relevant [154].  Early studies of CcP provided extremely important 
information in understanding interactions of protein-protein electron transfer [154]. 
However, it was less useful for understanding the nature of binding interactions with small 
molecule ligands.  
NMR studies with HRP and those using phenylhydrazine to mimic small molecule 
substrates indicated that substrates were interacting with the ∂-heme edge [157–160]. In this 
regime it was assumed that small molecules bind close to the heme and electron delivery 
occurs via the ∂-heme edge, with the CcP’s protein-protein transfer seen as an outlier. First 
the crystal structure of MnP and then ascorbate peroxidase AXP challenged this general 
mechanism [161, 162]. Both structures show the substrate bound on the γ-heme edge with 
the heme propionates hydrogen bonding directly with the substrate. This evidence of an 
alternative election donation pathway through the heme propionates highlights the natural 
promiscuity of peroxidases.  
Most peroxidases can use small phenolic substrates as a source of electrons. Guaiacol is 
among the most studied as it is readily converted into its green-coloured tetramer, 
tetraguaiacol. In 2012 a crystal structure of CcP co-crystallised with guaiacol located two 
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possible binding sides [163]. One is a hydrophobic pocket around 23 Å from the heme, too 
far for direct electron transfer.  EPR data suggests it could be catalytically relevant if transfer 
proceeded through a Tyr71 radical which is between the heme and the hydrophobic pocket 
[164]. This type of long-range electron transfer has also been suggested to take place in 
versatile peroxidase (VP) and dye-decolorizing peroxidase (DypB) [165, 166]. The second is 
around 15 Å from the heme edge but is not thought to be catalytically active. Introducing a 
mutation that eradicates binding at this site does not affect the steady-state turnover. To add 
more uncertainty, inhibition studies with isoniazid, which is known to bind at the heme edge 
of CcP indicates that both compounds bind at the same site [163].  
1.7.2 Lignin peroxidase  
LiP is a class II peroxidase that is produced by wood-degrading fungi (white wood-rot 
fungus Phanerochaete chrysosporium) [167]. LiP has a reactive cycle similar to most peroxidase. 
LiP is secreted from fungi along with Veratrole alcohol (VA, 3,4-dimethoxybenzyl alcohol), 
H2O2 generating enzymes and manganese dependent peroxidase (MgP) and VP during the 
process of lignin degradation [168]. LiP and VP are able to oxidise high redox potential 
substrates like VA and other lignin breakdown products that HRP and other lower potential 
peroxidases cannot [169]. HRP will oxidise polycyclic aromatic compounds only with 
ionization potentials below 7.35 eV were as LiP oxidises polycyclic aromatics with ionizing 
potentials of approx. 7.5 eV or lower  [170, 171].  
VA has been proposed act as a diffusible redox mediator that could allow the oxidising 
power of the enzyme to be made available to degrade lignin, a large and insoluble polymer. In 
a similar regime to MnP that oxidises Mn2+ to Mn3+ which is released from the enzyme as a 
diffusible redox mediator. Alternatively, it has also been proposed that the LIP-VA•+ complex 
is the redox pair with the LiP stabilising the relatively short-lived VA•+ radical. VA turnover 
in the recombinant LiP isoenzyme H8 (LiPH8*) is completely lost on mutation of Trp171 
which is about 12 Å from the α-heme edge in an acidic pocket [172]. Reactivity towards other 
lower potential peroxidase substrates was retained. The current understanding is that LiP has 
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two possible binding modes: at the heme edge like classical peroxidases; and for high redox 
potential substrates another mediated through a Trp171 radical in an acidic pocket at the 
protein surface.  
The general picture of peroxidases and their substrates is that for non-specialised 
substrates there seems to often be multiple-low affinity binding sites. Most evidence suggests 
that kinetically-relevant binding occurs at the δ-heme edge. For more specialised peroxidases 
like AXP, MnP and CcP generally have a better-defined binding site for their native substrate 
and are less reactive with non-native substrates. Long range electron transfer is also not 
uncommon. It occurs via production of protein radicals, and both Trp•+ and Tyr•+ have been 
observed in such peroxidases. 
1.7.3 DyP-type heme peroxidases 
Dye-decolorizing peroxidase (DyP) is a member of the DyP-type peroxidase family 
produced by Bjerkandera adusta [152]. This novel family of heme peroxidases is 
phylogenetically and structurally unrelated to the classical animal and plant peroxidase super 
families [173]. DyPs have a widespread distribution across bacteria and fungi suggesting that 
they come from an ancient evolutionally root [174]. Similar to other heme peroxidases they 
contain b-type heme ligated proximally with a conserved histidine residue [175]. DyP has a 
mix of α-helices and β-strands forming a βαββαβ secondary structure motif with the two βαβ 
sections sandwiching the distal heme site [175].  
Instead of the distal histidine seen in classical peroxidases, DyP has an active site aspartic 
acid (Asp171) and arginine (Arg329) that are involved in the formation of compound I. 
Replacing Asp171 with asparagine abolishes enzymatic activity in DyP reinforcing its 
involvement in an acid–base catalytic mechanism at low pH [175]. DyPs are able to oxidise 
standard peroxidase substrates like ABTS and 2,6-dimethoxyphenol but also turn over high-
redox potential dyes such as Reactive Black 5 and Reactive Blue 5 [176, 177]. They are unable 
to oxidise veratryl alcohol into veratraldehyde which seems to be a unique feature of LiP and 
VP. Some DyPs are able to oxidise Mn(II) and a β-aryl ether lignin model compound, 
suggesting that they may be able to function as a lignin peroxidase [178]. 
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1.7.4 Dehaloperoxidase 
The classical heme peroxidases all have well-conserved folds and active sites. The 
hemoglobins are also heme B binding, α-helical proteins but have a different fold and lack the 
conserved active site residues seen in classical peroxidases [179]. Hemoglobin-
dehaloperoxidase (DHP) is multifunctional haemoglobin that was discovered from Amphitrite 
ornate, a terebellid polychaete. This “ornate” sea worm shares an ecological niche with 
unfriendly neighbours intent on poisoning it with toxic halogenated phenols and indoles 
[180]. DHP possesses both oxygen-transport and peroxidase activity that allows it to detoxify 
2,4,6-tribromophenol (TBP) to 2,6-dibromo-1,4-benzoquinone (DBQ). TBP is a native 
substrate but DHP is also active against 2,4,6-trichlorophenol (TCP) and 2,4,6-triflurophenol 
(TFP) converting them in to their less toxic 2,6-dihalo-1,4-benzoquinone (DXQ) equivalents. 
DHP and other haemoglobins have a high degree of structural similarity. Like other 
oxygen binding globins, heme B is proximally ligated by a histidine residue with another 
histidine residing at the distal face of the heme. A. ornata has two homologues of DHP, DHP-
A and DHP-B. While DHP-B differs from DHP-A by only five amino acids, it is substantially 
more conformational dynamic [181] and is 4.3-fold more active than DHP-A (DHP-B 
kcat/KM(H2O2) = 2.1×104 M-1s-1) [105]. For a globin, the activity is the highest yet discovered 
though it is significantly less than classical peroxidases such as HRP (HRP kcat/KM(H2O2 ) = 
4.6×106 M-1s-1) [182].   
The conformational flexibility of DHP-B means that the distal ligating histidine is able to 
occupy two different rotamers. One is inactive and oriented out into solvent, and the other 
active rotamer interacts with the heme oxygen species. It has been postulated that the binding 
of substrate to the entrance of the distal heme cavity forces the histidine into the active 
conformation [183]. Crystallographic binding investigations using TCP and TBP suggest that 
there are at least two binding sites in DHP. One internal site close to the heme at the α-heme 
edge with the phenolic OH moiety of TCP able to form a hydrogen bond to the water molecule 
above the heme iron [184]. The second site, referred to as the external or δ-site, is at the 
entrance to the heme cavity at the δ-heme edge [185]. There is still debate as to the exact 
functional nature of the two binding sites. One interesting explanation for the internal site, 
which may not be in the right position for turnover, is that it may serve to regulate the 
function of the globing between oxygen binding and dehaloperoxidase activity [184]. 
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DHPs lack the conserved peroxidase proximal residue pASP which is thought to relay 
charge back in to the ligating pHIS, then to support the delivery of more electron density onto 
the heme iron. The backbone carbonyl Lys38 in DHP forms a strong hydrogen bond with the 
pHIS but is not able to relay charge at the same level as a pASP acid group. DHPs have been 
observed to form tyrosine compound I radicals. Tyrosines 34 and 38 are 5.5 Å and 7.7 Å from 
the heme edge [186].  Tyrosine 34 is thought to account for the majority of the radical signal 
[183]. The mechanistic evidence for DHP strongly suggests the reaction proceeds similar to 
classical peroxidase in two discrete single electron transfers. As a multifunctional protein, the 
details are even less clear than for other peroxidases. There is evidence to suggest that DHP 
can initiate peroxidase activity from the ferrous oxidation state with oxygen bound. DHP has 
an abnormally high reduction potential (+205 mV) compared to other peroxidases [187], 
which is thought to allow for reduction by DBQ (or DCQ) facilitating the reaction to proceed 
from the oxyferrous form under high substrate concentrations.  
TCP and TBP both occur as intermediates in industrial synthesis. TBP is more common, 
as it is used in the synthesis of brominated flame retardants and can then be released into the 
environment as a degradation product of these substances. The environmental and public 
health impact of these compounds has not been extensively explored as yet. Enough is known 
to cause growing concern around their levels in aquatic environments and their impact on 
male foetal development in humans and other mammals [188, 189]. The concern around 
these pollutants makes them a target for bioremediation with a robust peroxidase.  
1.8 Classical peroxidase mechanism and kinetics 
Much of the early work on understanding the mechanisms of peroxidase kinetics was 
performed on HRP. A green intermediate (compound I) of HRP was isolated as early as 1942 
[190]. A three-step reaction mechanism with two single electron oxidations of substrate was 
then proposed in 1970 [191]. Due to the structural and mechanistic similarities between 
peroxidases, many results taken from one heme peroxidase can be applied to another. The 
equations below show the sequential reaction of HRP and two equivalents of ferrocyanide 
(Fe(CN)64-) as an electron donating substrate but could be generalized to any peroxidase and 
electron donating substrate.  
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HRP + H8O8
				ST				L⎯⎯N 	Compound	I +	H8O    (1.3) 
Compound	I	 + HC + Fe(CN)`		aB
				bc				L⎯⎯N 	Compound	II + 	Fe(CN)`		dB  (1.4) 
Compound	II + HC + Fe(CN)`		aB
				Se				L⎯⎯N 	HRP + 	Fe(CN)`		dB 	+	H8O   (1.5) 
This scheme is made up of experimentally observed steps. Each of the single electron 
reductions (1.4 and 1.5) must be accompanied by the addition of a proton if the peroxidase 
compound II is a protonated species [192]. However, there is conflicting evidence around this 
point. This will be discussed later in the chapter. 
1.8.1 Formation of Compound I 
The formation of compound I (1.3) experimentally appears to be a second order process 
with a typical rate constant of near 107 M-1s-1 [193]. Derived in HRP by monitoring pseudo-
first order decay at 405 nm with saturating enzyme concentration and varying H2O2 
concentration. In reality, compound I must be formed through an enzyme-substrate complex 
which is known as compound 0. Equation 1.7 shows the relationship between k1 and the 
microscopic rate constants involved in the formation of compound I (1.6) [152].  






     (1.7) 
The first widely discussed mechanism for the formation of Compound I in the literature 
is the Poulos-Krant  “dry” mechanism [194]. This was predominantly based on observations 
from the initial X-ray structures and mutation studies that showed a 105 reduction in 
Compound I formation by removing the dHIS in CcP [145, 194, 195]. In the dry mechanism 
the dHIS serves as an acid-base catalyst by facilitating the transfer of a proton directly back 
and forth from the peroxide. A drawback to this mechanism is that the distance seems too 
great for direct interactions between the dHIS and the hydrogen of peroxide closest to the 
heme (H1). It was also thought to be unlikely that the peroxide is deprotonated before the O-
Fe association as the pKa of peroxide is near 11.6. Initially, computational calculations 
supported the dry mechanism showing that the H1 of peroxide being deprotonated by the 
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dHIS to form ferric-hydroperoxide (compound 0) is a lower energy pathway when compared 
to moving the proximal oxygen to the distal oxygen (1,2- proton shift) [196]. Even the lower 
energy dry mechanism from this 2006 Shaik et al. study was far higher than the experimentally 
predicted for HRP (1.6 ± 0.7 kcal/mol)  [197].  
 
Figure 1.8.1 Compound I formation mechanisms. (A) shows the “Dry” mechanism of compound I 
formation [196]. (B) shows the “Wet” or water mediated mechanism [198, 199] 
 
Jones and Dunford in 2005 postulated that the dHIS pKa must be increased to make it a 
viable proton acceptor to deprotonate H2O2. This was inspired by the observation that the 
rate of compound I formation is pH independent from pH 2.5 to 11. They postulate that the 
pKa of the dHIS is shifted from around 2.5 in the resting state to near 11 during compound 0 
formation. One hypothesis was that an additional water molecule relays a proton and 
mediates an electrostatic influence on dHIS in HRP [200]. Using this as inspiration, further 
calculations with a mediating water during compound I formation gave more favourable 
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energy barriers [198]. The wet mechanism for compound I formation in HRP was then further 
substantiated by Vidossich et al. with a combined MD and QM/MM analysis in 2010 [199]. 
Poulos recently updated the original Poulos-Krant mechanism to the new water-mediated 
mechanism explored by these computational studies [119].  
In 2014 the neutron structures of CcP compound I by Casadei et al. challenged the 
generally assumed peroxidase mechanism. They reported the dHIS to be doubly protonated 
(dHIS+) in compound I of CcP [5]. As a result, any mechanism to form compound I must 
require an additional proton from the solvent or another source. Both protons from peroxide 
may not be used to form water. An additional proton must be released between compound II 
and resting ferric states. Casadei et al. suggested mechanisms that seem to favour non-water 
mediated proton transfer between the dHIS and peroxiferric oxygen.  
The Poulos et al. responded to the results of the neutron structure reiterating their support 
of a water-mediated mechanism [201]. They suggest that the dHIS in CcP compound I has a 
pKa around pH 8. This could then be explained by protonation from the solvent under the 
crystallisation conditions of the neutron structure (pH 6). They performed two calculations: 
one used the H++ webserver (biophysics.cs.vt. edu/index.php); another compared the 
ΔGprotein, changing protonation state of a residue in the protein environment with the ΔGwater, 
the titration in solution [201]. The ΔGwater they used standard results supplied with AMBER12 
calculated with a Generalized Born implicit solvent model. ΔGprotein was calculated using 
Monte Carlo sampling of a 2 ns MD simulation with the backbone of the protein fixed in the 
same implicit solvent implementation. The pKa predicted for the resting state was 5.1 and for 
compound I 7.8. These are broadly in line with resonance Raman studies of HRP isoforms 
that suggest that the dHIS has a pKa of around pH 8.6 and interacts with the heme 
environment through the solvent [202].  
The role of the dARG in CcP has been shown to be mechanistically important but not 
essential. A dARG to Leucine CcP mutant had a 102 factor reduction in the rate of compound 
I formation [203]. It was initially proposed just to form H-bonds to stabilise compound 0 in 
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the formation of compound I, but with the first crystal structure in 2003 of the CcP compound 
I, its role was expanded to stabilise compound I itself. These structures showed that the dARG 
was in two conformations “out” in the ferric enzyme and “in” hydrogen binding to the 
compound I ferryl oxygen [204]. After the neutron structure showing compound I with a 
dHIS+ it has been suggested that dARG may mediate proton transfer from the solvent during 
the formation compound I and reduction [205]. 
1.8.2 Compound I radicals 
The first compound I intermediate to be observed was in HRP [190]. It was first seen as 
a green intermediate in the 1940’s and later assigned as a π-cation porphyrin radical [206]. 
W191 (pTRP) was conclusively identified as the radical site in CcP compound I by Electron 
nuclear double resonance (ENDOR) combined with isotopic labelling of either methionine or 
tryptophan including a W51 (dTRP) knockout [156]. A year earlier it had been shown that 
removing pTRP from CcP showed a 3000-fold decrease in rate of turnover [207]. The neutron 
cryo-crystallography structure of CcP compound I reveals a short Fe=O bond that is not 
protonated [5]. The  dHIS doubly protonated (HIP) and is not directly hydrogen bonding with 
the ferryl oxygen. The dARG is in the  “in” position, hydrogen binding to the ferryl oxygen 
[5, 204]. The crystal structure of APX revealed a tryptophan residue in the same proximal 
position as found in CcP. It was assumed that AXP would also produce a tryptophan radical. 
However, both freeze-quench EPR and stopped flow spectroscopy identified APX compound 
I as a porphyrin radical [208, 209]. The porphyrin radical is found in most other general 
peroxidases like HRP which has phenylalanine residues in place of the tryptophan residues 
found in APX and CcP. 
The protein environment of AXP and CcP are subtly able to electrostatically stabilise 
different radical cations. Mutation studies of CcP, removing pTRP, show the preferential 
binding of positive small molecules into the newly formed pocket [210]. This, along with 
results from computational models, support the view that protein environment of this pocket 
stabilises the pTRP+• positive charge in CcP [211]. Crystal structures of the plant peroxidases 
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APX, HRP and peanut peroxidase, have a cation binding site (K+ or Ca+) close to the proximal 
tryptophan (8Å in AXP) [148, 149, 212]. This K+ binding site in AXP has been shown to be 
structurally important and seems to play a role in destabilising the pTRP+• [213]. A K+ 
binding site can be engineered into CcP resulting in poor activity and a loss of the 
characteristic pTRP+• radical EPR signal [214]. CcP methionine 230, 231 and 172 have all 
been also implicated in stabilising the pTRP+• [215]. It is possible that there are many 
alternate radical sites in CcP owing to the unusually high content of aromatic residues for a 
30 kDa protein: 7 tryptophans and 14 tyrosines. It is possible (and highly likely) that the 
radical site can migrate amongst these residues. CcP forms tyrosine crosslinks (on residues 
32 and 48 on surface) in the absence of electron donor [216]. This suggests that the oxidation 
of these sites could also be preferable to oxidation of the porphyrin. 
1.8.3 Compound II 
The structure of AXP compound II has been solved by neutron diffraction and shows the 
dHIS to be doubly protonated (dHIS+) and the heme intermediate to be a Fe4+-OH [6]. A 
protonated compound II oxygen is consistent with the other heme enzyme CYP-158, a 
bacterial P450, which has been observed to have an unprotonated compound I 
(Fe4+=O;Porphyrin•+) but a  protonated compound II (Fe4+-OH) [217, 218]. This is the same 
trend observed in aromatic peroxygenases and chloroperoxidases [219–222]. A typical heme 
Fe4+=O bond length is 1.65 Å, and in Fe4+-OH, the Fe-O bond would typically fall between 
1.76-1.81 Å. For Fe2+-OH and Fe3+-OH, typical Fe-O bond lengths would be 1.81-1.85 Å and 
1.85-1.92 Å respectively [223]. A number of techniques have been used to estimate the pKa 
of compound II in HRP, which is predicted to be less than 4. If this is the case, it would 
normally be deprotonated at HRP optimum pH 4.6. The conflicting evidence from different 
peroxidases means that it is still not known if CcP is an outlier amongst peroxidases. 
1.8.4 Reduction of compound I and II 
The reduction of compound I occurs rapidly in the presence of an electron donating 
substrate. This step is generally considered to be rapid, with the reduction of compound II 
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considered the rate-limiting step in most conditions [224]. In peroxidases where substrates 
typically associate at the heme edge, this is perhaps a result of the different electron transfer 
distances between Compound I and II. In compound I reduction the electron travels to 
delocalised the porphyrin radical but in the reduction compound II the electron must travel 
further to reduce the heme iron[152]. Compound II is always reduced with proton-coupled 
electron transfer. The donating substrate is often the source of this proton but this is not 
always the case. For HRP, the compound II reduction is dependent on a distal amino acid 
sidechain with a pKa near 8.6, and above this pH it is inactive. This group is generally assumed 
to be the dHIS. The reduction of compound II is known to be the rate limiting step. 
1.8.5 Comparison of Peroxidases and P450s 
P450s and peroxidases access the same reactive intermediates (Compounds 0, I and II) 
but conduct quite different chemistries. The differences in the heme environment between 
these two families of heme oxidoreductases can help to rationalise the differences in 
reactivity. The topology of the heme cavity in P450s is larger and more hydrophobic and 
allows the binding of substrate close to the heme iron [119]. The opposite is true for 
peroxidases as their distal heme cavities are more restricted and substrates are force to bind 
at the heme edge.   
The cysteine ligand of P450s is more electron donating than the histidine in peroxidases. 
The thiolate-iron ligation must generate an oxidant strong enough to break the 100 kcal.mol-
1 C–H bond of a typical hydrocarbon [144]. The difference between peroxidase and oxygenase 
activity is thought to be due to the pKa of the Fe(IV)-OH hydoxyferryl species (compound  II). 
P450s generally possess a long Fe-O bond in compound II - around 1.82 Å - where in 
peroxidases it is typically 1.7 Å. The more electron donating thiolate ligation in P450s results 
in a basic pKa ferryl oxygen (above 8.2) that supports hydrogen bond abstraction [144]. 
1.9 Computational description of proteins  
Computational models allow the relationship between structure and dynamics to be 
explored at the atomic level. Quantum mechanical (QM) methods involve solving 
approximately the electronic Schrödinger equation to determine the wave function and energy 
1.9. Computational description of proteins 
  58 
of a system. In practice this in-depth description of electronic structure can only be calculated 
for systems with a small number of atoms around 200 [225]. For proteins, made up of many 
thousands of atoms, molecular mechanics (MM) methods are instead employed [226]. The 
results chapters of this project include molecular dynamics (MD) calculations which solve a 
MM description of the system through time. Chapter 4 discusses work that combines QM 
and MM calculations. An introduction to the QM method used is discussed in Section 5.1. 
1.9.1 Molecular Dynamics  
Molecular mechanics methods assume that the energy of the system can be calculated 
solely by the nuclear positions, disregarding the computationally expensive electronic 
components. Atoms are modelled as small particles and bonds as connecting springs [227]. 
The system is described by classical mechanics (MM, Newtonian equations of motion) using 
potential-energy functions for inter- and intra-molecular forces. This description of the 
system is known as the force field. It contains generalised descriptions of bonded interactions 
(bond: stretching, bending, rotation) and non-bonded interactions  (electrostatic and Van der 
Waals interactions) for all the different atom types in the system (Figure 1.9.1) [225]. 
Results using a force field, rigorously parameterised by experimental and QM data, can in 
some cases produce structures as accurate as QM calculations but take a fraction of the 
computational resources. Molecular dynamic (MD) simulations build up a dynamic picture of 
a molecule by applying the MM description of the system over time. It offers a compromise 
between accuracy, validity and practicality [227]. Two widely tested protein force fields were 
used in this project (CHARMM22 and AMBER14ffSB) across two different software packages: 
AmberTools15 and Gromacs 4.6.4 [228–231].  
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Figure 1.9.1 MM energy terms. 
Illustration of different energetic terms parameterized in a MM force field 
Aside from the inherent approximations and assumptions of the force fields method, the 
largest source of uncertainty lies in the validity of the starting structure. Generally, the length 
of MD simulation limits the conformational search of the starting structure, only allowing the 
simulation to converge in a local energy minimum [227]. This means that the less accurate 
the starting structure the less representative the MD simulation will be of reality. The current 
computational model used for the maquettes in this project is not directly based on an 
experimental structure, as there is not one available for C45. However, a related protein was 
crystallised in 2003, which shares 45% sequence identity [65]. Experimental observations 
with circular dichroism spectroscopy show that C45 is almost completely helical. The 
computational structure of C45 is based on the assumption that it folds to a similar gross 
structure of the crystallised maquette.  
The different conformations sampled by the protein during the MD simulation can then 
be used as a starting structure for QM calculations and ligand docking calculations. When 
combined with docking experiments, MD simulations can give information on the structural 
stability of the enzyme and interactions with small molecules. 
1.10 Aims 
This project focuses on c-type heme binding maquettes that have been designed to mimic 
the functionality of peroxidases en route to the more commercially interesting oxygenase or 
peroxygenase chemistry. Chapter 2 aims to explore the final design iteration that produced a 
mono-histidine heme ligation in a c-type heme maquette, named C45. Biophysical, kinetic 
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and computational characterisation of the peroxidase maquette will be employed with the aim 
of furthering our understanding of the minimum structural requirements for peroxidase 
activity.  
The third chapter aims to study the reactive intermediates generated during the 
peroxidase cycle of C45. In particular, the presence or absence of a tryptophan protein radical 
and its effect on the functionality of the peroxidase. The fourth chapter aims to complement 
the bottom up approach to studying peroxidase activity by using high level computational 
modelling to study the reactive intermediates of natural peroxidases (CcP and AXP). The dual 
purpose of these calculations is to both shed light on a contentious issue in the natural 
peroxidase mechanism and to investigate computational techniques that could be used in the 










The maquette design process has been successful in producing functionalised de novo 
proteins. Section 1.3 details the progression of the maquette protein discussed in this chapter 
from a short four-helix bundle (4HB) produced on a peptide synthesiser, to longer proteins 
looped together and capable of binding cofactors [39, 63]. Heme B binding maquettes could 
modulate the redox properties of their cofactors and could be designed to mimic the 
functionality of haemoglobins in reversibly binding oxygen [61, 62]. More recently the design 
of c-type heme maquettes has allowed for the cofactor to be covalently incorporated in vivo 
allowing for greater control of the orientation and positioning of the heme within the bundle 
[69].  
The aim of creating the heme binding maquettes is to reproduce and potentially exceed 
the sophisticated enzymatic activity found in natural heme oxidoreductases. The first target 
is peroxidase activity, en route to oxygenase chemistry as a long-term goal. Natural peroxidases 
such as HRP, CcP, AXP and LiP all have heme in a pentacoordinate ligation scheme [145, 
147–149]. The distal site is then free to bind water in the resting state and for H2O2 to start 
the reactive cycle [119]. Removing one of the heme-ligating histidine residues in the heme B 
binding maquettes severely diminishes heme binding. For c-type heme only a single histidine 
is required for binding in the CXXCH biding motif. The cysteine residues of the recognition 
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sequence are covalently bound to the heme by the endogenous Cytochrome c biogenesis 
system I (Ccm) in E. coli [71]. 
The aim of this chapter was to produce a mono-histidine ligated maquette and then 
characterise any resulting enzymatic activity. Covalent heme binding in c-type maquettes has 
unlocked the possibility of removing the distal histidine of the heme without a loss in heme 
binding. The design rational was to mimic natural peroxidases where the distal site of the 
heme is free to interact with solvent. The c-type heme maquette produced, C45, is the first 
peroxidase maquette, indeed the first maquette to exhibit enzymatic activity on the same 
order of magnitude as natural enzymes. This chapter is a detailed characterisation of the 
structure, kinetic activity, substrate binding and substrate promiscuity. The work is essential 
for understanding what the minimal requirements for producing peroxidase activity in a de 
novo scaffold are.  
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2.2 Materials and Methods 
2.2.1 Mutagenesis and Cloning  
The mutagenesis of the maquette variants was performed using a Site-directed, Ligase-
Independent Mutagenesis (SLIM) protocol [232]. Both the SLIM protocol and subsequent 
PCR experiments were performed using Q5 High-Fidelity DNA Polymerase. The proteins 
were expressed from a pMal-p4x vector with the maltose binding proteins removed. The 
sequences encoding the Sec signal sequence, a Histidine affinity tag and the tobacco etch virus 
(TEV) cleavage site were all placed directly upstream of the maquette gene. The primers used 
in the mutagenesis were designed using the programme CloneMUTS2 and synthesized by 
Eurofins (MWG, UK) [233].  
After mutagenesis, a QIAGEN PCR cleanup kit was used to prepare the plasmid for 
transformation. 50 µl of E. coli Stellar competent cells (New England Biolabs, UK) were 
transformed by 42°C heat shock for 45 seconds after a 30 minute incubation with 1 µl of 
plasmid on ice. After heat shock, cells were then left on ice for 2 minutes before adding 450 
µl of super optimal broth (SOC, [2 % tryptone, 0.5 % yeast extract, 2.5 mM KCl, 10 mM NaCl 
and MgSO4, 20 mM glucose]) as a growth medium. The transformed cells were incubated at 
37 ˚C for 1 hour before pelleting and spreading onto 1 % agar lysogeny broth (LB) plates 
containing 50 µg/ml carbenicillin. 
After overnight incubation, selected colonies were used to inoculate 5 ml of LB (50 
µg/ml carbenicillin) and incubated overnight with shaking. Samples were centrifuged at 4000 
xg for 5 minutes to harvest the cells. Plasmid DNA was extracted using a standard miniprep 
kit (Sigma, UK) and sequenced by Eurofins. Two steps on the standard miniprep protocol 
were modified to increase plasmid yield. The plasmid DNA was bound to the column with a 
slow spin (800 rpm for 2 min, followed by a pulse to 13,000 rpm) and the plasmid was eluted 
with water at 70 ˚C.  
Correctly mutated plasmid DNA was co-transformed into E. coli T7 express cells (New 
England Biolabs, UK) with a pEC86 constitutive expression vector housing the Cytochrome 
c biogenesis system I genes and chloramphenicol resistance [234]. The co-transformation only 
deviates from the above method in that cells incubated with 1 µl of both plasmids for 30 
minutes on ice before a 10 second heat shock. The mutagenesis was determined to have been 
successful by sequencing the relevant portion of the plasmid (Eurofins, MWG).  
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2.2.2 Protein expression and Purification  
Glycerol stocks of successfully co-transformed E. coli were used to inoculate 50 ml of 
LB as a starter culture. All LB used in the expression contained carbenicillin (50 µg/ml)  and 
chloramphenicol (34 µg/ml). After incubation with shaking overnight at 37 ˚C, starter 
cultures were added to 1 L of aerobic LB. The 1 L culture was incubated in the same 
conditions. When the optical density of the cultures at 600 nm reached 0.6-0.7, maquette 
expression was induced with the addition of 0.5 mM isopropyl-D-1-thiogalactopyranoside 
(IPTG, Apollo Scientific). 4 hours of incubation (37 ˚C with shaking) completed the 
expression phase of production. The cells were pelleted by 4,000 xg centrifugation and 
resuspended in lysis buffer (300 mM NaCl, 50 mM NaPhos, 20 mM imidazole, pH 8.0). 
Phenylmethanesulfonylfluoride (PMSF), a serine protease inhibitor, was added to 
1 mM and the lysate kept below 4 ˚C when handling to avoid proteolysis. Three cycles of 
Sonication (using Soniprep 150, MSE UK) at 100% amplitude with 30 second pulses 
separated by 30 seconds of mixing lysed the cells pellets. The aqueous and lipid phases of the 
lysed sample were subsequently separated by centrifugation at 40,000 xg for 30 minutes.  
A 5 ml Nickel affinity chromatography column (HisTrap HP, GE Healthcare, UK), 
equilibrated in lysis buffer was loaded with the aqueous lysate (filtered through 0.2 µm pore 
filter). A red band showing the his-tagged, heme-containing maquette clearly binds to the 
column whilst the vast majority of cellular proteins flow through. The histagged maquette 
was eluted with an increasing gradient of elution buffer (300 mM NaCl, 50 mM NaPhos, 250 
mM imidazole, pH 8.0). The fractions containing maquette were collected and dialysed into 
TEV cleavage buffer (20 mM Tris, 0.5 mM EDTA, pH 8.0) in 8,000 MW tubing overnight.  
The N-terminal His-tag was cleaved during a 4 hour incubation (room temperature in 
anoxic conditions) with TEV protease (100 µg/ml) and tris(2-carboxyethyl)phosphine 
(TCEP, 1 mM). The sample was then loaded onto a nickel affinity column in the same 
conditions as the first nickel column, and the flowthrough is harvested. The sample was then 
loaded onto a HiLoad Superdex 75 pg size exclusion column after being concentrated to 
approximately 4 ml using a spin concentrator (Vivaspin 20, 5,000 MWCO). The column was 
then equilibrated with redox buffer (100 mM KCl, 20 mM CHES at pH 8.6). The maquette 
eluted around 43 minutes after injection with a 1 ml/min flow rate. Samples were taken 
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throughout the purification to perform sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS -PAGE). 
The pure samples were then concentrated to a useful concentration, above 100 µM. A 
pyridine hemochrome assay was used to accurately determine the concentration of heme-
containing protein. The assay was performed in a low volume cuvette. 90 µl of diluted heme-
protein sample (typically and 75 times dilution) was added to the cuvette and spectra 
recorded. Then 90 µl of a solution containing 40 % pyridine and 0.4 M NaOH in the same 
buffer as the sample (redox buffer pH 8.6) was added. The solutions were mixed thoroughly 
for 15 seconds (30 aspirations) and the oxidised spectra recorded directly after. Immediately 
after this the sample was reduced by the addition of sodium dithionite (a small but saturating 
quantity of powder). The sample is mixed once more for 15 seconds on the addition of sodium 
dithionite and the reduced spectra taken immediately after. The concentration of heme was 
calculated by the difference in oxidised and reduced spectrum (ε A550 red - A550 Ox = 21840 M-
1.cm-1) [235]. 
2.2.3 UV-Visible Spectroscopy  
A Cary 60 spectrophotometer (Agilent Technologies) was used to record all UV-visible 
spectra. Reduced (ferrous) spectra were measured after the addition of sodium dithionite in 
excess.  
2.2.4 Circular Dichronism  
Circular Dichronism (CD) was used to examine the secondary structure of the protein 
maquettes. The temperature dependence of folding was assessed using a J-1500 spectrometer 
(Jasco, UK). Experiments used 300 µl of 10 µM protein in 1 mm path length quartz cuvette 
sealed with a stopper. For the melt experiments the samples were heated from 5 to 95 ˚C at 
a rate of 40˚ C/hour. At each degree of temperature change the ellipticity at 222 nm was 
recorded to assess the α-helical content of the protein. At 5, 25, 35, 55, 75 and a 95 ˚C full 
spectrum scans from 250 to 190 nm were taken. Cooling experiments were performed on the 
heated sample with the same conditions but in reverse. The ellipticity output (mdeg) was 
converted to mean residue ellipticity (deg.cm2dmol.res-1) using Equation 2.1.  
j = k
fl(m.n)o
       (2.1) 
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In Equation 2.1: “θ“ is the mean residue ellipticity, “E” is the ellipticity in mdeg, “P” 
is the number of peptide bonds (number of residues – 1), “c” is the molar concentration of 
the protein (M) and “l” is the path length in cm. Melts with 2, 4 and 6 M Urea were also 
performed in the same way. 
2.2.5 NMR 
The maquette protein expressed from E. coli grown in 15N-enriched media was 
examined by 1D 1H and 2D 1H -15N-HSQC experiments on the BrisSynBio Cryo 700MHz 
(Bruker, UK) instrument at The University of Bristol. The same growth and purification 
protocol explained in Section 2.2.2 was used except for the addition of 1 g/L 15N-ammonium 
chloride before induction for 4 hours. A preparation of 15N-enriched C45 was produced with 
the heme iron removed. For this 1.5 ml of Hydrogen fluoride-pyridine (70% HF) was added 
to lyophilized C45 in a 50 ml Falcon tube (Polypropylene), and stirred for 10 minutes. The 
resulting metal-free protein was light sensitive and so was kept in the dark. The reaction was 
quenched by addition of 10 ml of 50 mM ammonium acetate (pH 5.0). Then Nitrogen was 
flowed over the sample for 2 hours before buffer exchange and 4 h of dialysis against 10 mM 
sodium acetate (pH 5.0) [236]. A 60 µl sample of 200 µM was then examined by 1D proton 
and 2D 15N-HSQC experiments. 
2.2.6 Molecular Dynamics 
The majority of the computational work was run on the University of Bristol’s 
supercomputer, BlueCrystal phase 3. Both AMBER and GROMACS MD simulations used the 
same pdb coordinate file as a starting structure. Each was simulated in a cuboidal periodic 
box (> 18 Å from protein) with TIP3P explicit solvent and with 150 mM sodium and chloride 
ions added. The histidine residue in the CXXCH motif of C45 was singly protonated on the 
Nδ (HID). All other ionizable residues were in their physiologically relevant protonation 
states. The trajectories from both simulations were visualised and analysed in VMD [237]. 
The structural identity (QH value) was determined using Multiseq [238].  
2.2.6.1 GROMACS 4.6.4  
MD of C45 in GROMACS was built and minimised on a local Linux machine. The pdb 
file was converted into a structure file (.gro) and a topology file (.top) in the GROMACS 
format. Then the periodic boundary conditions were added, the box solvated with TIP3P water 
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and ions were also added. The CHARMM27 force field was used to parameterise the system, 
and the covalently bonded heme and histidine-iron coordination bonds were specially 
parameterised in a separate file [239]. For C45 the CHARMM27 force field was modified to 
include a set of c-type heme parameters derived from the standard CHARMM heme B 
parameters.  The initial energy minimisation was run with no restraints and a steepest descent 
algorithm that converges when the maximum force is smaller than 200 kJ mol-1 nm1. Second, 
a pressure equilibration was performed for 200 ps without generating initial velocities. For 
both the second minimisation and the production MD an NPT ensemble was used with 
verlosity-rescale temperature coupling and isotropic Berendsen pressure coupling at 300 K 
and 1 atm . The production MD was run on Bluecrystal at 2 fs steps producing in total a 100 
ns trajectory written out into 100 frames (saving every 100 ps). The results were processed 
and water removed with trjconv and then visualised and analysed in VMD [237]. 
2.2.6.2 AMBER 
It was important to convert the MD setup into AMBER as the output files from AMBER 
simulations are readily compatible with Chemshell and ORCA, programmes used to perform 
QM calculations [240, 241]. The same initial coordinate file as the GROMACS simulations 
and the same CHARMM22 force field (the protein portion of the CHARMM27 force field) 
were used [228, 239]. Empirically-derived topologies and parameters for c-type heme in the 
AMBER format were helpfully provided by the Luthey-Schulten group [242]. The MD was 
setup on a local machine using VMD to build a TIP3P water box with ions. VMD was also 
used to patch together the protein and c-type heme parameter, topology and structure files 
into a coordinate file (pdb) and protein structure file (psf).  Chamber within parmed.py (part 
of AMBERtools16) was used to produce AMBER compatible parameter-topology and 
coordinate files (.prmtop and .inpcrd). Finally, before running the energy minimisations, 
atom names of the TIP3P water had to be edited to make them compatible with AMBER 
naming conventions. A number of preliminary energy minimizations were performed; a 
minimisation of solvent and hydrogens with protein heavy atoms restrained, a heating of 
solvent with restraints for the protein, a minimisation of the entire system, a quick heating 
of the entire system and a final 200 ps NPT ensemble MD equilibration of the system (details 
in Appendix B). The first minimisation was performed on a local machine with AMBER16 
installed whilst the remaining minimisations and the production MD were calculated on a 
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graphics processing unit (GPU) node of Bluecrystal phase 3. The production MD was run at 
2 fs time steps for a total length of 100 ns. A weak-coupling algorithm to maintain a constant 
temperature at 300° K and isotropic Berendsen pressure coupling at 1 atm were used [243]. 
Structures were saved every 100 ps. The system was initially run with a non-bonded cutoff of 
12 Å (the AMBER default is usually 8 Å) so that the Amber and GROMACS results could be 
more directly compared. Cpptraj in AMBER tools and VMD were used to analyse and visualise 
the results. 
2.2.7 Preliminary computational folding with Rosseta  
 Rosetta 3.8 (rosettacommons.org) was downloaded and compiled on a local Linux 
desktop running Ubuntu 16.04 LTS (Ubuntu.com). To run the folding calculations, the 
AbinitioRelax.default.linuxgccrelease program was used [30]. All Rosetta ab initio 
calculations require an amino acid sequence in fasta format and fragment files that are 
generated using the ROBBETTA webserver (robetta.bakerlab.org). These are short structural 
motifs mined from the Protein Data Bank (PDB) of either 3 or 9 amino acids long. Two 
different conditions were run: one with and without the heme. Calculations without heme 
were setup with the default setup parameters and can be found in Appendix B1. 
Simulations with heme required additional Rosetta parameter files: full-atom heme 
residue parameters, centroid heme residue parameters, full-atom constraint file, centroid 
constrain file and residue pair jump constraint file were all employed. The constraint files 
contain additional harmonic restraints to force a c-type heme conformation of the CXXCH 
motif. The residue pair jump constraint file contains the instructions to link the non-standard 
residue to the structure as a rigid body. All these files were designed from scratch taking 
inspiration from a sparsely commented setup included with Rosetta, ab initio fold of a zinc 
chelating protein (found in main/test/integration/tests/metalloprotein_abrelax/). Whilst 
this setup was valuable in outlining the method, a large amount of trial and error was still 
required to produce a useful output, let alone something resembling a folded protein. The full 
atom and centroid heme residue parameters were based on a c-type heme mol2 file adapted 
from AMBER ferrous heme B parameters [244]. A python script bundled with the Rosetta 
installation (molfile_to_params.py) was used to generate the first template of these files 
which had to be manually edited to function as a c-type heme.  
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Whilst the development of the setup was performed on a local linux computer, the 
bulk of the calculations were run on the University of Bristol’s BlueGem Synbio cluster.  
2.2.8 Kinetic assays for ping-pong fitting 
Ping-pong kinetics with ABTS and H2O2 were carried out using KinetAsyst SF-61DX2 
Stopped-Flow Spectrophotometer (Hi-Tech Limited, UK). Six concentrations of ABTS (3, 2, 
1, 0.5, 0.2, 0.1 mM) were all tested against six concentrations of H2O2 (5, 10, 25, 50, 100, 150 
mM) monitoring at 525 nm (ABTS ε525nm= 4250M−1 cm−1). The dynafit software package was 
used to fit the data to a Ping-Pong mechanism. The data was recorded in triplicate with Dr 
Katie Grayson and fitting was performed with the help of Dr Gus Cameron, as cited in [70]. 
2.2.9 pH-dependent kinetics and spectroscopy  
The buffers used were: 20 mM Potassium Phosphate (pH 6 to 8), 20 mM CHES (pH 8.5 to 
10), and 20 mM CAPS (pH 11). The same protocol as described for kinetic assays with ABTS 
as described in Section 2.2.12 was used except all reagents were made up in the relevant 
buffer for pH. The pH dependent Optically transparent thin-layer electrochemistry (OTTLE) 
was performed by the same method as seen Section 3.2.7 except the relevant buffer for the 
pH rage as (described above) was used. 
2.2.10 Temperature-dependent kinetics 
Temperature dependent kinetics were performed in 100 µl reaction volumes with 
0.25 µM C45, 100 µM H2O2 and 0-100 µM ABTS concentrations. Spectra were recorded with 
a Cary-60 UV-visible spectrophotometer (Agilent Technologies) using a TC 1 peltier 
(Quantum Northwest) and BATH 10 circulator (Quantum Northwest) to control the 
temperature in a t2 Sport/Cary 60 cuvette holder (Quantum Northwest). 90 µl of ABTS and 
C45 in redox buffer at pH 8.6 was equilibrated for 5 minutes at either 20, 30, 40, 50, 60 or 
70 ˚C. A new stock of 1 mM H2O2 was prepared for each temperature and equilibrated. 
Reactions were recorded in triplicate and initiated by mixing 10 µl H2O2 into the solution of 
C45 and ABTS. These experiments were performed by Daniel Watkins as cited in [70]. 
2.2.11 Computational binding screen with BUDE 
BUDE (The Bristol University Docking Engine) surface scanning mode was used for 
19 ligands on 10 different snapshots from a 100 ns GROMACS MD simulation of C45 [245]. 
The snapshots were taken every 10 ns of the simulation. The structures of the ligands were 
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taken from the Zinc database online and parameterised with the programme acpype.py using 
Antechamber and the General AMBER Force Field (GAFF) [246–248]. BUDE only requires 
mol2 coordinates and autotypes as input for ligands. A single conformer of each ligand was 
used except for ABTS where 10 different conformers were used, generated by a previous MD 
simulation. Charges of ligand functional groups were set to their value at pH 8.6 (see Figure 
2.3.17). The BUDE setup, BUDE running, processing for MD, MD setup and MD post-
processing was scripted where appropriate. Each combination of ligand and snapshot of C45 
simulation (receptor) had 1,200 randomly assigned surface positions tested. At each of these 
positions 3,000 conformational iterations of the starting ligand pose were tested with the top 
30 energies selected to be parents. These parent poses were then randomly iterated a further 
3,000 times and a new generation of top 30 energy parents selected. This process was repeated 
for ten generations at each starting pose. In total 1.08 x 1010 conformations are sampled per 
ligand with C45, with each generation following a path to stronger binding. The top 50 
binding modes per ligand were then individually processed and run as a 5 ns MD simulation 
using the AMBER setup, as previously described.  
VMD was used to process the trajectories aligning all frames from across all ligands by 
the protein backbone and then calculating the centre of mass for each ligand with respect to 
the heme iron. For each frame, if the heavy atoms of the ligand were found to be over 5 Å 
from any part of the protein it was classified as dissociated. This information was then 
analysed using python, where a three-dimensional cluster analysis was performed on both the 
BUDE input structures and the MD results after 5 ns, separately. This was to give an 
approximate quantification of possible binding hotspots. Each of the start and end data sets 
analyzed the centre of mass of all ligands together. The cluster analysis used sklearn DBSCAN 
and comp [249]. All ligands marked as dissociated were binned in one cluster for the 5 ns 
analysis. VMD was also used to generate lists of close interactions (<3 Å) between the heavy 
atoms of the ligands and protein. The frequency of these interactions on the final structure of 
the 5 ns MD simulation were binned per protein residue and per protein atom and used to 
produce ligand binding heat map figures. An example of the BUDE setup, running and 
processing for MD script is found in the appendix (Appendix B) 
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2.2.12 Kinetic assays for various substrates 
Kinetic assay were performed with the following substrates: ABTS (2,2′-azino-bis(3-
ethylbenzothiazoline-6-sulfonicc acid)), 2,4,6-Trichlorophenol (TCP), 2,4,6-Tribromophenol 
(TBP), Amplex red, Guaiacol, 3,3’-dimethoxybenzidine, Luminol, o-Phenylenediamine, p-
Aminobenzoic acid, Ascorbate, Veratrole alcohol (VA), and 1,4-Dimethoxybenzene. All 
substrates were purchased from sigma at high purity (>95%). All experiments were 
performed a pH 8.6 in CHES buffer at 25 ˚C (referred to as Redox Buffer). In general, stock 
solutions of the substrates were diluted to stock concentrations of 400 µM and 10 µM in 
Redox buffer prior to use.   
Exploratory experiments were performed on Cary 60 spectrophotometer (Agilent 
Technologies) scanning from 200 to 800 nm every 6 seconds and a 1 cm path length. These 
were performed at either 80 or 100 µM of electron donating substrate, 0.1 µM enzyme and 
100 µM peroxide concentration. Reactions were initiated by mixing equal volumes of one 
solution containing enzyme and electron-donating substrate and another solution of 
peroxide. 
Michaelis–Menten kinetic data were obtained using a KinetAsyst SF-61DX2 Double-
mixing Stopped-Flow Spectrophotometer (Hi-Tech Limited, UK) with a 1 cm path length. 
Reactions were initiated by mixing equal volumes of one solution containing 0.1 µM C45 with 
various concentrations of electron-donating substrate, and a solution of 100 µM hydrogen 
peroxide. The initial linear portion of each trace was fit to a straight line and the gradient 
(∆Abs.Sec-1) determined using an interactive python script. The initial rates were converted 
to change in concentration over time using the relevant extinction coefficient for the 
substrate.  Then these were fit to a Michaelis–Menten curve (equation 2.2) or substrate 
inhibition (equation 2.3) using GraphPad Prism.  
p = 	 bhgq.[s]
uvC[s]
           (2.2) 




      (2.3) 
3 mg of ABTS were dissolved as green powder into buffer, protected from light and 
kept at room temperature. This was made fresh for each use and diluted to make up stock 
required for kinetic experiments. In these conditions ABTS was stable over the course of 6 
hours, however, some degradation was observed overnight. Oxidation of ABTS was 
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monitored at 405 nm (ε405nm = 36,800 M−1.cm−1) [250]. ABTS concentrations used were 1, 5, 
10, 20, 40, 80, 100, 150 µM. 
1 mg of TCP crystals were dissolved in 100 µl ethanol and then diluted to 400 µM in 
redox buffer. The concentration was determined spectroscopically (ε312 nm = 3,752 M-1.cm-1) 
[251]. In these conditions no degradation of TCP was evident, even after overnight 
incubation. Oxidation of TCP was monitored at 272 nm, monitoring the increase in dichloro-
1,4-benzoquinon (DCQ) formation (ε272 nm of DCQ - TCP = 13, 200 M-1.cm-1). TCP 
concentration used were 1, 5, 10, 20, 40, 80, 100, 150 µM [252]. 
40 mg of TBP (off-white solid pellet) was dissolved in 100 µl ethanol and then serially 
diluted to 400 µM in redox buffer. The extinction coefficients of the three UV-visible peaks 
of TBP were determined in redox buffer (316, 249 and 214 nm). This was achieved by 
recording the absorbance peaks at know concentrations of TBP in the range 1 – 150 µM, then 
using linear regression to determine the gradient. In these conditions TBP is stable over the 
course of 6 hours. Oxidation of TBP was observed at 249 nm (and 316 nm at substrate 
concentration above 70 µM) monitoring the decrease in substrate (ε249nm 1,118 M-1.cm-1, ε249 
nm 4,994 M-1.cm-1). The concentrations used were 2.5, 5, 10, 20, 40, 80, 100, 150 µM. 
Amplex red was purchased from ThermoFisher (UK). 10 mM stock solutions were 
prepared in the dark in DMSO and stored at -20 ˚C, as recommended by the supplier’s 
protocol (Amplex Red Glutamic Acid/Glutamate Oxidase Assay protocol, Invitrogen). 
Amplex red was protected from light and kept on ice throughout the experiment. 400, 20 and 
0.12 µM stocks of Amplex Red were made up in redox buffer. In these conditions little 
degradation of Amplex Red was seen after 6 hours. Oxidation of Amplex red was observed at 
575 nm, monitoring the increase of the product resorufin (ε572nm 73,000 M-1.cm-1)[253]. The 
concentrations used were 0.05, 0.5, 1.2, 2.5, 5, 10, 40, 75, 150 µM. 
40 mg of luminol was dissolved in 200 µl 1 M KOH, then 800 µl deionized water was 
added to 1 ml. It was then diluted to 400 µM in redox buffer. The extinction coefficients of 
the three UV-visible peaks of luminol were determined in redox buffer (348, 302, 221 nm). 
This was achieved by recording the absorbance peaks at known concentrations of luminol in 
the range of 1 – 150 µM and using linear regression to determine the gradient. In these 
conditions luminol is stable over the course of 6 hours. Oxidation of luminol was observed at 
302 nm (and 221 nm at substrate concentration above 70 µM) monitoring the decrease in 
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substrate absorbance (ε302nm 6,830 M-1.cm-1, ε221nm 27,760 M-1.cm-1). The concentrations used 
were 2.5, 5, 10, 20, 40, 80, 100, 150 µM. 
1 µl guaiacol was diluted to 1 ml in deionized water and then diluted to 400 µM in 
redox buffer. The concentration was determined spectroscopically (ε274 nm = 2550 M-1.cm-1) 
[254]. In these conditions guaiacol is stable over the course of the experiment. Oxidation of 
guaiacol was monitored at 470 nm monitoring the increase in tetraguaiacol formation (ε470 nm 
= 3,800 M-1.cm-1) [254]. The guaiacol concentrations used were 1, 5, 10, 20, 40, 80, 100, 150 
µM. 
1 mg o-dianisidine was dissolved in 500 µl of deionized water. After the addition of 
100 µl 1 mM KCl solution was made up to 1 ml. The concentration was determined 
spectroscopically in acid (ε251 nm = 2,550 M-1.cm-1) and then serially diluted to 400 µM in redox 
buffer  [255]. In these conditions o-dianisidine is stable over the course of the experiment. 
Oxidation of guaiacol was monitored at 440 nm monitoring the increase in oxidized o-
Dianisidine formation (ε440 nm = 11,300 M-1.cm-1)[255]. The o-dianisidine concentrations used 
were 1, 5, 10, 20, 40, 80, 100, 150 µM.  
40 mg o-phenylenediamine was dissolved in ethanol and then diluted to 400 µM in 
redox buffer. In these conditions, o-phenylenediamine is stable over the course of the 
experiment. Oxidation of o-phenylenediamine was monitored at 450 nm monitoring the 
increase in phenazine-2,3-diamine formation (ε450 nm = 16,300 M-1.cm-1) ([256] 
supplementary information). The o-phenylenediamine concentrations used were 1, 5, 10, 20, 
40, 80, 100, 150 uM. 
2.2.13 Live Cell kinetics  
To investigate C45 in vivo activity preliminary experiments were performed with whole, 
live E. coli cells. As a control, a gene of C45 without a heme binding site was produced. Both 
the pSHT C45 and C45-NH (without a heme binding site) were co-transformed into E. coli T7 
express cells (New England Biolabs, UK) with a pEC86 constitutive expression vector 
housing the Cytochrome c biogenesis system I genes and chloramphenicol resistance. The 
transformation was achieved by heatshock with a 10 second incubation at 42 ˚C. After 
incubation with shaking overnight at 37 ˚C 100 ml starter cultures were added to 1 L LB 
with carbenicillin (50 µg/ml) and chloramphenicol (34 µg/ml). Both cell cultures grew at 
similar rates and were induced with 0.5 mM isopropyl-D-1-thiogalactopyranoside (IPTG, 
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Apollo Scientific) at an OD600 nm between 0.6 and 0.7. After 3 hours of expression, activity 
assays were conducted in a 96-well format on a Synergy Neo2 Plate Reader (BioTek, UK). 
30 µl of cells were diluted in 170 µl of electron-donating substrate in redox buffer (100 mM 
KCl, 20 mM CHES at pH 8.6). The reactions were initiated with a 100 µl injection of H2O2. 
The working concentrations of electron donating substrates was 1 mM, and H2O2 was at 
2 mM in a total well volume of 300 µl. Volume-corrected spectra were obtained rapidly 
before injection, after 20 minutes and after 90 minutes. ABTS, Guaiacol, Luminol and o-
phenylenediamine were used as electron-donating substrates and they were prepared in the 
same way as in the previous section.  
As a further positive control, 500 µl of both cells expressing C45 and C45-NH were 
spun down in a microcentifuge and resuspended in 90 µl redox and 10 µl of BugBuster (Sigma, 
UK) to lyse the cells.  10 µl of lysate was added to 190 µl of redox buffer with ABTS. Reactions 
were initiated with the addition of 100 µl of H2O2 and monitored spectroscopically. The 
concentration of ABTS was 800 µM and H2O2 was 300 µM. 
  
2.3. Results 
  75 
2.3 Results 
2.3.1 Design and mutagenesis 
The template used for producing C45 (the mono-his ligated c-type heme maquette) 
was a vector containing the parent protein C46 (the bis-histidine ligated c-type heme 
maquette). These vectors are modified pMal-p4x vectors where the maltose-binding protein 
gene has been deleted, leaving the MBP periplasmic translocation signal sequence to target 
the maquette for periplasmic export. Downstream of the cleavage site for the N-terminal 
signal sequence is a hex-his tag as well as the recognition sequence (ENLYFQ|G, where 
cleavage occurs between Q and G) for Tobacco Etch Virus protease (TEV). This facilitates 
removal of the his-tag during the purification of the maquette. Primers were designed to 




Figure 2.3.1 Schematic of C46 and C45 
Figure showing the design of C46 and C45. The coloured residues in the protein sequence correspond to 
the coloured residues displayed in the schematics. The cylinders represent the helices of the maquettes with 
the grey shaded portion depicting hydrophobic residues. The red underlined sequences are the c-type heme 
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2.3.2 Expression and purification  
Protein expression proceeded as described in the methods Section 2.2.2. After four hours 
of expression the cell cultures were pelleted by centrifugation and resuspended in lysis buffer. 
Sonication was used to lyse the cells followed by clarification by centrifugation.  Nickel affinity 
chromatography was used twice: first collecting the elution containing his-tagged C45, and 
second collecting the flow-through, after the cleavage of his-tag by TEV protease. Size 
exclusion chromatography (SEC) was used as the final step of the purification running into 
redox buffer at pH 8.6. 
 
Figure 2.3.2 SEC and SDS-PAGE results for C45. The 280 nm and 400 nm SEC trace is 
shown for C45. The x-axis shows the accumulated volume (in ml). The first peak is the void volume 
eluting around 43 ml after injection. Below the trace is the SDS-PAGE results of the purification. The 
lanes start with the ladder then 15, 25 and 35% elution buffer which is a wash of proteins weakly 
associated to the first nickel affinity column. The “TEV FT” 1 and 2 lanes are early and late in the flow 
through from the second nickel affinity column after cleavage of the his-tag. The “TEV Ni El” lanes show 
the elution from the second nickel affinity column, containing contaminants that bind to nickel and un-
cleaved C45 sample protein, at 25 35 and 100% elution buffer. Lanes labelled as P1 and P2 are the two 
peaks on the SEC trace. Elution from the first nickel affinity column after the TEV elution” is the elution 
from the second nickel column. The remaining bands are fractions from the SEC purification of the flow-
through from the second nickel column. 
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The new maquette, C45, expressed and incorporated heme well. Figure 2.3.2 shows a size 
exclusion chromatography trace and SDS-PAGE of a purification of C45. The split peak seen 
in SEC was also seen in the parent maquette but it is clear from the SDS-PAGE that it is the 
same protein in both peaks. 
2.3.3 UV-visible Spectroscopy 
The UV-Visible spectra showed a change in the Soret λmax value between the bis 
histidine-ligated parent protein C46 and the designed monohistidine-ligated C45. This 
suggests that the coordination state of the heme had changed. The ferrous (Fe2+) spectrum 
for C45 exhibits a split Soret peak, indicating a mixed spin state population.  
 
Figure 2.3.3 Maquette UV- visible spectra.  
(A) Shows a comparison of the ferric protein spectrum of C45 and C46. (B) Shows a comparison of 
the ferrous protein spectrum of C45 and C46. (C) Is the reduced and oxidised spectra of C45 during the 
Pyridine hemochrome assay showing the characteristic α-band absorbance at 550 nm 
 
C45 with imidazole added shows a similar peak to the bis-histidine ligated C46. The split 
peak of the ferrous spectrum of C45 is similar to the spectrum of Cytochrome c’. Cytochrome 
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c’ is a histidine ligated c-type hemeprotein that has a water molecule bound to the distal heme 
face in the resting state. It exhibits Soret λmax values of at 425 nm and 435 nm in similar buffer 
conditions [257]. The similarity Cytochrome c’ and the changes observed on mix C45 with 
imidazole suggest that the distal site is now ligated with water. The pyridine hemochrome 
concentration assay showed a characteristic c-type heme peak at 550 nm the (Q-band α peak). 
2.3.4 CD spectroscopy 
The CD melt and cool showed that the activating mutation had not destabilized the 
protein. It is still extremely robust with a TM=85 ˚C, similar to C46 (TM = 84 ˚C). C45 
refolds after denaturation to a similar helical content of the starting structure. The CD traces 
suggest that the protein is not completely denatured even at 95 ˚C as there is still some 
helical signal. The 222 nm melt and cool does not plateau indicating incomplete denaturation. 
Performing the same experiments with different concentrations of urea lowered the melting 
temperature of the protein (Figure 2.3.4.C and Figure 2.3.5). This highly helical signal 
demonstrates that the C45 has strongly defined secondary structure and is folded at room 
temperature.  
 
Figure 2.3.4 CD results for C45. (A) CD spectrum for C45. Scans of melts for 5-95 ˚C are 
displayed as solid lines going from red to yellow. Scans of cooling experiments from 95-5 ˚C are 
displayed as dashed lines from light to dark blue. (B) the mean residue ellipticity (θ) at 222 nm during 
both melt and cool. Table C gives the results for C45 with the Tm of unfolding at 3 urea concentrations. 
All experiments were conducted with 10 µM protein in Redox buffer at pH 8.6. 
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Figure 2.3.5 CD spectrum of C45 with urea. (A), (B) and (C) show CD spectra at increasing 
temperature for C45 in 2, 4 and 6 M urea respectively. (D) shows the thermal melt trace at 222 nm for 
the three different urea concentrations. 
2.3.5 NMR 
The high melting point observed in CD experiments encouraged further structural 
investigation. Regrettably, with many maquette proteins it is difficult to acquire atomistic 
structural information as they do not readily crystallise. The long and flexible loop regions 
are likely to be a key reason why the maquettes used in this project have not formed crystals. 
Maquettes are also flexible, dynamic and lack the design of rigorous core packing interactions 
seen in more rigid coiled-coil structures [46]. Both traits present a challenge to crystallisation. 
As a small soluble protein, NMR spectroscopy on a 15N enriched sample could offer a means 
to determine high resolution structural information. In protein NMR, iron (III) causes 
paramagnetic broadening of the spectra. With this in mind, both Fe3+ heme and metal-free 
porphyrin-containing samples were produced. Spectra of C45 with and without iron can be 
seen in Figure 2.3.6. 
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Figure 2.3.6 NMR of C45 
(A)1D 1H NMR spectra C45 with Fe3+ (blue) and demetalated C45 (red), * denotes up-field shifted 
methyl peaks. (B, C) 1H-15N SoFAST HMQC spectra of C45 (C) and demetalated C45 (B). (D) 
Expansion of (C) showing the numerous dispersed weak peaks.  
 
In the demetalated 1D 1H NMR spectrum, three indole NH peaks are clearly resolved 
(corresponding to W8, W43 and W80). In addition, several up-field shifted methyl peaks are 
clearly visible indicative of core structuring. In the Fe3+ coordinated C45, only a single 
tryptophan resonance is visible. This may be cautiously assigned to either of the tryptophans 
separated from the paramagnetic broadening effects of the iron (W8 or W80) or over-lapped 
peaks for both. The helices of C45 have near identical sequences. This has contributed to the 
broadening of peaks in the HSQC experiments. Peaks corresponding to the random coil 
chemical shifts of glycine (GG and SG pairs) and serine found in the connecting loops are also 
W8/W43/W
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observed. A number of low intensity resonances in Figure 2.3.6.C, can be seen as a 
consequence of dynamic conformational heterogeneity and paramagnetic broadening from the 
Fe3+. This is consistent with observations from other related maquette systems. C45 differs 
from intrinsically disordered or unfolded proteins showing numerous dispersed weak peaks 
(Figure 2.3.6.D) [66].  
C45 has a highly repetitive sequence and a significant degree of conformational flexibility, 
which has limited the structural information that can be gained from NMR and attempts at 
crystallographic studies. These results, in combination with CD spectroscopy, show C45 to 
be similar to other reported maquette proteins. C45 clearly has defined secondary structure, 
randomly coiled loops and some core packing. 
2.3.6 Molecular Dynamics  
Molecular dynamics (MD) simulation is a powerful tool used for assessing protein 
dynamics. For easy compatibility with other software and to make use of GPU acceleration, it 
was necessary to compare running MD simulations with both GROMACS and AMBER16 
using the CHARMM27 force field. Both AMBER and GROMACS simulations were completed 
successfully. A comparison of the final structures and root-mean-square deviation (RMSD), 
from the starting structure, throughout the trajectory is displayed in Figure 2.3.7. The average 
structural identity during the simulation was very high, QH = 0.8347 (SD = 0.0367). A similar 
value could be expected when comparing different frames of the same simulation. A QH of 1 
is expected for identical structures. Both simulation methods are in agreement, which is 
unsurprising since both programmes use the same force field.  
The starting atomic coordinates for the MD were generated computationally, partly 
using a homology based on a related maquette X-ray structure. The model has been used 
previously and was modified to match the sequence of C45 [69]. The MD results show a 
stable RMSD over 100 ns around 1.5 Å. Generally, this is considered to indicate that the 
model is in an energy minimum and is a value you would expect when simulating an 
experimentally derived structure of a natural protein.   
Four additional repetitions of the AMBER MD simulations were run for C45. The MD 
results for C45 show a stable four-helical bundle with dynamic loop regions. The helices show 
little structural perturbations. There are two kinks in the α-helical structure, one on the fourth 
helix at the heme binding site and one on the second helix on the other side of the bundle. 
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The well-defined helices and dynamic loop regions are similar to natural four-helix bundles 
like cytochrome b562 [50].  
The heme propionates face into the solvent and much of the γ and δ-heme edge are 
also solvent accessible. The bulk of the heme is buried in the hydrophobic core of the bundle. 
The site of the distal histidine ligation in the parent maquette, C46 H46, is now a 
phenylalanine (F46), which contributes further to the hydrophobic nature of the distal heme 
site. The MD simulations show that F46 in C45 is in a position to form π-stacking interaction 
with the heme. In natural heme proteins π-stacking interactions have been seen to be 
important in stabilising ligand binding as well as modulating the redox potential of the heme 
[118].  
 
Figure 2.3.7 C45 MD comparison. 
 (A) Is a comparison between the last frame of the GROMACS (Orange) and AMBER (Blue) 
simulations, this is after 100 ns of simulation. (B) Shows a comparison of AMBER and GROMACS 
RMSD over the course of the simulation. Each RMSD is calculated against its first frame using only 
backbone atoms. The Average values of the RMSD for AMBER was 1.550 (SD = 0.2177) and for 
GROMACS was 1.387 (SD = 0.1832). 
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Figure 2.3.8 MD structures of C45. (A) and (B) are images of the same frame from MD simulation 
of C45 for two different viewpoints. In (A) residues Q45, F46 and K52 and the direction of the helices 
are labelled. (C) is from the MD simulation where a large movement of the second helix occurs. Hydrogen 
atoms are present but not depicted.  
 
Q45 and K52 are polar residues that can closely associate with the heme during MD and 
could play a role in stabilising charge during the reactive cycle (labelled in Figure 2.3.8.A). 
Q45 can be seen as close as 5.8 Å to the heme iron. K52 forms hydrogen bonds with the heme 
propionates, with the ammonium nitrogen around 6 Å from the heme edge. The pH 
dependence of C45 ‘s spectroscopic and kinetic profile suggest a residue with a pKa of 9.1 is 
involved in the reactive cycle. Lysine is the most likely candidate considering its proximity to 
the heme.  
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In one of the repeated MD runs there is a notable shift of the second helix, directly above 
the heme. This was only seen once and seemed to be caused by movement in the loop region 
causing a shift in the helix. Figure 2.3.8.C shows the cavity that opens up above the heme as 
a result of this movement. The helix movement occurred after 60 ns and persisted to 100 ns.  
2.3.7 Preliminary computational folding with Rosetta  
With new, timely advances in protein structure prediction, an attempt was made to 
fold C45 with the Rosetta ab initio folding software. Baker et al. have constantly demonstrated 
that Rosetta is extremely successful at predicting the structure of many natural proteins even 
before an experimental structure is made public [30, 258, 259].  It achieves this success using 
primary amino acid sequences alongside small structural fragments from the PDB. At the time 
of writing, these predictions seldom include cofactors. Regarding examples that do implicitly 
include cofactors, modelled cofactors often become bespoke descriptions of individual 
systems rather than general solutions. Artfully creating Rosetta compatible parameters for c-
type heme was outside the scope of this project and, to date, there are no published examples 
of ab initio-folded heme proteins to provide hope that it is an endeavour worth pursuing. With 
this in mind, it is necessary to state that the results discussed here are very much preliminary.  
Despite some considerable effort, all simulations could only run successfully with the 
histidine rotamer singly protonated on Nε nitrogen (HIE not HID in the AMBER naming 
convention). This shortcoming meant that all simulations with the heme contain a steric clash 
between the proximal histidine ligand and the heme iron. This clash, along with other 
restraints imposed to bind the heme in the correct orientation, have resulted in less negative 
Rosetta scores for simulation with heme than without. It was not possible to calculate a 
comparable Rosetta score for the existing C45 MD structure because of the implementation 
of the constrains to bind the heme. The results for both the simulation with and without the 
heme do not appear to have converged on a single low energy structure. For a converged 
simulation, the plots of the Rosetta score against the RMSD (of the structure compared to 
the native or lowest energy structure) should form a funnel converging on low energy and 
low RMSD structures. The plots in the bottom right of Figure 2.3.9 and Figure 2.3.10 should 
look more like this funnel with the lower scores sampling a reduced number of more similar 
conformations. 
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Figure 2.3.9 Rosetta structures with heme.  
The first structure (top left) is a MD snapshot of the existing model of C45. The subsequent structures are 
the results of the Rosetta ab initio calculation they are named by their Rosetta score, ranked 1 to 10,000.  
The second number following the black name/rank for each structure is the RMSD (Å) compared to the 
existing MD model of C45. The third number is the Rosetta score for that structure. The structures are 
coloured by residue number, blue for the first to red for the last. Heme is in grey. The white numbers on 
the structures are the helix number. The plot in the bottom left is a comparison of all the Rosetta results, 
red points denoting the structures displayed in this figure. 
 
The folding simulations with heme resulted in less realistic structures. Two of the top 
ten lowest energy structures did not manage to fold into a four-helix bundle, as one helix was 
extended away from the bundle in these cases. The top scoring results could be grouped into 
three main folded topologies (not including extended chains). The first is shown in Figure 
2.3.9.2 where the helices are all linked by “small” loops. The longer loop does not reach 
diagonally across the bundle. The heme propionates in this orientation face directly into the 
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bundle, which seems unlikely a native-like structure. The second is shown in Figure 2.3.9.4 
& 33 and exhibits the same overall topology as the existing C45 model. The longer loop links 
helix 2 and 3 diagonally across the bundle with the heme propionates facing out to the solvent. 
The third topology is shown in Figure 2.3.9.5. In this model, helix 2 and 3 are swapped relative 
to each other, the longer loop still linking them diagonally across the bundle, with the heme 
propionates facing out into the solvent. 
The folding simulations without heme resulted in structures with the same three 
topologies as the simulations with heme.  The first in Figure 2.3.10-1, without the diagonal 
long loop across the bundle, comprised 7 of the top 10 lowest energy structures. Both the 
second and third helix topologies with the long diagonal loop were also seen in the top 10 
lowest energy results. Figure 2.3.10.2 and 15 are similar to the existing C45 model. Figure 
2.3.10-6 shows the third topology with helix 2 and 3 swapped. The fourth helix of all obtained 
structures would need to move considerably to accommodate a heme group.  
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Figure 2.3.10 Rosetta structures without heme. 
 The first structure (top left) is a MD snapshot of the existing model of C45. The subsequent structures 
are the results of the Rosetta ab initio calculation. They are named by their Rosetta score, ranked 1 to 
10,000.  The second number following the black name/rank for each structure is the RMSD (Å) 
compared to the existing MD model of C45. The third number is the Rosetta score for that structure. The 
structures are coloured by residue number, blue for the first to red for the last. The white numbers on the 
structures are the helix number. The plot in the bottom left is a comparison of all the Rosetta results with 
the red points denoting the structures displayed in this figure. 
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2.3.8 Kinetic assays for Ping-pong fitting  
To test the peroxidase activity of C45 or C46, they were simply mixed with an excess 
of hydrogen peroxide (1 mM H2O2, 0.5 µM C45 or C46) at room temperature in a small 
volume cuvette. The reaction was observed using UV-visible spectroscopy, monitoring the 
Soret absorbance band corresponding to the most intense heme π-π* transition. There was 
no significant change in the UV-visible spectra of the bis-histidine ligated maquette, C46, on 
the addition of peroxide. Conversely, with C45 there is a red shift of the Soret λmax (406 to 
411 nm) and bleaching of the heme signal. This bleaching corresponds to oxidative damage 
of the heme and is likely a result of generating heme reactive species (compound I and II) in 
the absence of an electron donating substrate. Compound I and II are highly redox active and 
capable of oxidising protein or heme, leading to the degradation of the Soret absorbance.  
 
 
Figure 2.3.11 ABTS reaction with C45 
Panel (A) Shows the structure of ABTS and Radical cation in green, with equation below. 
(B) Shows the visible absorbance changes on addition of H2O2 to C46 (left) and C45 (right). The red 
line is 0.1 µM protein. The purple line is Protein with ABTS (1 mM). The green line is 120 seconds after 
the addition of 1 mM H2O2 to 1 mM ABTS and 0.1 µM protein 
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ABTS, a widely-used electron donating peroxidase substrate, was used to investigate 
the peroxidase activity of C45. ABTS oxidation generates an intensely coloured ABTS•+ radical 
cation allowing the reaction to be monitored using UV-visible absorption spectroscopy. In the 
absence of a catalyst, solutions of H2O2 mixed with ABTS exhibit no spectroscopic changes 
over the course of the experiments at room temperature and pH 8.6. Figure 2.3.11.B shows 
the spectral changes on the addition of hydrogen peroxide to C46 and C45. C46 shows almost 
no peroxidase-type activity, whereas C45 efficiently oxidises ABTS to the corresponding ABTS 
radical cation. 
The reaction of ABTS with C45/H2O2 can be used to study the kinetic mechanism of 
this de novo peroxidase. Steady-state assays were conducted by individually varying the 
concentration of both substrates (ABTS and H2O2) at the optimum pH (see Section 2.3.9) and 
recording the initial rates for ABTS oxidation. Taking a phenomenological approach, the data 
fit best to a standard ping-pong mechanism. The general form of the ping-pong mechanism 
is seen in scheme in Figure 2.3.12.A . It involves the modification of the enzyme (E) by 
substrate A forming E’ which is then able to turn over a second substrate B. In the standard 
mechanism A and B are not bound in the enzyme at the same time.  
 
Figure 2.3.12 Ping-pong kinetics C45 
(A) Shows a general scheme of the ping-pong mechanism  
(B) Shows the result of ping-pong fitting on the steady-state kinetics of various concentrations of ABTS 
and H2O2. On the right is an Eadie-Hofstee plot of the result. 
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The fit results for C45:  
kcat = 1200 s 
Km(ABTS) = 379 μM   Km(H2O2) = 94 mM 
kcat/Km(ABTS) = 3.2 x 106 Ms  kcat/Km(H2O2)  = 1.3 x 104 Ms 
 
Equation 2.4 is the equation for the ping-pong mechanism that can be derived using the 
King-Altman Method and was subsequently used to perform the fitting [260]. Under the 
steady-state approximation, equation 2.4 describes the rate (v) using the Michaelis–Menten 
constants Km(A) and Km(B) for substrate A and B respectively. The results of the fitting for C45, 
displayed above, boasts the best yet recorded catalytic efficiency (kcat/KM) for a de novo enzyme. 
Å = [E]l$nJ& 	
[w]É[x]É
uv(Ñ)[w]ÉCuv(Ö)[x]ÉC[w]É[x]É
         (2.4) 
 
2.3.9 pH Dependence  
The pH-dependence of ABTS oxidation by C45/H2O2 was explored whilst varying the 
pH between 6 and 11. The results of the pH dependence assays can be seen in Figure 2.3.13. 
The optimum pH for catalytic activity for C45 was determined by plotting kcat(ABTS)* of the 
ABTS oxidation against pH. The data was fitted to a double pH curve (equation 2.5). The 
Optimum pH was found to be 8.6 for ABTS. The reactions for the pH dependence of H2O2 
were performed using a stopped-flow spectrophotometer and required high concentrations of 
ABTS. At high pH there appeared to be a problem with obtaining reliable and statically 
relevant results, possibly due to stability problems of high concentrations of ABTS at these 
pH values.  
The two pKa values from the double pH curve fitting (pKa1 and pKa2 in equation 2.5) 
were calculated to be 8.0 and 9.1. The lower pKa is likely to arise from the deprotonation of 
H2O2 in the formation of compound 0. The second pKa is expected to be the deprotonation of 
a residue that participates in the reactive cycle in some way. From the MD simulations, this 
is most likely to be K52. 
Ü(á) = 	 àbÉ.fl
(âägT	–	z)åCbT	Càbc.fl(z	ç	âägc)å
fCfl(âägT	–	z)C	fl(z	ç	âägc)
      (2.5) 
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pH kcat* (s-1) KM (µM) kcat/KM (M-1s-1) 
6 0.34  ± 0.02 1.81  ± 0.66 1.88 ± 0.71 x10 5 
7 0.47  ± 0.03 0.41  ± 0.23 1.15 ± 0.65 x10 6 
8 0.91  ± 0.07 1.8  ± 0.69 5.06 ± 1.98 x10 5 
8.5 1.11  ± 0.06 2.22  ± 0.61 5.00 ± 1.40 x10 5 
9 1.05  ± 0.13 7.14  ± 3.18 1.45 ± 0.67 x10 5 
10 0.55  ± 0.02 0.72  ± 0.16 0.76 ± 1.74 x10 5 
11 0.53  ± 0.05 4.07  ± 1.42 1.30 ± 0.46 x10 5 
Table 2.3.1 pH dependence Michaelis–Menten fit values. The concentration of ABTS was varied 
with C45 and H2O2 and the initial rates fitted to Michaelis–Menten curve. The kcat* is because reactions 
were conducted at rate limiting H2O2 concentrations (100 µM). The ± error are the standard deviation. 
 
Figure 2.3.13 pH dependent steady-state kinetics. (A) shows the Michaelis–Menten results for 
reactions with C45 H2O2 and various concentration of ABTS at different pH. (B) show the pH 
dependence of the kcat* fitted to a double pH curve using equation 2.5. (C) is the pH dependent changes to 
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pH EM1  EM2  
6.0 -166.2 ± 3.5 -107.3 ± 3.2 
7.5 -187.2 ± 6.5 -126.2 ± 5.9 
8.6 -173.1 ± 0.4 NA 
10.0 -208.3 ± 1.3 NA 
Table 2.3.2 C45 pH dependent midpoint potentials (EM). Values are shown in mV vs NHE. OTTLE 
results have been fit to are displayed for C45 at four pH values. This data was collected by Daniel Watkins 
[70]. The error bars show the standard deviation. 
2.3.10 Temperature-Dependent kinetics  
The high thermal melting temperature observed in CD experiments made it clear that 
C45 is structurally tolerant to temperature. To test the effect increasing the temperate had on 
the activity of C45 its kinetic assay with ABTS and H2O2 were performed at various 
temperatures. Increasing the temperature increased both the kcat* and the KM. The maximum 
kcat* and KM were recorded at 70 ˚C (seen in Table 2.3.3). The data for this experiment was 
collected by Daniel Watkins [70]. 
 
Figure 2.3.14 Temperature-Dependent steady-state kinetics. Reactions were performed with 
ABTS, 0.25 µM C45 and 100 µM H2O2. Fit values from the initial rates are shown in Table 2.3.3. Error 
bars are the standard deviation.  
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20 0.61  ± 0.01 1.72  ± 0.15 3.53  ± 0.31 x10 5 
30 0.94  ± 0.01 2.16  ± 0.13 4.35  ± 0.27 x10 5 
40 1.62  ± 0.06 4.55  ± 0.72 3.56  ± 0.58 x10 5 
50 2.04  ± 0.11 5.57  ± 1.22 3.66  ± 0.83 x10 5 
60 2.38  ± 0.07 5.26  ± 0.58 4.52  ± 0.51 x10 5 
70 2.86  ± 0.17 10.8  ± 2.09 2.65  ± 0.54 x10 5 
Table 2.3.3 Temperature dependence Michaelis–Menten fit values. The concentration of ABTS 
was varied with C45 and H2O2 and the initial rates fitted to Michaelis–Menten curve. The kcat* is because 
reactions were conducted at rate limiting H2O2 concentrations (100 µM). The ± error are the standard 
deviation. 
2.3.11 Computational binding screen 
A computational binding screen was performed on MD snapshots of C45 and 19 small 
molecule peroxidase substrates. The Bristol University Docking Engine (BUDE) was used to 
search for low energy binding conformations. Each generated position of a ligand on the 
surface of the protein is termed a pose. The top 50 binding poses for each ligand were then 
tested in a 5 ns MD simulation. For TCP, only the top 40 poses were selected, as all top 50 
were in the same locus. This resulted in 940 (18 x 50 + 40) starting structures for simulation. 
18 starting structures produced badly minimized simulations that crashed during the 
production MD and were not investigated further. The 922 completed 5 ns MD trajectories 
for the 19 ligands represent approximately 77 days of GPU time. 
 
 
Figure 2.3.15 BUDE process illustration. Ten MD structures were used as the input into the 
BUDE calculation. The green dashed box represents the BUDE calculation which iterates through 
millions of binding poses using a genetic search algorithm. Each generation is made up of a cycle of 
generating or refining the binding poses, scoring and then selecting the highest energy poses to be used in 
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The results from the computational binding screen reveal several proposed binding hot 
spots close to the heme. To probe the interaction of substrates with C45 further and to discern 
which ligands share similar binding loci, a 3D clustering analysis was performed. Figure 
2.3.16 shows a centroid representation of ligands grouped by the results of the clustering 
analysis at the end of the 5 ns trajectory. The pivot table in Figure 2.3.16 catalogues the 
binding hot-spots for each ligand.  
Successful ligand poses in this context are counted as those that are still associated 
with the protein at the last frame of the 5 ns MD simulation. An association with the protein 
was defined as the heavy atoms of the ligand within 5 Å of any part of the protein or heme. 
The full structures of ligands at the end of the 5 ns production MD are displayed in Figure 
2.3.18 and Figure 2.3.19.  
Although somewhat extended, cluster 3 (Figure 2.3.16) is the most frequent and 
widely sampled location with 52% of successful ligands bound in that site after MD. It is 
above the heme between helix 1 and 2 of the protein. The small phenolic substrates (TCP, 
TBP, Guaiacol), o-Phenylenediamine and 1,4-Dimethoxybenzene have a strong preference for 
binding on the side of cluster 3 closest to heme. This population within group 3, that is 
situated close to the heme, could be defined as the small phenolic binding pocket (SP pocket), 
although non-phenolic small molecules also bind. The majority of Luminol, o-Dianisidine, 
p-Anisidine and Isoniazid binding poses are also found in the SP pocket. The centre of mass 
of ligands in this position is around 10 Å from the heme iron, or around 7 Å from substrate 
to heme edge. These small non-charged substrates sit deep in the protein, in a location 
centered over leucine 22, shown in red inside the blue box in Figure 2.3.19. The distance 
between heavy atoms of ligands and the two closest tryptophan residues is approximately 11 
Å (W43) and 22 Å (W8). 287 of 353 poses in the SP pocket before MD were found in cluster 
3 after MD. Luminol, Isoniazid and 1,4-Dimethoxybenzene were more likely to migrate into 
cluster 12 during the simulation. 27 luminol poses found in the SP pocket before the MD 
had dissociated after MD, indicating that luminol may bind less stably than TCP, where all 40 
poses persisted without moving. Veratrole alcohol and Ascorbate have been categorized by 
the analysis as within cluster 3 but are closer to cluster 12, and are generally around 20 
Å from the heme iron.  
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Figure 2.3.16 Binding Screen Clusters 
Results from 3-dimensional cluster analysis of the last frame of 5 ns MD. Each dot represents the centre of 
mass of a ligand. The number assigned to each cluster is arbitrary. Ligands that were associated with the 
protein but not assigned a cluster are not displayed and given cluster number -1. 
Below is a pivot table comparing ligands and assigned clusters. Ligands associated with protein but not 
clustered are given cluster number -1. Taking p-Anisidine as an example, 44 top binding poses were associated 
with to the protein at the end of 5 ns in the cluster 3 locus, 3 in other groups, 1 associated but not grouped and 
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The second most frequently sampled binding pocket is cluster 6. It makes up 6.1 % of 
successful poses and is situated on the opposite side of the protein to the heme between helix 
1 and 3 of the model (Figure 2.3.16). The centres of mass of the ligands in cluster 6 are on 
average 27.1 Å from the heme iron or about 22 Å from the heme edge. Electron transfer at 
this distance is not impossible, but would be expected to be much slower [83]. This cluster 
is very close to the two tryptophan residues (<10 Å) at the further end of the maquette from 
the heme (W8 and 80).  
Clusters 5 and 8 make up 5.4 % of successful hits and are situated in a cavity between 
helices 3 and 4 (Figure 2.3.16). Here TPB, Guaiacol, Amplex Red and Veratrole alcohol 
associate stably after 5 ns of MD. The centre of mass of ligands in this group are on average 
11.9 Å away from the heme iron or around 6 Å from substrate to the heme edge. The distance 
between heavy atoms of ligands and the closest tryptophan residue is approximately 11 
Å (W43). 
Clusters 1 and 2 are in a similar position at the heme edge or interacting with the 
distal histidine. Combined, these groups make up 5.2 % of successful poses. Cluster 1 and 
2 are found on the δ and γ heme edges respectively. The red box within Figure 2.3.19 is a 
heat map of heme atoms and the frequency of close contacts with ligands displayed. This 
analysis indicates that ligands that interact with heme do so mainly on the δ and γ heme 
edges. In general, the larger ligands displayed less well-defined binding modes. For ABTS, 
33 of the top binding poses were still associated with the protein after 5 ns but the majority 
(23) were defined by the analysis as unclustered (cluster -1). Reactive blue 4 follows a 
similar trend. 
The results of the BUDE docking calculation show several small molecule binding sites 
on C45. The stability and promiscuity of substrates bound in the SP pocket within cluster 3, 
as well as its proximity to the heme, make this an extremely convincing candidate binding 
site. To validate these computational results, this pocket should be the target for further 
computational and experimental studies, producing mutants that perturb or enhance the 
substrate binding in this site. From the frequency of close contact analysis, residues L22, E19 
and E47 are the three top candidates for mutation. The fact that this pocket does not appear 
to be highly selective is in line with very similar experimentally derived KM values for different 
substrates (Table 2.3.4).  
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Cluster 6 is most likely too far from the heme to be kinetically relevant, unless 
tryptophan radicals on W8 and W80 are formed prior to binding, thus mediating long-range 
electron transfer. The cluster 5 binding site is within range for rapid, direct electron transfer 
to the heme and is just 6 Å from the α-heme edge. This could also be a secondary candidate 
for further computational and experimental study. Clusters 1 and 2 that make direct contact 
with the heme could also be experimentally relevant, even though they are less frequently 
sampled computationally. The proximity to the heme edge means that electron transfer would 
be rapid and even highly transient interactions with electron donating substrates could result 
in successful electron transfer. This close but transient interaction could also explain the lack 
of variation in experimentally derived KM values. As discussed in Section 1.7 most natural 
peroxidase are generally thought to bind small molecule substrates near the heme edge. These 
binding results support this trend with a number of ligands remaining in clusters 1 and 2 
close to the heme over the duration of the 5 ns MD simulation.  
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Figure 2.3.17 Structures of small molecule ligands 
Structures of ligands used in the computational binding screen protonation states taken at pH 8.6.  
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Figure 2.3.18 Binding screen results. An overlay of ligands associated with protein after 5 ns is 
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Figure 2.3.19 Binding screen results continued. An overlay of ligands associated with protein 
after 5 ns is shown for each ligand. The red and blue boxes show the results of calculating the frequency of 
close contacts with ligands for the heme atoms and all residues respectively. 
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2.3.12 Substrate promiscuity  
Like natural peroxidases, C45 oxidises a broad range of organic substrates. This section 
details the Michaelis-Menten kinetic analysis of a number of substrates that are oxidised by 
C45 and others for which C45 displays little to no activity. The methods for these experiments 
are detailed in Section 2.2.12. Unless otherwise stated, reactions with C45, electron-donating 
substrates and H2O2 were carried out in redox buffer (100 mM KCl, 20 mM CHES and pH 
8.6), at room temperature (298 K) and with the addition of H2O2 (100 µM final concentration) 
to initiate the reaction. This concentration of H2O2 was used to limit heme degradation which 
is especially evident with poorly reacting substrates and at low substrate concentrations. The 
observed kcat for these reactions where H2O2 is at a rate limiting concentration are denoted as 
kcat*. Rate limiting concentrations of peroxide meant conducting the experiments to fit to 
ping-pong reaction mechanism was not possible. High background oxidation of the substrate 
and product degradation also become problematic at high H2O2 concentrations. 
The substrates for which it was possible to obtain Michaelis-Menten kinetics for 
C45/H2O2-catalysed oxidation were (in order of redox potential): Cytochrome c, o-
Phenylenediamine, Amplex Red, Guaiacol, Luminol, o-Dianisidine, 2,4,6-tribromophenol 
(TBP) and 2,4,6-trichlorophenol (TCP). Homovanillic acid, p-Anisidine and Orange II were 
oxidised by C45 but experimental complications made it difficult to characterise fully. 
Homovanillic acid is not stable in redox buffer at pH 8.6. A convenient wavelength for 
monitoring substrate depletion in p-Anisidone and Orange II. 4-Aminobenzoic Acid 1,4-
Dimethoxybenzene, Veratrole Alchohol were oxidised poorly or not at all by C45. 
2.3.12.1 Cytochrome c 
Cytochrome c (Cyt c) is a small soluble redox-active protein found in the inner 
mitochondrial membrane of eukaryotes. Its primary role is in the electron transport chain, 
transferring electrons from the Cytochrome c-oxidoreductase (Complex III) to Cytochrome c 
oxidase (Complex IV). At pH 8.3 it has a redox potential of +261 mV (vs SHE) [261]. In S. 
cerevisiae it is the natural substrate of Cytochrome c peroxidase (CcP) which oxidises Ferrous-
Cyt c (Fe2+) to Ferric-Cyt c (Fe3+). Over the course of one peroxidase catalytic cycle, two 
electrons are required from 2 Ferrous-Cyt c’s, to reduce both compound I and then II. Figure 
2.3.20A shows the general reaction scheme as well as illustrating the complimentary surface 
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charges of the two proteins. The complementary surfaces may facilitate electron transfer and 
transient binding.  
Reactions carried out in the absence of peroxidase (C45) result in the Cytochrome c 
being slowly oxidised. This background does not significantly impact steady-state 
experiments at this low concentration of hydrogen peroxide. The steady-state kinetics for 
ferrous-Cytochrome c oxidation are found in Figure 2.3.20.D. The concentration of ferrous-
cytochrome was varied between 0 and 50 µM and results fit a simple Michaelis-Menten model. 
C45 has a kcat(cyt c) at limiting H2O2 concentration (kcat*(cyt c)) of 0.51 ± 0.01 s-1 and a KM(cyt c) of 
1.2 ± 0.6 μM resulting in a kcat*/KM(cyt c) of 4.3 ± 2.1 x 105 M-1s-1. This catalytic efficiency 
(kcat/KM) is two orders of magnitude lower than the natural enzyme and substrate 
combination (CcP and Cytochrome c pH 6) [262]. A full comparison of enzyme kinetics for 
all substrates tested is found in Figure 2.3.30. 
 
 
Figure 2.3.20 Cytochrome c oxidation with C45. 
(A) The reaction of Cytochrome c with C45 with protein surface representations showing blue as 
positive and red as negative. (B) The reaction word equation between ferro-cyctochrome c and C45. (C) 
UV-visible spectral changes occurring on mixing 250 nM C45, 100 µM Cytochrome c and 100 µM H2O2. 
“T:x” is the time in seconds from initial mixing. 
(D) Steady-state kinetics at (rate-limiting) 100 µM H2O2, fitted to a Michaelis–Menten curve. 
Steady-state data from this figure was collected with Dan Watkins [70] 
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2.3.12.2  o-Phenylenediamine 
o-Phenylenediamine (oPDA) is a common small molecule peroxidase substrate. 
Product formation can be monitored spectroscopically at 450 nm where 2,3-
diaminophenazine absorbs. Figure 2.3.21.A shows the reaction scheme, two molecules of o-
Phenylenediamine are required per peroxidase cycle. o-Phenylenediamine was stable over the 
course of the experiment at pH 8.6 and mixing with H2O2 in the absence of C45 did not 
produce any significant oxidation. It has a redox potential of +400 mV at pH 7 [263]. In the 
computational binding study with C45 (Section 2.3.11) it was predicted to bind close to and 
above the heme (cluster 3). 
 
Figure 2.3.21 o-Phenylenediamine oxidation with C45. 
(A) The reaction of 1 o-Phenylenediamine (oPDA) dehaloperoxidase producing primary product 2,3-
diaminophenazine (B) UV-visible spectral changes occurring on mixing 100 nM C45, 100 µM o-
Phenylenediamine and 100 µM H2O2. “T:x” is the time in seconds from the initial mixing. (C) Steady-
state kinetics at (rate-limiting) 100 µM H2O2, fitted to a Michaelis–Menten curve. 
 
Steady-state kinetics were collected by monitoring product (2,3-diaminophenazine) 
formation at 450 nm on a stopped-flow spectrophotometer. The steady-state kinetic analysis 
of C45 with o-phenylenediamine gave a kcat* of 1.1 ± 0.03 (s-1), a KM of 6.2 ± 0.7 (μM) and 
kcat*/KM of 1.8 ± 0.19 x105 (M-1s-1). The C45’s catalytic efficiency of oPDA oxidation is an 
order of magnitude lower than the reaction with HRP. This is down to C45’s low kcat* being 
matched by a similarly low KM, whereas HRP has a much higher kcat but also a high KM. 
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2.3.12.3 Amplex Red 
Amplex Red (AmR) is a peroxidase substrate that, after peroxidase-induced 
dealkylation, produces a highly fluorescent product resorufin. Resorufin also produces a 
distinct absorption spectrum allowing the reaction to be followed by the change in absorbance 
at 572 nm. Amplex Red was stable over the time course of the experiment at pH 8.6 and 
mixing with H2O2 in the absence of C45 did not produce any significant oxidation. It has a 
redox potential of +600 mV (pH 7.4 [264]). In the computational binding study with C45 
(Figure 2.3.16), Amplex red had a high number of binding sites that remained associated with 
C45 (45/50) after the molecular dynamics simulations. Fourteen of these bound far from the 
heme (cluster 6), sixteen in clusters close to the heme (clusters 3 and 6), and four associated 
with the heme edge (cluster 1).  
 
Figure 2.3.22 Amplex Red oxidation with C45 
(A) The reaction of amplex red and C45 producing resorufin (B) UV-visible spectral changes occurring 
on mixing 100 nM C45, 75 µM amplex red and 100 µM H2O2. “T:x” is the time in seconds from initial 
mixing. (C) Steady-state kinetics at (rate-limiting) 100 µM H2O2, fitted to a Michaelis–Menten curve 
 
The kinetic analysis of C45 with Amplex Red gave a kcat* of 0.41 ± 0.01 (s-1), a KM of 
0.53 ± 0.04 (μM) and kcat*/KM of 7.8 ± 0.65 x105 (M-1s-1). When compared to HRP (kcat*/KM 
= 8.1 ± 1.06 x106 M-1s-1, pH 7.4) the catalytic efficiency is an order of magnitude lower [265]. 
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2.3.12.4 Guaiacol 
Guaiacol is a small phenolic molecule that has a rich history as a peroxidase substrate. 
The production of tetraguaiacol is monitored by the absorbance change at 470 nm. Guaiacol 
was stable over the time course of the experiment at pH 8.6 and mixing with H2O2 in the 
absence of C45 did not produce any significant oxidation. It has a redox potential of +680 
mV (pH 7 [266]). In the computational binding study with C45 (Figure 2.3.16), guaiacol had 
36/50 binding sites that remained associated with C45 after MD. The majority of these (23), 
bound close to and above the heme in cluster 3.  
The kinetic analysis of C45 with Guaiacol gave a kcat* of 0.76 ± 0.01 (s-1), a KM of 2.6 
± 0.3 (μM) and kcat*/KM of 2.9 ± 0.33 x105 (M-1s-1). Having a very low KM means that it 
outperforms CcP and AXP kcat*/KM of (7.7 ± 1.04 x104, 3.2 ± 0.43 x103 M-1s-1) in terms of 
catalytic efficiency by at least an order of magnitude. Despite a kcat* three orders of magnitude 
lower, C45 matches the catalytic efficiency of HRP (kcat*/KM 1.4 ± 0.37 x105). 
 
Figure 2.3.23 Guaiacol oxidation with C45. 
(A) The reaction of guaiacol peroxidases producing primary product tetraguaiacol 
(B) UV-visible spectral changes occurring on mixing 100 nM C45, 100 µM guaiacol and 100 
µM H2O2. “T:x” is the time in seconds from initial mixing. (C) Steady-state kinetics at (rate-limiting) 
100 µM H2O2, fitted to a Michaelis–Menten curve. 
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2.3.12.5 Luminol 
Luminol is used in crime scene forensics, as it is oxidised via a chemiluminescent 
process when it comes into contact with blood and other bodily fluids [267]. It was stable in 
redox reaction buffer over the course of the experiment and shows minimal oxidation when 
mixed with H2O2 without C45. To quantify the concentration of product using the 
chemiluminescent signal requires extensive calibration of the detector. As a result, the 
absorbance changes associated with substrate loss were used to follow the reaction. Luminol 
has a redox potential of +750 mV (pH 9 [268]). The computational binding study with C45 
(Figure 2.3.16) showed luminol had 22 binding sites that remained associated with C45 after 
MD. Five were un-clustered (cluster -1) but over 15 Å from the heme iron, 17 were close to 
and above the heme in cluster 3.  
The kinetic analysis of C45 with luminol gave a kcat* of 0.65 ± 0.03 (s-1), a KM of 2.9 ± 
0.7 (μM) and kcat*/KM of 2.3 ± 0.52 x105 (M-1s-1). Once again the observation of a low KM for 
C45 when fitting to Michaelis–Menten kinetics means that C45 and HRP are in the same 
order of magnitude when it comes to catalytic efficiency (HRP kcat*/KM = 1.9 ± 0.14 x105 M-
1s-1 [269]). 
 
Figure 2.3.24 Luminol oxidation with C45 
(A) The reaction of luminol peroxidases. (B) UV-visible spectral changes occurring on mixing 
100 nM C45, 75 µM luminol and 100 µM H2O2. “T:x” is the time in seconds from initial mixing. (C) 
Steady-state kinetics at (rate-limiting) 100 µM H2O2, fitted to a Michaelis–Menten curve. 
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2.3.12.6 o-Dianisidine 
o-Dianisidine (oDi) can be used as an azo dye-precursor as well as being used as a 
substrate in colorimetric peroxidase assays. It was stable in redox reaction buffer (pH 8.6) 
over the course of the experiment and shows minimal oxidation when mixed with H2O2 
without C45. The absorbance changes associated with the formation of the oxidised product 
were used to follow the reaction. o-Dianisidine has a redox potential of +809 mV (in water 
[270]). Figure 2.3.16 from the computational binding study showed o-Dianisidine had 38 
binding sites that remained associated with C45 after MD. 19 found in cluster 3 in and around 
the same small phenolic binding pocket above the heme. 4 were clustered group 6 on the 
other end of the maquette far from the heme. 2 of the 9 un-clustered (cluster -1) were within 
15 Å of the heme iron. The kinetic analysis of C45 with o-Dianisidine gave a kcat* of 1 ± 0.08 
(s-1), a KM of 1.9 ± 0.42 (μM) and kcat*/KM of 5.4 ± 1.26 x105 (M-1s-1). 
 
Figure 2.3.25 o-Dianisidine oxidation with C45 
 (A) The oxidation of o-Dianisidine by peroxidases. (B) UV-visible spectral changes occurring on 
mixing 100 nM C45, 40 µM o-Dianisidine and 100 µM H2O2. “T:x” is the time in seconds from initial 
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2.3.12.7 TCP and TBP 
2,4,6-trichlorophenol (TCP) and 2,4,6-tribromophenol (TBP) are halogenated phenol 
derivatives whose environmental impact is of growing concern [189]. They occur as 
intermediates in industrial synthesis, in the breakdown of flame retarded products and some 
organisms release them as secondary metabolites to eliminate competition in their 
environmental niche [188]. A worm-like terebellid polychaete (Amphitrite ornate) cohabits 
among organisms that secrete bromophenols, so expresses a dehaloperoxidase (DHP) as a 
response [180]. See Section 1.7.4 for details on DHP and its two isoforms (DHP a and DHP 
B). The results of computation binding study show all of the highest energy TCP binding 
positions are in cluster 3, the pocket close to and above the heme. For TBP the majority of 
the binding poses that remained after MD were in the same position as TCP with only 11 
associating at other positions around the protein (Figure 2.3.16).  
  
 
Figure 2.3.26 TCP oxidation with C45 
(A) The reaction of TCP dehaloperoxidase producing primary product 2,6-dichloroquinone. (B) UV-
visible spectral changes occurring on mixing 250 nM C45, 100 µM TCP and 100 µM H2O2. “T:x” is the 
time in seconds from initial mixing. (C) Steady-state kinetics at 100 µM H2O2 (rate-limiting), fitted to 
Michaelis–Menten curve 
 
The absorbance changes associated with TCP and TBP oxidation to their primary 
products 2,6-dichloro-1,4-benzoquinone (DCQ) and 2,6-dibromo-1,4-benzoquinone (DBQ) 
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are seen in panel A of Figure 2.3.26 and Figure 2.3.27. Spectra of both were stable over the 
duration of the experiments at pH 8.6. There was no evidence of oxidation of either when 
mixing with H2O2 in the absence of C45. 
The kinetic analysis of C45 with TCP gave a kcat* of 0.5 ± 0.01 (s-1), a KM of 12 ± 1.1 
(μM) and kcat*/KM of 4.2 ± 0.40 x104 (M-1s-1). For TBP C45 has a kcat * of 0.43 ± 0.01 (s-1), a 
KM of 11 ± 0.70 (μM) and kcat*/KM of 4 ± 0.25 x104 (M-1s-1). Table 2.3.4 shows that in terms 
of catalytic efficiency C45 beats the natural DHP A and matches DHP B isoform. The results 
with C45 were at limiting H2O2 concentration (100 µM) when the kinetics for DHP were 
taken at 160 µM H2O2.  
 
Figure 2.3.27 TBP oxidation with C45 
 (A) The reaction of TBP dehaloperoxidase producing primary product 2,6-dibromoquinone (B) 
UV-visible spectral changes occurring on mixing 100 nM C45, 40 µM TBP and 100 µM H2O2. “T:x” is 
the time in seconds from initial mixing. (C) Steady-state kinetics at (rate-limiting) 100 µM H2O2, fitted 
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2.3.12.8 Other substrates turned over by C45 
Homovanillic acid (HVA), p-Anisidine (pAN) and Orange II (ORA) are documented 
peroxidase substrates with redox potentials of +430, +766 and +868 mV respectively [271–
273]. While they were all oxidised by C45, a full kinetic characterisation was not carried out 
owing to practical complications. Homovanillic acid is sensitive to light and was unstable at 
pH 8.6. However, it was clear to see that with mixing with C45 and H2O2 turnover was 
increased relative to the background rate of decomposition by at least 2 orders of magnitude. 
There was no bleaching of the heme Soret λmax, which occurs when mixing C45 and H2O2 in 
the absence of an electron donating substrate, indicating that homovanillic acid can be 
oxidised by C45. p-Anisidine and Orange II were stable at pH 8 but it was not possible to 
obtain UV-visible extinction coefficients for their oxidation products; and measuring 
substrate decrease proved challenging at higher concentrations. Figure 2.3.28 shows the UV-
visible changes after oxidation with C45 as well as the structure of the substrates.  
 
Figure 2.3.28 Substrates without steady-state kinetics. 
(A) UV-visible spectral changes on mixing 700 nM C45, 100 µM Homocanillic acid and 100 
µM H2O2. (B) UV-visible spectral changes occurring on mixing 250 nM C45, 100 µM p-Anisidine and 
100 µM H2O2. (C) UV-visible spectral changes occurring on mixing 100 nM C45, 40 µM Orange II and 
100 µM H2O2. (D) Skeletal structures of small molecule substrates. “T:x” is the time in seconds from 
initial mixing. 
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2.3.12.9 Substrates not oxidised by C45 
4-Aminobenzoic acid (4ABA), 1,4-dimethoxybenzene (DEOB) and veratrole alcohol 
(VA) all have relatively a high oxidation potentials and +1080, +1300 and +1360 mV [272, 
274, 275]. All are oxidised by peroxidases with high redox potentials, like Lignin Peroxidase 
(LiP). Veratrole alcohol is produced as a secondary metabolite by white-rot basidiomycetous 
fungi and is thought to act as an intermediate in the degradation of lignin (see in Section 
1.7.2) [276]. Figure 2.3.29 shows the UV-visible spectra of mixing these compounds with 
C45 and H2O2. In all cases substrates were stable with C45 at pH8.6 and reactions were 
initiated be 5 µl of H2O2. The T:-1 trace in panel A,B and C is before the addition of H2O2. For 
all substrates there are clear spectral changes corresponding to heme degradation of C45 
(decrease at 406 nm). This is the same phenomenon observed when mixing C45 and H2O2 in 
the absence of an electron donating substrate, the only exception being the very slight 
reduction in the absorbance peak of 4-Aminobenzoic acid. 
 
Figure 2.3.29 Substrates with very poor or no turnover. 
(A) UV-visible spectral changes on mixing 100 nM C45, 100 µM 4-Aminobenzoic acid and 100 
µM H2O2. (B) UV-visible spectral changes occurring on mixing 250 nM C45, 100 µM 1,4-
Dimethoxybenzene and 100 µM H2O2. (C) UV-visible spectral changes occurring on mixing 100 nM 
C45, 40 µM Veratrole Alcohol and 100 µM H2O2. (D) Skeletal structures of small molecule substrates. 
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4-Aminobenzoic acid performed relatively poorly in the computational binding study with 
only 3/50 top binding poses remaining associated with the protein after MD. 1,4-
dimethoxybenzene and VA exhibited very similar results, with the majority of top biding 
poses remaining associated with the protein after MD (41/50 and 45/50). Figure 2.3.16 
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Enzyme Substrate kcat (s-1) KM (µM) kcat/KM (M-1s-1) Condition 
C45 Cyt c 0.51* ± 0.01 1.2 ± 0.6 4.3 ± 2.13 x10 5 pH 8.6 
CcP Cyt c 1510 ± 259 93 ± 31 1.6 ± 0.61 x10 7 pH 6 [262] 
C45 oPDA 1.1* ± 0.03 6.2 ± 0.7 1.8 ± 0.19 x10 5 pH 8.6 
HRP oPDA 1860 ± 43 600 ± 200 3.1 ± 1.03 x10 6 pH 6 [277] 
C45 Amplex Red 0.41* ± 0.01 0.53 ± 0.04 7.8 ± 0.65 x10 5 pH 8.6 
HRP Amplex Red 860 ± 38 106 ± 13 8.1 ± 1.06 x10 6 pH 7.4 [265] 
C45 Guaiacol 0.76* ±0.01 2.6 ± 0.3 2.9 ± 0.33 x10 5 pH 8.6 
CcP Guaiacol 4.1 ± 0.3 53 ± 6 7.7 ± 1.04 x10 4 pH 6 [262] 
AXP Guaiacol 41 ± 5 13000 ± 800 3.2 ± 0.43 x10 3 pH 7.4 [278] 
HRP Guaiacol 370 ± 30 2700 ± 700 1.4 ± 0.37 x10 5 pH 7.4 [278] 
C45 Luminol 0.65* ± 0.03 2.9 ± 0.7 2.3 ± 0.52 x10 5 pH 8.6 
HRP Luminol 275 ±10 1425 ± 93 19 ± 0.14 x10 5 pH 5 [269] 
C45 H2O2 (ABTS) 1200 ± 20 94 ± 6 1.3 ± 0.51 X10 4 pH 8.6 
C45 ABTS 1200 ± 20 379 ± 25 3.2 ± 0.43 x10 6 pH 8.6 
HRPc ABTS 4100  800  5.1   x10 6 pH 4.6 [182] 
HRP ABTS 332 ± 18 233 ± 21 1.4 ± 0.15 x10 6 pH 5 [265] 
C45 o-Dianisidine 1.0* ± 0.08 1.9 ± 0.42 5.4 ± 1.26 x10 5 pH 8.6 
C45 TCP 0.50* ± 0.01 12 ± 1.1 4.2 ± 0.40 x10 4 pH 8.6 
DHP A TCP 8.1 ± 0.3 1004 ± 90 8.1 ± 0.78 x10 3 pH 7 [181] 
DHP B TCP 14.1 ± 0.7 297 ± 35 4.7 ± 0.61 x10 4 pH 7 [181] 
C45 TBP 0.43* ± 0.01 11 ± 0.70 4.0 ± 0.25 x10 4 pH 8.6 
DHP A TBP 1.81 ± 0.14 641 ± 84 2.8 ± 0.43 x10 3 pH 7 [181] 
DHP B TBP 2.04 ± 0.1 91.9 ± 16.2 2.2 ± 0.41 x10 4 pH 7 [181] 
Table 2.3.4 Comparison of kinetics results. 
Showing Michaelis–Menten kinetic fit results for each electron donating substrate (column 2) 
with various peroxidases (column 1). The results fro C45 are shaded in blue. * result is kcat* obtained at 
limiting H2O2 with 100 nM C45 and 100 µM H2O2. Values for other enzymes are not shaded and have 
their literature reference in the last column. The ± errors quoted are standard deviation. 
 
 
Figure 2.3.30 C45 of kinetics results. 
(A) Graph of C45 kcat* values at rate limiting H2O2. (B) Graph of C45 KM values for various 
substrates (C) Graph of C45 kcat*/KM values for various substrates   
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 E0 oxidation potential 
(mV vs SHE) Conditions REF 
CcP Fe3+/Fe2+ -234 pH 7 [100] 
P450cam Fe3+/Fe2+ -216 pH 7.4 [99] 
CYP119 Fe3+/Fe2+ -214 pH 7 [99] 
APX Fe3+/Fe2+ -206 pH 7 [101] 
C45 Fe3+/Fe2+ -174 pH 8.6 [70] 
HRP Fe3+/Fe2+ -136 pH 7.0 [98] 
Lignin peroxidase Fe3+/Fe2+ -126 pH 7.0 [103] 
MnP Fe3+/Fe2+ -122 pH 7.0 [103] 
DHP B Fe3+/Fe2+ 206 pH 7 [105] 
Cytochrome c Fe3+/Fe2+ 261 pH 8.3 [261] 
o-Phenylenediamine 400 pH 7.0 [263] 
Homovanilic Acid 430 pH 7.0 [271] 
Amplex Red 600 pH 7.4 [264] 
Guaiacol 680 pH 7 [266] 
Isoniazid ~700 Indirect a [279] 
Luminol 750 pH 9 [268] 
 ABTS 760 pH 4 [280] 
p-Anisidine 766 pH 5.1 [272] 
o-Dianisidine 809 In water [270] 
Orange 2 868 pH 8 [273] 
TCP 930 50% IPA pH 5.1 [281] 
HRP CPDI/CPDII 949 pH 7.0 [282] 
TBP 984 pH 6 90% Ethanol [283] 
HRP CPDII/Fe3+ 991 pH 7.0 [282] 
C45 CPDI/CPDII ~1000  Indirect pH 8.6 b  
4-Aminobenzoic Acid 1080 pH 5.1 [272] 
CcP CPDI/CPDII 1087 pH5.3 [108] 
HRP CPDI/CPDII 1120 indirect low pH [169] 
APX CPDI/CPDII 1156 pH 7 [101] 
1,4-Dimethoxybenzene 1300 pH 4.5 [274] 
MnP CPDI/CPDII 1300 pH <4 [98] 
Veratrole Alchohol 1360 pH 3.6 [275] 
LiP CPDI/CPDII ~1450 Indirect c [169] 
P450’s CPDI/CPDII 1500-2000 d [109] 
Table 2.3.5 Oxidation Potentials 
Table gives oxidation potential of various small molecules and enzyme species vs the standard hydrogen 
electrode (SHE). Blue shading denotes potential peroxidase substrate single electron oxidation potentials. 
Potentials with compound I or II have been abbreviated to CPD I and CPD II. b C45 CPDI/CPDII is an 
estimate based on the substrates it will oxidise. The last column is the literature reference (REF). a 
Obtained though mediator. c Inferred though reactivity with a series of substrates. d P450 CPDI 
oxidation potentials are difficult to measure directly but inferred through reactivity.  
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2.3.13 Live Cell Assays 
These experiments aimed to test the reactivity of C45 in vivo. There appeared to be no 
indication of ABTS, luminol or Guaiacol oxidation in live cells when compared to a control of 
cells expressing a variant of C45 with no heme, C45-NH. Only o-phenylenediamine displayed 
any significant spectroscopic changes showing product formation (2,3-diaminophenazine) 
after 90 min. o-Phenylenediamine oxidation with C45 expressing cells was significantly 
greater than the control. Figure 2.3.31-E and F show the reaction of the samples with ABTS 
after lysis of the cells. C45 expressing cell lysate will readily oxidise ABTS whereas the cells 
expressing C45-NH cannot.  
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Figure 2.3.31 Live cell Assays.  
Panels A to D show the reactions with ABTS, o-phenylenediamine, Luminol and Guaiacol at 1 mM and 
H2O2 at 2 mM with 30 ul of live cells. The lines show an average of 4 repeated experiments. The control is 
cells expressing C45-NH (with no heme binding site) shown with dashed lines. The time of each scan is 
denoted as T=x in seconds. E shows positive control with ABTS, H2O2 and lysed cells that were 
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2.4 Discussion  
C45 represents a step-change in the maquette protein design methodology, as it is the 
first to achieve a level of catalytic activity that places it in an exclusive club of fully de novo 
enzymes. While questions remain about the exact nature of its structure and mechanism, 
these do not diminish from the broader triumph for rational design that it signifies. In 
contrast to most other protein design methodologies, which are generally structurally driven, 
the design of C45 was unashamedly activity driven. Incorporating a c-type cytochrome heme 
cofactor in the de novo four-helix bundle allows the protein to be expressed as a holoenzyme 
in vivo. Taking inspiration from natural peroxidases that have a penta-coordinate heme 
ligation, the last design step for C45 was to remove the distal ligating histidine, leaving the 
final iron coordination site accessible to water. This modification transformed an unreactive 
parent protein into a highly catalytically efficient thermostable de novo enzyme.  
2.4.1 Structure  
C45 has a highly repetitive sequence and a significant degree of conformational 
flexibility. This has limited the structural information that can be gained from NMR and 
renders attempts at crystallographic studies futile. The NMR results in combination with CD 
spectroscopy show C45 to be similar to other reported maquette proteins [284]. C45 has 
clearly has defined secondary structure, randomly coiled loops and some amount of core 
packing. MD simulations show the model of C45 to have a stable core with highly dynamic 
loops and surface sidechains.  
The results of the Rosetta ab initio fold calculations do not show convergence on a 
single structure. The simulation using constrains to bind heme produced many physically 
unrealistic high-energy results. The folding simulations without heme more reliably produced 
four-helix bundles but are purely speculative as it is unknown if they would be able to 
accommodate the heme. The general result that these preliminary calculations highlight is 
that by removing the distal heme ligation it now may be possible for two different topologies 
to support realistic heme orientations. Figure 2.3.9.1 and 5 show those two topologies. Figure 
2.3.9.1 is the same overall structure as the existing C45 model which is based on the previous 
generations of maquettes. In Figure 2.3.9.5 helix 2 and 3, which are linked diagonally across 
the barrel by a longer loop, have swapped positions. The first step in investigating these 
topologies would be to run molecular dynamics simulations to see if they are stable and 
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realistic. The structures generated by Rosetta ab initio folding with heme contain a large 
number of unfavorable backbone torsions so would need to be very rigorously minimized. If 
this was not possible the helical arrangements could be used as starting points for Rosetta 
flexible backbone packing software to generate better starting structures for MD.  Florescence 
quenching experiments with mutants of C45 could be designed to test which of the topologies 
predominates experimentally [285]. 
To be structurally complete, C45 must incorporate heme. For C45, the covalent 
attachment of heme is mediated by Cytochrome c biogenesis system I (Ccm) in E. coli. Work 
leading up to the production of C45 has shown that the Ccm is able to accommodate non-
natural protein substrates [111].  The exact limits of what types of non-natural substrates the 
Ccm will process have not been studied in depth. However, work with c-type binding 
maquettes has suggested that flexibility of the maquette scaffold may be important for 
efficient recognition of the CXXCH heme binding motif [69].  
Flexibility of the maquette scaffold is likely to be an important factor in the peroxide 
binding. In majority of natural peroxidases, the distal heme site is accessible to solvent and 
peroxide but not the small molecule electron donor substrates [152]. The MD simulations of 
C45 do not sample any conformations where water is bound above the heme, but it is 
experimentally clear that this is probably the case. One MD result did hint at this possibility 
(Figure 2.3.8.C). Further investigations of simulations that force water or peroxide binding 
at the heme are needed to investigate this further. MD simulations of C45 in the compound 
I and II states could also help to better rationalize what structural changes occur in C45 to 
accommodate these highly-charged species. The current hypothesis is that flexibility in the 
second and forth helix allows for the peroxide to bind and be activated at the heme. 
2.4.2 What can be learned from pH dependent activity  
The UV-visible spectra of C45 in the ferrous form (Figure 2.3.3) show a split Soret 
λmax, indicating more than one heme iron environment or electronic state. This  split peak 
profile is similar to monohistidine-ligated Cytochrome c′ and distal mutants of Cytochrome c 
[286, 287]. Split Soret maximum peaks can be explained by either a quantum admixture of 
high and low-spin states at the heme iron, or mixed populations of protonation states in the 
titratable water ligand occupying the distal site (H2O to OH-), or a combination of both [288, 
289]. Figure 2.3.13 shows that C45 transitions between two Soret maxima, in the neutral to 
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alkaline range, with a pKa of 8.1. This pKa value of ‘the acid–alkaline transition’ is sometimes 
referred to as pKaAA. Horse heart myoglobin and DHP display very similar transitions (pKaAA 
8.9 and 8.1) caused by changes in the protonation state of the water bound to the heme [180, 
290]. Changes in pH also have a profound effect on the redox potential of C45, moving from 
-208 mV at pH 10, to -174 at pH 8.6. Two redox potentials are observed at pH 7.5 (-187 and 
– 126 mV) which are likely the result of the water/hydroxide equilibrium at the heme iron.  
It is also possible that changes in the hydrogen bonding of the proximal histidine may also 
have an influence on the pH dependent redox properties. 
Most natural peroxidases have an acidic pH optimum, as having OH- as the axial ligand 
makes it more difficult to bind and activate H2O2 [152]. The protonation of compound 0, I 
and II is also aided by a proton rich environment, giving natural peroxidases a preference for 
operating under acidic conditions. Studies with a thermophilic P450 from Sulfolobus tokodaii 
(P450st) show a pH optimum for peroxygenase activity at mildly alkaline pH’s. Experiments 
with P450st showed that the Lewis acidity of the heme is related to the pKaAA (H2O to OH- 
axial ligand transition) [291].  A mutational study of P450st demonstrated that decreasing 
the pKaAA from 8.7 in the WT to 8.1 in the mutant results in increasing the Lewis acidity of 
the heme and increasing the peroxygenase activity [292]. The kcat of H2O2 turnover in the 
P450st mutant increased sigmoidally with increasing pH, fitting well to a Henderson–
Hasselbalch equation. The apparent acid dissociation constant (pKaapp) from this fit was pH 
7. This reveals that the rate-limiting step is a deprotonation event with a pKa of 7, before the 
formation of the active oxidant [292]. Within the substrate regime being used, this 
observation could only be attributed to the deprotonation of Compound 0 (Fe3+-H2O2). 
Deprotonation of H2O2 before heme binding was not considered as H2O2 in solution has a 
very high pKa (near pH 12).  
With this information in mind we can hypothesise that the observed increase of kcat 
with increasing pH up to 8.6 is a result of increasing the rate of deprotonation of compound 
0. This still leaves the question of why kcat then decreases after pH 8.6? The MD model of 
C45 shows that the amine groups of 4 lysine residues (29, 44, 52 and 101) are within 15 Å of 
the heme. In particular, K52 is seen to form a hydrogen bond with both heme propionates 
and is only around 6.5 Å from the heme edge. The pKa of these residues is predicted to be 
between 9 and 11 and changes in their protonation states will likely influence the redox 
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properties of the heme. The deprotonation of this lysine at alkaline pH could explain the 
decrease in kcat after pH 8.6 if it is involved in the modulation of the heme redox potential or 
if it plays a role in protonation the compound 0. At high pH, K52 will be deprotonated and 
would no longer be able to stabilise the development of negative charge on the bound 
peroxide during O-O bond cleavage.  
2.4.3 Proposed mechanism 
Incorporating and activating heme has allowed C45 to access the same redox active 
species as natural heme oxygenases and peroxidases, namely compound I and II (seen in 
Figure 2.4.1). These natural peroxidases tend have a conserved structure around the distal 
site of the heme. HRP, CcP and AXP all have conserved distal histidine and arginine residues. 
These have been proposed to facilitate the binding of H2O2 and then to stabilise the negative 
charge produced during H2O2 cleavage. In the latter stages of the mechanism these residues 
help facilitate the protonation of compound I and then compound II [119]. A description of 
natural peroxidase mechanisms can be seen in Section 1.8. C45 does not have this conserved 
structure of the distal site. We can then conclude that either these structures are not essential 
or that in C45 other residues are performing and analogous function. The candidate residues 
that could assist in proton delivery and charge separation are glutamine 45 and lysine 52. The 
nitrogen of the amide group on Gln45 can be seen as close as 5.8 Å from the heme iron and 
the amine group of K 52 can be seen 8.3 Å from the heme iron. The second pKa of the pH 
dependence of kcat* for C45 is pH 9, making K52 the most likely candidate. The backbone 
amino groups of leucine 50 and alanine 49 are directly over the distal site of the heme and 
might also be able to assist in accommodating charged species.  
As discussed in Section 1.8.2, some peroxidases, such as CcP, form a compound I 
where the radical cation is on a nearby tryptophan residue rather than the porphyrin ring 
itself. C45 has three tryptophan residues, one predicted to be around 7 Å from the heme edge 
and two on the far end the helix. EPR spectral analysis of C45 indicated that it can form a 
tryptophan compound I radical. The next chapter will detail the work performed to assign the 
radical intermediate of C45. 
Figure 2.4.1 shows a summary of the C45’s peroxide cycle. In the resting state, it 
appears that C45 has water bound in the distal axial position with a pKa of 8.1. Without the 
distal residues found in most natural peroxidases, C45 must wait for spontaneous 
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deprotonation of the peroxyferric complex. This is inferred from C45’s weakly alkali pH 
optimum, which is similar to P450 peroxygenase activity [292]. The rate of kcat increases as 
pH increases up to the pKa of deprotonation of the peroxyferric complex, around pH 8. The 
rate is then limited at higher pH by the deprotonation of a nearby lysine residue (K52) with 
a proposed pKa of 9. This lysine must be involved in the protonation of the heme reactive 
species, stabilisation of peroxide cleavage, modulation of the redox potential of the heme or 
some combination of all three.  
 
 
Figure 2.4.1 C45 Mechanism. A suggested mechanism for the peroxidase cycle of C45. The pKa 
values shown in the ferric, peroxyferric and compound 0 are suggested from the interpretation of 
spectroscopic and kinetic experiments at various pH’s 
2.4.4 The sticky question of binding 
C45 like many natural peroxidases exhibits activity with a range of electron donating 
substrates. The steady-state kinetic results for quite different substrates are strikingly similar 
in terms of the KM (Figure 2.3.30). This could be because no attempt has been made to design 
in a substrate binding site. Additionally C45 is small and the heme is relatively exposed.  A 
full ping-pong kinetic analysis was only performed for ABTS with limiting peroxide 
concentrations were used for all other substrates. If a full ping-pong kinetic analysis could be 
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calculated for more substrates it could possibly reveal that similarity in observed KM values 
could be result of the rate-determining step being linked to another part of the mechanism. 
 The results of the binding study, that used a computational model of C45 to search 
for binding sites, were broadly in line with the experimental results. All the substrates that 
have been kinetically characterised display one or more possible binding loci that persist 
through 5 ns of molecular dynamics simulation. Homovanillic acid is a possible outlier in that 
the computational study showed very poor association with the protein, however, preliminary 
experimental data (Figure 2.3.28) suggests it can be oxidised. These data come with the 
caveat that Homovanillic acid was not particularly stable in the reaction buffer.  
The results of the BUDE docking calculation show several small molecule binding sites 
on C45. The stability of substrates bound in the small phenolic (SP) pocket within cluster 3, 
as well as its proximity to the heme, make this a convincing candidate binding site. The fact 
that this pocket does not appear to be highly selective is in line with very similar 
experimentally derived KM values for different substrates. To validate these computational 
results this pocket should be the target for further computational and experimental studies, 
producing mutants that perturb the binding in this site. From the frequency of close contact 
analysis residues L22, E19 and 47 are the 3 top candidates for mutation.  
Clusters 1 and 2, from the computational screen, make direct contact with the heme 
edge. They also appear to be relatively unselective with 10 different substrates binding in 
these clusters. The proximity to the heme edge means that electron transfer would be rapid 
and even highly transient interactions with electron donating substrates could result in 
successful electron transfer. This close but transient interaction could also explain the lack of 
variation in experimentally derived KM values. As discussed in Section 1.7.1 most natural 
peroxidases are generally thought to bind small molecule substrates near the heme edge. 
Isoniazid binds to the heme edge in CcP and AXP and has been used to understand 
the location of binding with other substrates by examining the inhibition it causes [163]. 
Looking at the inhibitory effects of C45 substrates on the oxidation of a different substrate 
could be used to study whether they share binding sites. Veratrole alcohol and 1,4-
dimethoxybenzene are both seen to bind in the small phenolic pocket of cluster 3 but are not 
oxidised because of their high redox potentials. These could be the first candidates for use in 
inhibitory kinetic studies of other substrates that bind in the same pocket, such as TCP.  
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If one or more of the tryptophan residues form protein radicals, electron transfer could 
proceed through an alternative pathway, analogous to LiP and CcP. LiP is known to form a 
tryptophan radical to react with veratrole alcohol. Removing this residue eliminates activity 
towards veratrole alcohol but electron transfer via the heme edge to low potential peroxidase 
substrates can still proceed. This is especially true in mutants where the normally narrow 
heme cavity of LiP has been widened [293]. Many natural peroxidases do not have a single 
well-defined binding site for small molecule peroxidase substrates. CcP, LiP, VP, DypB and 
DHP have all been seen to have at least two small molecule binding sites with one normally 
situated near the heme edge [163, 165, 166, 172, 184]. This is also true for C45, the 
computational study shows 4 well sampled binding sites one of which is at the heme edge. 
Having several binding sites and the potentially transient nature of interaction at the solvent 
exposed heme edge could explain the lack of variation in KM vales from different substrates. 
The unifying characteristic that appears to predict substrate reactivity with C45 is the 
substrate’s redox potential. By testing a range of substrates, it is possible to infer that the 
redox potential of C45 compound I is close to that of 4-aminobenzoic acid (~1000 mV vs 
SHE). It is important to note that some of the literature midpoint potentials quoted in Table 
2.3.5 may have pH dependent redox properties and many not necessarily be the same under 
the reaction conditions in this project. 
The work in this chapter to biophysically, computationally and kinetically characterise 
C45 has significantly improved our understanding of how this catalytically efficient de novo 
peroxidase functions. Structural characterisation has highlighted that C45 is an ordered but 
highly flexible protein, which may be a blessing for catalysis but a curse for obtaining 
atomistic structural information. C45 is structurally and catalytically resistant to high 
temperatures. The pH dependent kcat* change observed, along with MD simulations, have 
allowed a detailed catalytic mechanism to be proposed and investigations with many different 
peroxidase substrates has allowed the redox potential of C45 compound I to be assigned to 
~1000 mV vs the NHE. The knowledge developed though these experiments can now go on 






3 Studying the de novo peroxidase 
radical  
3.1 Introduction 
As discussed in Section 1.8, some natural peroxidases can form a protein compound I 
radical. Cytochrome c peroxidase (CcP), lignin peroxidase (LiP) and dehaloperoxidase can 
form tryptophan or tyrosine protein radicals during their reactive cycles [156, 172, 183]. The 
radical produced by a peroxidase can have a dramatic effect on its activity. In CcP, W191 
radical formation is essential for efficient inter-protein electron transfer [207]. In LiP, W171 
is required for turnover of certain substrates, such as veratrole alcohol, which cannot be 
oxidised by many other peroxidases (i.e. HRP, CcP and AXP) [172]. In the de novo peroxidase 
maquette, C45, it is useful to understand what radical intermediate is being produced to test 
how it affects its activity. The maquettes also offer a unique platform for studying radical 
formation. Specifically designed radical species could be an important tool for achieving the 
desired chemistry in future de novo enzymes. 
For a protein of only 294 residues, CcP has a large number of redox-active amino acids: 
seven tryptophan and fourteen tyrosine residues [145]. Other peroxidases of a similar size 
have far fewer redox-active amino acids. Ascorbate peroxidase has two tryptophan and seven 
tyrosine residues [147]. Lignin peroxidase has only three tryptophan residues [148]. W191 
in CcP is required for it to efficiently oxidise its native electron donor ferrocytochrome c 
[207]. Many of the remaining redox-active residues in CcP are capable of radical formation in 
the absence of an electron donating substrate [216]. These are thought to be involved in the 
role of CcP in conveying oxidative stress signals, which has been studied in Saccharomyces 
cerevisiae [294].  
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The role of tryptophan 51 and 191 as well as tyrosine 36, 39, 42, 187, 229, and 236 in CcP 
have been investigated by mutagenesis [295]. Sequential mutation of these residues to 
phenylalanine caused an increase in the stability of compound I. The rate of decay of the 
compound I reduced from 57 s-1, in single W191F mutant, to 7 s-1 in the mutant with all seven 
residues mutated. The characteristic spectroscopic peaks of the compound I were also better 
defined in the W51,191F mutant [295].  All the mutants displayed very little activity towards 
ferrocyochrome c after the mutation of W191. However, an increase in catalytic efficiency 
(kcat/KM) was observed with a small molecule electron donor (2,6-Dimethoxyphenol) as more 
redox–active residues were removed [295].  
The de novo peroxidase maquette C45 discussed in the previous chapter contains three 
tryptophan residues, seen in Figure 3.1.1. The focus of this chapter is to investigate the nature 
of the radical produced during its reactive cycle [70]. To do this, a series of tryptophan 
knockout mutants (dW) were designed and characterised (shown in bold in Table 3.1.1). 
 
Protein Amino acid at position 
8 43 46 80 
C46 W W H W 
C45 WT W W F W 
dW3 FFF,     W8,43,80F F F F F 
dW3Y FFYF, W8,43,80F F46Y F F Y F 
dW2.1 WFF, W43,80F W F F F 
dW2.2 FWF, W8,80F F W F F 
dW2.3 FFW, W8,43F F F F W 
Table 3.1.1 Tryptophan knock-out mutants.  
The protein names in bold are investigated in this chapter. 
 
Two of the tryptophan residues (W8 and W80) are on the on the far end of the four-helix 
bundle, around 26 Å from the heme group. W43 is on the second helix situated close (around 
6 Å) to the heme. One of the proteins investigated (dW3Y) also has a F46Y mutation. F46 is 
positioned directly above the heme and was the site of the histidine residue in the bis-
histidine ligated parent maquette C46 (see Table 3.1.1 and Figure 3.1.1) 
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Figure 3.1.1 Tryptophan positions in C45 model.  
The residues that have been mutated in this chapter are shown by the Van der Waals radius of their heavy 
atoms. The closest distance between heavy atoms of the conjugated system of the heme and amino acid side 
chain are shown by the blue dashed line. The distance to the heme is shown next to the residue label in 
each case.  
 
3.1.1 Radical scavenging  
Radical scavenging is a method of identifying radical species by forming a stable adduct 
with another molecule [296]. Unlike spin-trapping, where a spin-adduct is formed that 
retains the radical spin, the adducts formed in radical scavenging are covalent and do not have 
unpaired spin. TEMPO (2,2,6,6-tetramethylpiperidinyl-1-oxy) is a stable nitroxide radical 
that is known to scavenge carbon-centred radicals [297]. It has been used identify protein 
based radicals in CcP and myoglobin by mass spectrometry [296]. The proteins were mixed 
with H2O2 and TEMPO to generate the protein radicals and TEMPO-radical adducts. The 
samples were digested into peptide fragments and the products were analysed by electrospray 
ionization (ESI) mass spectrometry (MS). One TEMPO adduct was identified in myoglobin 
and nine in CcP [296].  
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3.2 Materials and Methods 
3.2.1 Mutagenesis and Cloning  
The same cloning and mutagenesis protocols were used as in Section 2.2.1. Mutagenesis 
was performed using the C45 plasmid, produced in Section 2.3.1, as a starting template for 
the first round of site-directed ligase-independent (SLIM) mutagenesis, producing the single 
tryptophan knockout mutants (dW1.1-3 in Table 3.1.1). The successful single tryptophan 
mutant plasmids were used as templates for a second round of tryptophan knockouts, using 
the same primers, to produce the double tryptophan mutants (dW2.1-3). One of the 
successful tryptophan double mutants (dW2.1) was then used in a third round of mutagenesis 
to produce the triple tryptophan knockout (dW3). To produce dW3Y an additional starting 
round of mutagenesis was performed to produce the phenylalanine 46 to tyrosine mutant. 
This was then used as the starting template for three rounds of mutagenesis.  
3.2.2 Protein expression and Purification  
The same expression and purification protocol was used as described in Section 2.2.2. 4 L 
cultures of E. coli expressing each mutant were grown and purified.  
3.2.3 UV-visible spectroscopy 
A Cary60 spectrophotometer (Agilent Technologies) was used to record all spectra unless 
otherwise stated. 
3.2.4 CD  
CD melts were performed on all dW mutants with the same protocol as detailed in Section 
2.2.4. The refolding “cool” experiments were only conducted on dW3 and dWY. 
3.2.5 Molecular dynamics 
The MD AMBER protocol is found in Section 2.2.6.2. The starting structures were 
generated using UCSF Chimera to mutate a model of C45 into single, double and triple 
tryptophan mutants. The dW3Y mutant was then produced from the dW3 model. For each 
protein, four 100 ns MD simulations were conducted. Although the protein starting 
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coordinates for each replicate were identical, the solvation and starting velocities were 
randomly assigned. 
3.2.6 Mass Spectrometry 
Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-
TOF MS) was used to find the mass of the maquettes. 3 µl of 50 µM protein sample was mixed 
with 3 µl of matrix solution. A small volume of this mixture (<1 µl) was spotted on to steel 
target plates and left to crystallise and evaporate. The linear positive ion mode on an 
UltrafleXtreme mass spectrometer (Bruker Daltonics, UK) was used in the University of 
Bristol’s mass spectrometry facility. Matrix solution was equal parts water and acetonitrile, 
0.1 % 2,4,6-trifluoroacetic acid (TFA) and a saturating mass of sinapinic acid. 
3.2.7 Electrochemistry  
Optically transparent thin-layer electrochemistry (OTTLE) allows the UV-visible 
properties of different redox species of a sample to be monitored in situ. It was used to measure 
the reversible conversion of ferric to ferrous heme iron species of the maquette proteins. A 
custom built OTTLE cell was constructed from a flat electron paramagnetic resonance (EPR) 
quartz cuvette (Wilmad, USA). Potentials were applied to samples with a platinum working 
and counter electrodes from a Biologic SP-150 potentiostat. An AgCl2 reference electrode 
(BASi, USA) was used. All recorded potentials have been converted to mV vs the Nernst 
hydrogen electrode (NHE) by the addition of 270 mV, determined through calibration with a 
known protein sample. The following mediators were added (potentials are given in mV vs 
NHE): 20 μM methyl viologen (-430 mV), 20 μM benzyl viologen (-311 mV), 20 μM 
anthroquinone-2-sulfonate (-225 mV), 20 μM phenazine (-180 mV), 25 μM 2-hydroxy-1,4-
napthoquinone (-152 mV), 6 μM indigotrisulfonate (-90 mV), 10 μM pyocyanine (-34 mV), 
50 μM duroquinone (5 mV), 20 μM phenazine ethosulfate (50 mV), 20 μM phenazine 
methosulfate (80 mV) and 25 μM 1,2-napthoquinone (130 mV) . 
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120 µl of 50 µM protein samples were prepared with 10% glycerol and mediators in redox 
buffer (100 mM KCl, 20 mM CHES at pH 8.6). This was then pipetted into the cell. The 
working electrode was then submerged into the sample and any bubbles gently removed. 
Next, redox buffer without glycerol was pipetted on top of the sample taking great care not 
to disrupt the interface between sample and buffer. The counter and reference electrodes were 
added to the buffer only layer of the cell. Increasingly reducing potentials were applied to the 
sample followed by increasingly oxidising potentials. Each potential was held for 30 minutes 
to ensure that the cell was well equilibrated. A baseline run was taken in the same conditions 
but without the addition of protein to the sample solution. The baseline readings were 
subtracted from the protein measurements at each potential.   
The ferrous Soret λmax showed the highest dynamic range in absorbance during the 
experiments. It was used to normalise the data to the fraction of reduced protein throughout 
to the experiment. This was plotted against the potential and fitted to either a single (3.1) or 













    (3.2) 
“mV” is an independent variable referring to the applied potential vs NHE. “R” is the 
fraction of ferrous heme iron. “A” and “B” are coefficients corresponding to the maximum 
and minimum values of R, respectively. “Em” refers to the midpoint potential of heme iron. 
3.2.8 Steady-state kinetics assays  
Michaelis–Menten kinetic data were obtained using a KinetAsyst SF-61DX2 Double-
mixing Stopped-Flow Spectrophotometer (Hi-Tech Limited, UK) with a 1 cm path length. 
Reactions were initiated by mixing equal volumes of one solution containing 0.1 µM protein 
and various concentrations of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 
(ABTS) and another solution of 100 µM H2O2. Both solutions were buffered with redox buffer 
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at pH 8.6. The initial linear portion of each trace was fit to a straight line and the gradient 
(∆Abs.Sec-1) determined using an interactive python script. The initial ranges for each 
substrate concentration were then fit to a Michaelis–Menten curve using GraphPad Prism. 
Turnover of ABTS was monitored at 405 nm (ε405 nm = 36,800 M−1.cm-1) [250]. The ABTS 
concentrations used were 1, 5, 10, 20, 40, 80, 100, and 150 µM. 
3.2.9 Total Turnover (TON) 
Turnover number (TON) is the number of moles of substrate that can be turned over 
per mole of enzyme. In an enzyme that is not inhibited by its substrate or product, this can 
be calculated by reacting a small enzyme concentration in an excess of substrate. High 
peroxide concentrations cause destruction of the heme in C45. The high KM for peroxide in 
C45 means that at lower peroxide concentrations reactions proceed very slowly. This 
combination of a high KM and heme degradation made choosing reaction conditions difficult. 
Brief tests were conducted with guaiacol, 2,4,6-Trichlorophenol (TCP) and ABTS as electron 
donating substrates, and glucose oxidase (GOX) and glucose to produce a steady supply of 
peroxide. However, this setup was not taken further as it requires extensive optimisation to 
produce a reliable assay.   
TON assays for all the dW mutants and the WT were conducted in a 96-well format 
on a Synergy Neo2 Plate Reader (BioTek, UK). Six replicate wells were set up for each protein 
with 100 µl of ABTS and protein to be at a working concentrations of 2.4 mM and 10 nM 
respectively. Spectral scans were taken before the injection of 100 µl H2O2 to be at a working 
concentration of 500 µM. Redox buffer at pH 8.6 was used for all samples. ABTS radical cation 
production was monitored and a final absorbance value taken at 120 min. Two controls were 
also set up: one an injection of buffer into a sample of C45 and ABTS; the second was injecting 
H2O2 in to ABTS without any enzyme present. This was used to baseline the results from the 
protein samples. The concentration of ABTS turned over was calculated using the 405 nm 
extinction coefficient (ε405 nm= 36,800 M−1.cm−1) [250]. 
3.2.10 Heme degradation assay 
Heme degradation was monitored using SX20 Stopped-Flow (Applied photophysics) 
fitted with a photodiode array detector (PDA). 8 µM of protein was mixed with 800 µM H2O2, 
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both in redox buffer at pH 8.6 at 25 ˚C. The decrease in Soret λmax was monitored at 405 nm; 
repeated measurements were fit to a two-phase exponential decay using GraphPad Prism.  
3.2.11 Intermediate formation 
Intermediate formation was monitored using a SX20 Stopped-Flow (Applied 
photophysics) fitted with a photodiode array detector (PDA). 8 µM of protein was mixed with 
800 µM H2O2, both in redox buffer at pH 8.6 at 25 ˚C. The increase in 520 nm signal was 
monitored until it started to decay (~5 seconds). Repeated measurements were fit to a one-
phase exponential association using GraphPad Prism.   
3.2.12 Radical scavenging  
Preliminary radical scavenging experiments were conducted with TEMPO (2,2,6,6-
tetramethylpiperidinyl-1-oxy). TEMPO is a stable nitroxide radical that is known to scavenge 
carbon-centred radicals [297]. Two different MS methods were tested.  
The first was using the Proteomics Facility at the University of Bristol. 20 µl reaction 
samples contained: 3 µM C45 or myoglobin, 200 µM H2O2 and 200 µM TEMPO. Controls 
without H2O2 and TEMPO were also prepared. Samples were reacted for 10 minutes before 
tryptic digest overnight by the Proteomics Facility. Fragments were then analysed by nano-
LC MSMS using an Orbitrap Fusion Tribrid mass spectrometer (Thermofisher, UK).  
The second method was without tryptic digest and using MALDI-TOF MS. 50 µM 
protein, 500 µM H2O2 and 2000 µM TEMPO were made up in 5 µl reaction volumes. After 10 
minutes incubation at room temperature, samples were prepared by the same methods as 
described in Section 3.2.6.  
3.2.13 EPR 
Electron Paramagnetic Resonance (EPR) was performed at the Manchester Institute of 
Biotechnology (The University of Manchester, UK). An ELEXSYS E580 
spectrometer (Bruker, UK) was operated by Dr Muralidharan Shanmugam (The University 
of Manchester) who also gave advice on sample preparation. X-band cw-EPR spectra were 
recorded of the resting state and radical protein samples at 12 K. A narrow magnetic field 
sweep of 100 Gauss was used to sample the radical signal. Samples of the resting state were 
220 µl of 300 µM protein in redox buffer pH 8.6. These were loaded into quartz EPR sample 
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tubes and carefully frozen in liquid nitrogen. Radical samples were produced by mixing 220 
µl of 300 µM protein with 24 µl of 10 mM peracetic acid (PAA) in redox buffer pH 8.6. The 
working concentration of PAA was then close to 1 mM. Samples were then rapidly loaded in 
to sample tubes and frozen in liquid nitrogen. Care was takes to avoid sample tube fracture 
during freezing. The time taken for mixing, loading and freezing was around 3 seconds. 
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3.3 Results 
3.3.1 Design and mutagenesis 
The template used for producing the tryptophan knockout (dW) mutants was the vector 
containing C45 (the mono-his ligated c-type maquette), produced in Section 2.3.1. Primers 
were designed to remove W8, 43 and 80 replacing them with phenylalanine. Primers for 
mutating phenylalanine 56 to tyrosine were also produced. Table 3.3.1 shows the sequential 
mutations made. The dW3 naming convention corresponds to the full tryptophan knockout. 
The name dW2.1 corresponds to the mutant with two tryptophan residues knocked out with 
one remaining in the first position. The mutagenesis was determined to have been successful 
by sequencing the relevant portion of the plasmid (Eurofins, MWG).  
Protein Amino acid at position 8 43 46 80 
C46 W W H W 
C45 WT W W F W 
dW3 W8,43,80F F F F F 
dW3Y W8,43,80F F46Y F F Y F 
dW2.1 W43,80F W F F F 
dW2.2 W8,80F F W F F 
dW2.3 W8,43F F F F W 
dW1.1 W8F F W F W 
dW1.2 W43F W F F W 
dW1.3 W80F W W F F 
dW1.1Y W8F F46Y F W Y W 
dW1.2Y W43F F46Y W F Y W 
dW1.3Y W80F F46Y W W Y F 
dW2.1Y W43,80F F46Y W F Y F 
dW2.2Y W8,80F F46Y F W Y F 
dW2.3Y W8,43F F46Y F F Y W 
Table 3.3.1 Tryptophan knock-out genes produced 
This table details the maquette genes produced by sequential SLIM mutagenesis of C45. The protein 
names in bold were investigated in this chapter. The genes below the dotted line were not used to express 
protein but were produced for possible further study.  
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Figure 3.3.1. Design of tryptophan knock-out maquettes 
The coloured residues in the protein sequence correspond to the coloured residues displayed both in the loop 
schematic and the bundle schematic. The cylinders represent the helices of the maquettes with the grey 
shaded portion depicting hydrophobic residues. 
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3.3.2 Expression and purification  
 
Figure 3.3.2 SEC and SDS-PAGE results for dW mutants. 
For each protein the 280 nm and 400 nm SEC trace is shown. The x-axis shows the accumulated volume 
(in ml). The first peak in each case is the void volume eluting around 43 ml after injection. Below each 
trace is the SDS-PAGE results of the purification. The bands (not including the ladder) start with the cell 
lysate then “25% B elution” which is a wash of proteins weakly associated to the first nickel affinity 
column. The “TEV end” lane is the elution from the first nickel affinity column after the cleavage of the 
his-tag. The “TEV elution” is the elution from the second nickel column containing contaminants that 
bind to nickel and uncleaved sample protein. The remaining bands are samples of 3 ml fractions from the 
SEC purification of the flow-through from the second nickel column. 
 
The expression and purification of the tryptophan knockouts was performed in the 
same way as C45 in Section 2.2.2. The new maquettes expressed and incorporated heme well. 
Figure 3.3.2 shows a size exclusion chromatography (SEC) trace and SDS-PAGE results for 
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each of the mutants during the purification. The SEC traces show that the maquettes are not 
in a homogeneous conformation and may associate transiently as dimers at pH 8.6.  
3.3.3 UV Visible spectroscopy 
 The UV visible spectrum of the resting state ferric (Fe3+) and oxidised ferrous (Fe2+) 
heme of all the tryptophan knockout mutants (dW) were recorded. The ferrous spectrum 
shown in Figure 3.3.3 are taken from OTTLE experiments. Traces were all normalised to the 
Soret λmax value of the WT protein before conducting the curve fitting. Fityk curve fitting 
software was used to deconvolute the spectra of the ferrous maquettes [298]. It allowed the 
intensity of the 430 nm shoulder peak to be quantified (see Figure 3.3.4.B).  
 
Figure 3.3.3 UV-Visible spectroscopy of dW mutants. (A) and (B) are the spectra of the 
maquette in the ferric form. (B) is the same results as (A) in a staggered arrangement. (C) and (D) are 
the spectra of the reduced maquettes in the ferrous form. (D) is the same results as (C) in a staggered 
arrangement. 
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Table 3.3.2 Deconvoluted UV visible peaks. Fityk curve fitting software was used to deconvolute the 
Soret and Q bands. The Soret peak could be fit with just the Soret λmax and 430 nm shoulder peak, but 
including a third absorbance peak (Soret 0 at 413 nm) resulted in a better fit. 
 
The positions of the peaks of all the dW mutants are very similar to C45, differing by 
only 1 nm or less. There is a clear reduction in the 280 nm absorbance in the dW mutants 
compared to C45 (see Figure 3.3.4.A). This is expected as tryptophan contributes to 
absorbance at 280 nm There is no observable increase in 275 nm absorbance for the tyrosine 
mutant (dW3Y).  
 
 
Figure 3.3.4 Ferric 280 nm signal and ferrous 430 nm shoulder heights comparison. 280 
nm values for (A) were taken from ferric spectra normalised to the Soret λmax of C45. Values for (B) were 
derived using Fityk curve fitting software on the normalised ferrous spectra.  
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3.3.4 CD  
CD spectrum of the WT and dW mutants shows the typical absorbances for α-helical 
proteins. These are negative bands at 222 nm and 208 nm and a positive band at 
193 nm [299]. The positive band at 193 nm for the dW3 mutant is particularly pronounced. 
dW3Y is the only mutant to show a significant spectral difference in helical signal. dW3Y is 
less helical and has a lower melting temperature TM = 76 ˚C. The melting temperatures for 
the single tryptophan mutants (dW2.1-3) are all very similar and only 3 or 2˚ lower than the 
WT. The refolding experiments conducted with dW3 and dW3Y show refolding but to a lesser 
extent than observed in C45 WT (Figure 2.3.4).  
 
Figure 3.3.5 CD results comparison for dW mutants.  
(A) and (C) show the folding and re-folding of dW3 and dW3Y between 5 and 95 ˚C, the trace 
monitors the mean residue ellipticity (θ) at 222 nm. (B) shows a comparison of the CD spectrum of the 
five dW mutants and the WT at 25 ˚C. (D) is a comparison of the same 6 proteins unfolding from 5 to 
95 ˚C. Table (E) displays the Tm of unfolding calculated as the temperature with the maximal gradient. 
All experiments were conducted with 10 µM protein in Redox buffer at pH 8.6. 
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Figure 3.3.6 CD thermal melt spectrum scans for dW mutants and C45. Scans of melts for 5-
95 ˚C are displayed as solid lines going from red to yellow. Scans of cooling experiments from 95-5 ˚C 
are displayed as dashed line from light to dark blue. All experiments were conducted with 10 µM protein 
in Redox buffer at pH 8.6. 
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3.3.5 Molecular dynamics 
The MD of each protein was run in four replicates of 100 ns each. Each replicate had 
unique starting velocities and solvation patterns to increase the level of conformational 
sampling. The mutations did not cause any large structural changes from the WT C45. Figure 
3.3.8.A shows the average and variance of the RMSD in each protein compared to an average 
backbone structure of all proteins. The RMSD are all near 1.5 Å and stable indicating that 
they all adopt very similar structures.  
 
Key: C45 WT - dW3 FFF - dW3Y FFYF - dW2.1 WFF - dW2.2 FWF - dW2.3 FFW  
Figure 3.3.7 MD structures. The colour of each structure corresponds to the colour key above. (A) 
is an alignment of MD structures from each of the 6 maquettes. (B) shows the same viewpoint as (A) 
with the backbone ribbons made transparent to show the positions of mutated residues more clearly. The 
labels correspond to the residues in C45 WT. (C) is the structures that make up (B) separated for clarity.  
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Figure 3.3.8 Averaged MD data. (A) is the average RMSD from all frames of all four replicates. 
The RMSD is compared against to an average backbone structure of across all replicates of all mutants. 
(B-E) shows the shortest distance between the heavy atoms of the heme conjugated system and heavy 
atoms of the side chain conjugated system for the WT positions; W8, W43, F46 and W80 respectively. 
The shortest distance was measured at each frame (every 100 ps) and the value graphed is an average 
across all frames and replicates. The error bars show the standard deviation. The white letters at the 
bottom of each bar are the residue in that position for that protein.   
 
The shortest distance between the heme and the side chain was defined as the shortest 
distance between the heavy atoms of the heme conjugated system and heavy atoms of the side 
chain conjugated system. These average distances for each residue position deviate by less 
than 1 Å from each other. The most notable structural change is that the W8F mutation 
moves to sample a more buried conformation (seen in Figure 3.3.7: dW3, dW3Y and dW2.2 
FWF). The mutation W80F also causes the W8 position to sample conformations, on average, 
slightly closer to the heme as it causes a small movement in the end of the first helix. The 
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combination of the four mutations in dW3Y has also caused the existing kink in the second 
helix to grow. The π-stacking interaction seen in C45 WT between F46 and the heme is 
maintained in all mutants including dW3Y, with the F56Y mutation. The side chains of K52 
and Q45, which are likely to play a role in the catalytic cycle of these peroxidase maquettes, 
are found close to the heme edge in all mutants. K52 samples a conformation that hydrogen 
bonds to the heme propionates in all mutants with a variance comparable to C45 WT.  
3.3.6 Mass Spectrometry 
MALDI-TOF MS with a sinapinic acid matrix was performed for the WT and all dW 
mutants. The laser intensity required was 95 % of its maximum which could be the cause of 
some fragmentation and mass adducts. All the major mass peaks shown in Table 3.3.3 are 
heavier than expected. Common MALDI adducts and their mass increases include: hydrogen 
(1), oxygen oxidation (16.0), water (18.0), sodium (22.8), potassium (39.0) and methyl 
cyanide (42.0). The protein sample buffer contained potassium ions. The inclusion of a 
potassium adduct and the high laser strength causing degradation or fragmentation could 
account for the variability in the observed mass. Figure 3.3.9 shows the major mass peaks in 
the region 14000 to 16500 m/z. Lower mass peaks, corresponding to the doubly ionised 
analyte, were seen in all samples. In the samples with higher signal intensities, very small 
peaks at double the mass of the major peak could be seen, corresponding to protein dimers. 
 
 
Figure 3.3.9 Mass spectra.  The peaks show an overlay of the mass peaks for all samples. The y 
axis is the intensity in arbitrary units. The scale bar is 20,000 (AU). The spectra have been clipped to 
show the major peaks of the samples. Lower mass peaks were present in all samples for the doubly ionised 
analyte. 
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Comparing the difference between the WT and mutant masses shows mass changes 
consistent with the mutations being successful. The greatest deviation in mass from the WT 
was for the dW3 mutant which has three tryptophan residues removed.  The mutants with 
two tryptophan residues removed (dW2.1-3) are all a similar mass, closer than the other 
mutants to the WT mass.  
 
Table 3.3.3 MADLI mass peak compared to predicted mass. The first row shows the mass of the 
major peak from MALDI TOF MS. The second row shows the difference between the WT mass peak and 
the other samples. The third and fourth rows show the predicted mass of the protein with heme and the 
difference from the WT protein expected with each mutation. The last row shows the difference between 
the experimental mass and predicted mass. 
3.3.7 Electrochemistry (OTTLE) 
Figure 3.3.10 shows the midpoint potentials fit from spectra taken during the OTTLE 
experiments. The midpoint potentials of dW3, dW3Y and dW2.3 FFW are all quite similar, 
between 6 and 7 mV more positive than the WT. The midpoint potential for dW2.2 FWF and 
dW2.1 WFF mutants are 10 and 15 mV more positive than the wild type. Changes in the 
heme environment lead to changes in the midpoint potential of the heme. The changes in 
midpoint potential do not seem additive with removal of two and then three of the tryptophan 
residues. This would suggest that the changes are down to subtle structural rearrangements 
associated with adding more hydrophobic residues to the core of the protein.  
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Figure 3.3.10 OTTLE results. The fraction of reduced protein has been fitted to a single electron 
Nernst equation. The midpoint potentials (EM) are shown on each graph. The values taken during the 
reduction are shown in circles and the subsequent oxidation values are shown as squares. All EM values 
from the curve fitting have a standard deviation of less than 1. 
3.3.8 Steady-state kinetics with ABTS  
The steady-state kinetics for the tryptophan mutants was performed using ABTS as an 
electron-donating substrate and with 100 µM H2O2. The kcat values for the different mutants 
remained similar to the WT. The exception to this was the dW2.2 FWF mutant which showed 
a 0.8 s-1 reduction from the WT. All the dW mutants show a decrease in KM which, in classical 
Michaelis–Menten kinetics, would indicate that the enzyme requires a lower concentration of 
substrate to become saturated. Including the tyrosine at position 46 in the dW3Y mutant 
increases KM. There is also a slight increase in KM moving from the dW3 mutant to those with 
a single tryptophan remaining, the greatest increase coming from the dW2.2 FWF mutant 
where the tryptophan is in the position close to the heme. As a result of the decrease in KM, 
the kcat/KM for dW3, dW2.1 WFF and dw2.3 FFW have more than doubled.   
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Figure 3.3.11 Steady-state results for dW mutants. 
(A) Steady-state kinetics at (rate-limiting) 100 µM H2O2, fitted to a Michaelis–Menten curve. (B) 
shows the kcat* values at rate limiting H2O2. (C) shows the KM values. (D) shows the kcat*/KM values. 
Error bars represent the standard deviation. 
 
Enzyme Substrate kcat* (s-1) KM (µM) kcat/KM (M-1s-1) Condition 
C45 WT ABTS 2.0* ± 0.028 3.10 ± 0.21 6.4 ± 0.43 x10 5 pH 8.6 
dW3 FFF ABTS 1.7* ± 0.033 0.98 ± 0.15 1.7 ± 0.27 x10 6 pH 8.6 
dW3Y FFYF ABTS 1.9* ± 0.026 2.20 ± 0.16 8.7 ± 0.64 x10 5 pH 8.6 
dW2.1 WFF ABTS 2.0* ± 0.025 1.30 ± 0.11 1.6 ± 0.14 x10 6 pH 8.6 
dW2.2 FWF ABTS 1.2* ± 0.023 1.60 ± 0.19 7.4 ± 0.92 x10 5 pH 8.6 
dW2.3 FFW ABTS 1.8* ± 0.023 1.40 ± 0.11 1.4 ± 0.11 x10 6 pH 8.6 
Table 3.3.4 Comparison of dW mutant kinetic results. 
The Michaelis–Menten kinetic fit results for ABTS with the dW mutants and WT (column 1) have 
been tabulated. The * result is that kcat* has been obtained at limiting H2O2 with 100 nM C45 and 100 
µM H2O2. The ± errors quoted are standard deviation. 
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3.3.9 Turnover Number (TON) 
The turnover number (TON) is a measure of the number of moles of substrate a mole of 
enzyme can turnover. High experimental variation and relatively few repeats (n=6) meant 
that only comparisons of the WT to dW3Y and WT to dW2.2 are statistically different (using 
a Tukey's multiple comparisons test). If the trend of this result was extended over further 
repeats it would suggest that retaining the tryptophan has a protective effect on the C45 WT 
and that the effect comes from the tryptophan residues far from heme.  
 
Figure 3.3.12 Turnover number dW mutants with ABTS.  
Means are displayed above each bar. Error bars shown are the standard deviation. 
 
3.3.10 Heme degradation assay 
The fast rate of the two-phase exponential decay corresponds to the formation of the 
reactive intermediate. The slow rate is the degradation of the heme by the reactive 
intermediates in the absence of an electron donating substrate. dW3 and dW2.1WFF have a 
notably faster kfast rate. The dW2.2 FWF mutant with a tryptophan still close to the heme has 
a kfast comparable to the WT. Having tryptophan or tyrosine residues near the heme appears 
to slow the rate of formation of compound I. 
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Figure 3.3.13 Soret peak changes on mixing with H2O2. 
(A) Shows an averaged trace of Soret peak at (405 nm) decrease fitted to a double exponential decay. 
Traces have been staggered for ease of viewing. (B) and (C) show the kfast and kslow rates from the results 
of the curve fitting. The error bars show the standard deviation. 
  
kFast (s-1) kSlow (s-1) 
C45 WT 0.84 ± 0.0042 0.055 ± 0.00029 
dW3 FFF 1.7 ± 0.0075 0.05 ± 0.00016 
dW3Y FFYF 1.0 ± 0.0089 0.062 ± 0.00044 
dW2.1 WFF 1.5 ± 0.011 0.052 ± 0.0003 
dW2.2 FWF 0.83 ± 0.002 0.05 ± 0.00014 
dW2.3 FFW 1.1 ± 0.0038 0.049 ± 0.00015 
Table 3.3.5 Heme degradation rates. The rates for the fast and slow phases of the decay are 
tabulated for each protein sample investigated. The ± errors are the standard deviation.  
 
The kslow rate is increased compared to the WT in the dW3Y mutant with a tyrosine in 
the distal site above the heme. All other dW mutants have a reduced kslow rate compared to 
the WT. This suggests that tryptophan residues do not have a protective effect against heme 
degradation in the absence of an electron donating substrate. The opposite seems more likely 
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to be the case as the mutant with the closest protein radical-forming residue shows the fastest 
degradation. 
3.3.11 Intermediate formation 
Intermediate formation was monitored by the absorbance increase at 520 nm on 
mixing of 8 µM protein with 800 µM H2O2. Figure 3.3.15 shows a comparison of the C45 WT 
and dW mutants intermediates with HRP, CcP and AXP intermediates. The Soret λmax  of HRP 
is blue shifted on  compound I formation and then red shifted in compound II formation 
[300].  There also is an increase in absorbance in the 600-700 nm range in HRP compound I. 
HRP compound I forms a porphyrin radical cation whereas CcP forms a stable compound I 
intermediate with a tryptophan protein radical [301]. The Soret peak of CcP compound I is 
significantly red shifted and, unlike HRP, it has distinct peaks at 530, 560, and 632 nm [301]. 
This characteristic signal in the Q-band region of CcP is similar to HRP and AXP compound 
II signals.  
The C45 WT and dW mutants all produce similar intermediate spectra. The Soret λmax 
in all the maquette intermediates is red shifted compared to the ferric absorbance. The two 
major peaks in the Q-band region are blue shifted by about 10 nm compared to CcP compound 
I and HRP and AXP compound II. All the intermediates including the dW3 without any 
tryptophan residues form an intermediate similar to CcP compound I and HRP and AXP 
compound II. This would seem to suggest that the isolated maquette intermediate could be 
compound II rather than compound I. A measure of the definition of the intermediate Q-band 
peaks is seen in Figure 3.3.15.B. The dW3 mutant has the most defined intermediate spectral 
peaks with the intermediate peak absorbance (520 nm) greater than the trough (496 nm) by 
a ratio of 1.21. C45 WT has the least defined spectra followed closely by the mutant with the 
closest tryptophan (dW2.2 FWF) with ratios of 1.07 and 1.10.  
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Figure 3.3.14 Intermediate UV-visible spectra. The coloured trace on each graph shows the ferric 
resting spectrum at (t = 0.001 seconds). The black trace show the intermediate formed at (t=4 seconds). 
In each panel an inset enlargement of the Q-band region is included. 
 
 
Table 3.3.6 Q-band intermediate peak positions for dW mutants. 
 
520 nm was seen to have the greatest dynamic range during intermediate formation and 
was chosen to track formation over time (Figure 3.3.16). Change in 520 nm absorbance, for 
repeated measurements, were fit to a single-phase exponential association. The results 
reproduce the trend of the results in Figure 3.3.13.B. The rate of formation of the intermediate 
is fastest in the dW3 and dW2.1 WFF mutants followed by dW3Y and dW2.3 FFF. The dW2.2 
FWF and the WT maquette, which both have a tryptophan at the same end of the bundle as 
the heme, are the slowest to form the intermediate.  
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Figure 3.3.15 Intermediate spectra comparison. 
 (A)The coloured lines are an overlay of the intermediate at 4 seconds, seen in the inset of the previous 
figure. The solid and dotted  teal lines are HRP compound I (Cpd I) and compound II (Cpd II) 
respectively, taken from Berglund et al. [300]. The black solid and grey dashed lines are the spectra of 
CcP compound I and AXP compound II respectively, taken from Gumiero et al. at [301]. The y-axes of 
the HRP, CcP and AXP spectra have been scaled to produce this figure. They are not on the same scale as 
the coloured maquette traces, or each other. (B) shows the ratio of 520 to 496 nm absorbance. These 
positions are the peak and trough of the upper Q-band region. The ratio gives a measure of the definition 
of the intermediate heme spectra.  
 
 
Figure 3.3.16 Rate of formation of reaction intermediate.  
(A) Shows the average spectroscopic changes at 520 nm fit to a single exponential association curve. 
Only the initial association was plotted, not subsequent decay. Data for the 6 proteins was clipped 
between 4 and 8 seconds. 
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3.3.12 Radical scavenging 
Attempts were made to identify a protein radical using a spin scavenging adduct, 
TEMPO. Myoglobin is known to from a tyrosine radical on mixing with H2O2, which can then 
form a covalent adduct with TEMPO [302]. Myoglobin was used as a positive control for 
experiments with C45.  
The first attempt was made using the Proteomics Facility at Bristol University. 
Reactions with protein, H2O2 and TEMPO were analysed, after a tryptic digest, on nano-LC 
MSMS. No fragments were detected with the TEMPO adduct on C45 or myoglobin. In both 
the reaction with H2O2 and the controls without H2O2, 100% coverage of the C45 and 
myoglobin sequences was achieved.  
A second attempt, without tryptic digestion, was performed using MALDI TOF MS to 
detect any changes in mass. No mass change was detected between the myoglobin samples 
with and without H2O2 and TEMPO. The same was also true of C45. The C45 mass spectrum 
after mixing with H2O2 and TEMPO had very low signal intensity. 
 
3.3.13 EPR  
Electron Paramagnetic Resonance (EPR) spectra were collected for C45 WT and the 
dW mutants in the resting ferric state and for the radical intermediate. The radical 
intermediates were generated using peracetic acid (PAA). PAA was used instead of H2O2 as 
it is a stronger oxidising agent and may improve radical signal. Reaction with PAA has been 
shown to form spectroscopically identical intermediates in all maquettes so far tested [70]. 
Figure 3.3.18.A shows the EPR features labelled with their g-tensor values. All resting state 
spectra had the following signals: high spin axial heme iron (s = 5/2 at g = 5.943 and 2.032), 
low spin heme iron (s = 1/2 at g = 2.265) and high spin non-heme iron (g = 4.270 ) [286, 
303, 304]. The adventitious free iron signal could be a result of iron binding to the negative 
surface of C45 during the purification. These g-tensor values for these signals were the same 
(or within the error of the measurement) for all the dW mutants and WT.  
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Figure 3.3.17 Wide sweep EPR spectra. The black line on each graph is the resting state spectrum. 




Figure 3.3.18 EPR spectra annotated. (A) Is the spectra of C45 WT mixed with PAA. The EPR 
signals at all magnetic field positions are labelled with their g-tensor value. (B) is a comparison of the 
amount of radical produced in each sample. It is calculated by taking a double integral of the EPR 
absorption spectra of each radical.   
 
All of the dW mutants and the C45 WT produce a radical signal on mixing with PAA, 
seen in Figure 3.3.18.A labelled with a “g” value of 2.002. WT and all double tryptophan 
mutants (dW2.1-3) have a “g” value of 2.002 or 2.0019 which is consistent with them all 
having the same type of radical signal. dW3 and dW3Y radical signals have "g" vales of 2.0017 
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and 2.0024. This taken with the shape of the radical signal would suggest that they are 
different radical species. As the same amount of sample was used in each experiment the 
amount of radical signal can be directly compared. A double integral of the EPR absorption 
spectra of each radical gives a convenient comparison of the amount of paramagnetic radical 
signal seen in Figure 3.3.18.B. 
 
Figure 3.3.19 A comparison of radical signal. Narrow magnetic field sweeps (150 Gauss) of the 
radical signal in each sample were taken. The signal was then moddeled (see Appendix C.1) and the 
g-tensor calculated and displayed for each sample. 
 
  
3.4. Discussion  
  155 
3.4 Discussion  
The tryptophan knockout mutants display characteristic UV-visible absorbance and mass 
changes expected from mutating tryptophan residues to phenylalanine. All mutants are 
expressed and incorporate heme at a similar level as C45 WT. CD melts shows that all of the 
proteins are thermostable with highly α-helical structure. The dW3Y mutant has a reduced 
helical content and a decrease in melting temperature (TM = 76 ˚C), whereas all other 
proteins have close to identical amounts of helical content compared to C45 WT (Figure 
3.3.5). These results taken with the results for molecular dynamics simulations suggest that 
the mutants are folded to a similar level to C45.  
Generally, MD simulations only sample protein conformations in energetic minima close 
to the starting structures which may not be the global minima. Without atomistic structural 
information, it is not possible to say with certainty that structural or topological changes, 
introduced by making the mutations, are not the cause of any change in behaviour of the 
mutants. However, the striking similarity in the UV-visible, CD and MD results would lead 
to the assumption that large changes in the structure and topology of the four-helical bundles 
has not occurred. If structural changes have occurred, then the CD results seem to suggest 
the dW3Y had the largest deviation from the C45 WT. The midpoint potential of the dW 
mutants, other than dW2.1, are within 11 mV of C45. All mutations have caused a more 
positive shift. These relatively modest shifts are in line with all six maquettes having a c-type 
heme in a similar environment to the WT.  
The main trend observed in kcat*, is that having a tryptophan close to the heme has a 
negative effect (Figure 3.3.11). Having redox-active tryptophan residues far from the heme 
(WT, dW2.1 WFF and dW2.3 FFW), no tryptophan residues (dW3), and having only an 
tyrosine above the heme (dW3Y) are all significantly preferable to having a single tryptophan 
close to the heme (dW2.2 FWF).  For all the mutants, there is a decrease in KM with 
decreasing the number of tryptophans. For hydrophobic small molecules, the mutations could 
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cause an increase in binding affinity by creating a more hydrophobic core with slightly less 
steric bulk. 
The result of the kcat* and KM changes is that mutants without redox-active residues close 
to the heme show a more than doubling of catalytic efficiency (kcat/KM) (Figure 3.3.11). This 
trend has been observed in CcP when the sequential removal of seven redox-active residues 
resulted in increased catalytic efficiency towards a small molecule substrate [295]. In C45 and 
its mutants this trend could be explained if substrate binding is not near the protein radical 
sites or if the proteins radicals are less productive in oxidising electron-donating substrates. 
If productive substrate binding is predominantly at the heme edge, then formation of the 
protein radical away from this site could cause a decrease in kcat/KM. The computational 
binding study of C45 (in Section 2.3.12) predicted ABTS binding predominately at the heme 
edge which is in line with the hypothesis that having alternative radical sites may reduce the 
efficiency of turnover. To test this further it would be interesting to compare steady-state 
kinetics of TCP, amplex red or other small molecules that are predicted to predominantly bind 
in other regions of the protein.  
 To probe the changes to the reaction mechanism further it would be helpful to investigate 
the H2O2 dependant changes and fit the results to a ping-pong mechanism. This might be 
particularly informative for the dW3Y mutant as the changes to the distal heme surface may 
well impact on peroxide binding and activation.   
The results of the total turnover number experiments would tentatively suggest that the 
tryptophan residues may make the peroxidase maquettes more resilient to degradation during 
catalysis (Figure 3.3.12). Tryptophan residues may provide an electron reserve for reaction 
cycles that occur in the absence of an electron donating substrate. However, these 
experiments require further repetition and optimisation to be considered reliable. As further 
work, an assay with glucose oxidase and superoxide dismutase producing a steady supply of 
H2O2 without any other oxygen radicals could be the best way of testing the total turnover 
number in peroxidase maquettes. Reactions of glucose and glucose oxidase quickly become 
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limited by the diffusion of oxygen into solution. With the right optimisation, mixing could 
then be used as a method of controlling H2O2 production. 
In contrast to the total turnover number experiments, the heme degradation assay showed 
almost the opposite trend (Figure 3.3.13). When mixing protein and H2O2 in the absence of 
an electron-donating substrate the rate of bleaching of the Soret peak was slowed in all the 
dW mutants compared to the C45 WT. The exception to this was dW3Y, with a tyrosine 
above the heme, which degraded quicker than the C45 WT and had the lowest TON. Moving 
from three to one to no tryptophan residues did not seem to produce an additive effect in the 
rate of heme degradation. This behaviour would suggest that removing redox-active residues 
from the protein helps to stabilise the compound I intermediate. This has been observed in 
CcP, where the rate of compound I decay was seen to decrease as more redox-active residues 
were removed from the protein [295].  
Removing two tryptophan residues from CcP also produced better defined UV-visible 
absorbance peaks for compound I [295]. This was also seen to be the case with the dW 
mutants of C45 (Figure 3.3.15). The dW3 mutant had the best-defined compound I 
absorption peaks in the Q-band region. The dW2.3 FFW, with the tryptophan furthest from 
the heme, has the second best defined intermediate spectrum. C45 WT and dW2.1 FWF have 
the worst defined compound I absorption peaks which suggests that tryptophan 43 closest to 
the heme affects the electronic environment of the heme the most. Other than this change in 
peak definition, the maximal absorbance of the peaks in all mutants were at very similar 
wavelengths. The major Q-band absorbance in all proteins under investigation was within 
0.5 nm of 523 nm, except for dW3Y which had a slight blue shift to 521.3 nm.  
The intermediate species in the c-type heme maquettes look most like compound I of CcP 
or compound II of AXP and HRP (Figure 3.3.15.A). This initially suggested that compound I 
in the maquette peroxidases may be very short lived and that the spectroscopic observations 
were of compound II. However, EPR spectroscopy suggested the presence of a radical species 
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in the maquette intermediate. As compound II does not have a radical species we could 
speculatively assign the maquette intermediate as compound I.  
The EPR spectrum taken of the radical intermediates was not able to conclusively assign 
which radical is being formed. All the maquettes containing any tryptophan residues produced 
radical signals with g-tensor values that are the same within the error of the measurement. 
Somewhat similar spectra have also been obtained for CcP compound I [305]. This could 
suggest that in a high concentration of oxidising substrate and without an electron-donating 
substrate even the tryptophan residues 25 and 27 Å away from the heme edge form protein 
radicals. However, the size of the tryptophan radical signal in CcP at g = 2 is 18-20 G whereas 
the maquette radical signals at about 8 G [306].   
 One possible confounding factor, which has not been investigated, is the potential for the 
maquettes to form dimers. Size exclusion chromatography of the maquettes shows that they 
do not run as a single species, but denaturing SDS PAGE reveals only one protein. As all the 
tryptophan residues are at the protein surface even transient association, at the high 
concentrations necessary for EPR, could lead to radical formation on an associated protein. In 
the first instance, possible dimerization could be investigated with a computational binding 
study to give an idea of if dimerization is feasible and the location of possible dimer interfaces. 
However, C45 has been designed with highly negative surface specifically to discourage 
dimerization. Additionally, SEC results are not conclusive evidence of dimerisation in 
solution. The proteins standards for SEC are only a rough estimate of size for proteins that 
have an extended rather than globular conformation. previous maquettes have shown similar 
SEC results but do not have a melting temperature that is concentration dependant which 
would be expected for samples that dimerise [111]. 
The dW mutants without tryptophan residues have radical signals that have slightly 
different g-tensor values and shapes (Figure 3.3.19). It was not possible to conclusively assign 
these signals so the dW3 signal is speculatively assigned as a porphyrin radical. The spectrum 
of the dW3Y radical only shows an isotropic EPR signal without g-anisotropy or hyperfine 
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coupling to the beta-methyl protons which are normally observed in tyrosine radical spectra 
[307]. Dehaloperoxidase is an example of a peroxidase that forms a typical tyrosine radical 
EPR spectra with hyperfine coupling interactions [308]. dW3Y cannot be assigned as a clear 
tyrosine radical but its radical signal is different from both the porphyrin radical (dW3) and 
tryptophan radical (dW2.1-3 and WT) signals.  
To conclusively assign the radical species, further work on the radical scavenging 
experiments is needed. Work to reproduce the radical scavenging detection used for 
myoglobin and CcP would be the first step. Wright and English were able to detect radical 
adducts only after tryptic digest using electrospray ionization MS [302]. The preliminary work 
in this project suggests that using MSMS after digestion is not a suitable method of detecting 
TEMPO-protein adducts. TEMPO adducts were not seen in ESI MS of intact proteins, which 
is thought to be a result of the steric hindrance of the protein destabilising the adduct [296]. 
In this work MALDI TOF MS of haemoglobin and C45 was also not able to detect TEMPO 
radical adducts, presumably for the same reason. 
An alternative hypothesis could be that C45 acts in a similar way to the non-native 
peroxidase activity of Cytochrome c (Cyt c). Mitochondrial Cc is the c-type heme protein that 
is the native substrate for CcP [309]. Under normal conditions the heme in Cyt c is bis-ligated 
by His18 and Met80. During apoptosis there is an increase in Cyt c binding and oxidation of 
an inner-membrane mitochondrial phospholipid called cardiolipin (CL) [310]. The binding of 
CL to Cyt c induces the dissociation of the Met80 ligation on the heme iron increasing its 
peroxidase activity [311].  
Work by Rajagopal et al. on a Cyt c G41S mutant that displays enhanced peroxidase activity 
indicates, that the c-type heme is not able to form stable intermediates observed in the 
classical peroxidase reaction cycles [312]. They were not able to convincingly isolate an 
intermediate UV-visible spectrum and saw heme degradation in the presence of H2O2 and CL 
[312]. EPR spectroscopy of the peroxidase was not able to assign the g = 2 radical signal to 
either of the tyrosine residues postulated to be the location of the protein radical. They 
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concluded that the radical signal is a result of the superimposition of many different protein-
bound radicals. They also observed a marked increase in the g = 4.2 free high spin iron signal 
during peroxidase turnover and rationalised this to be the result of heme degradation [312]. 
The g = 4.2 signal was not observed in the Cyt c control but first appeared after the addition 
of CL, and then grew further, over 200 seconds after the addition of H2O2.  
The Cyt c and its tyrosine mutants g = 2 radical signals show a very similar trend to what 
is seen in C45 and its dW mutants. This in combination with the lack of g-anisotropy or 
hyperfine coupling to the beta-methyl protons, and the failure of the TEMPO radical trapping 
experiments, could suggest that the radical signal in the maquettes is also a result of the 
superimposition of many different protein-bound radicals [302, 307, 308]. An arguable 
difference between C45 and Cyt c, is that the g = 4.2 free high spin iron signal in C45 does 
not show as marked an increase after adding H2O2 to resting state enzyme. This could suggest 
lower levels of heme degradation in the maquettes compared to Cyt c. 
The picture of radical formation in the maquette peroxidases is a complex one. Like 
natural peroxidases, C45 and its dW mutants can function with and without tryptophan 
radicals. One possible explanation of the results of this chapter could be that in the absence 
of electron-donating substrate all three tryptophan residues on C45 are capable of producing 
tryptophan radicals. Experiments with an electron donating substrate suggest the more 
distant tryptophan residues are not as kinetically relevant as the closest tryptophan residue. 
With ABTS as an electron donor, which is predicted to primarily bind at the heme edge, 
having redox-active residues producing alternative radical sites reduced the efficiency of 
turnover. Tryptophan residues in C45 may make the enzyme more resilient (increased TON), 
though more work is required to develop a reliable assay for this measure.  
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Chapter 4 
4 Computational investigation of 
peroxidase protonation state 
4.1 Introduction 
The de novo peroxidase C45 was inspired by the structure of natural peroxidases that have 
a penta-coordinate heme ligation. This chapter discusses high level QM (Quantum 
Mechanics) calculations of the reactive cycle of the natural peroxidases. The two peroxidases 
investigated are Cytochrome c Peroxidase (CcP) and Ascorbate Peroxidase (AXP). As 
discussed in Section 1.8, the role of the distal histidine in the peroxidase reaction mechanism 
is a subject of ongoing debate. Neutron cryo-crystallography structures of compound I and II, 
in CcP and AXP respectively, challenged the existing mechanism of proton delivery. In the 
formation of compound I the distal histidine was assumed to shuttle a proton from the 
peroxide to form compound 0, and then back to the peroxyferric species to form compound I 
(Figure 4.1.2.A) [198, 199].   
 
Figure 4.1.1 Naming convention for histidine tautomers in AMBER [229]. 
 
The focus of these calculations is to examine the proposed protonation states of the distal 
site histidine from high resolution neutron cryo-crystallography structures [5, 6]. These 
structures show that the distal histidine dHIS is in a doubly protonated state (dHIP). To probe 
the possible mechanistic differences between the two protonation states each species (ferric, 
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compound I and compound II) was setup in pairs with either dHIP or dHID. Understanding 
and testing these calculations in the natural systems could then pave the way for their use in 
models of the de novo system, informing potential designed changes in the protein 
architecture.  
 
Figure 4.1.2 Compound I formation mechanisms. (A) shows the traditional “wet” mechanism 
[198, 199]. (B) shows the mechanism adjusted for the dHIP protonation state observed in the neutron 
cryo-crystallography structure of compound I [5, 6]. 
4.1.1 QM modelling of natural peroxidase systems 
To study the subtle changes in the environment of compound I and II intermediates and 
their reactivity, a description of its electronic structure is needed. Density functional theory 
(DFT) is a widely used electronic structure method [313]. The advantage of DFT over other 
approaches such as ab initio Hartree-Fock (HF) theory is that the electron density is a function 
of just three variables, unlike ab initio methods where the number of variables describing the 
wave function is proportional to the number of electrons in the system [314]. The general 
expression of energy in a DFT calculation is made up of the kinetic energy of the non-
interacting electrons, the electron-nucleus attraction energy, exchange-correlation energy and 
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Coulombic electron-electron repulsion energy. The primary difficulty with DFT is obtaining 
a suitable expression for the exchange-correlation energy as there is no systematic method of 
improving the functionals used for the exchange-correlation potential. Some DFT methods, 
including B3LYP,  do not accurately model weak molecular interactions such as Van der Waals 
forces (dispersion) [315, 316]. Even though DFT calculations are much faster than ab initio 
methods and of comparable accuracy, they are still computationally laborious, limiting the 
reasonable number of atoms that can be handled by DFT to around 200.  
Hybrid density functionals include a mix of Hartree-Fock exchange with DFT exchange-
correlation. B3LYP (Becke, three-parameter, Lee-Yang-Parr) is a popular hybrid density 
functional comprising Becke's 3 parameter exchange correlation functional and Lee–Yang-Parr 
correlation functional [317, 318]. B3 uses 3 parameters to mix the exact Hartree-Fock 
exchange correlation and the non-local correlation provided by the LYP expression. The 
hybrid density functional B3PW91-D3 is also used in this chapter. It uses the same Becke's 3 
parameter exchange with the non-local correlation provided by Perdew/Wang 91 and a 
dispersion correction (D3) component to correct for the known failure of DFT to describe 
weak molecular interactions [315, 317, 319, 320]. The effect of dispersion and dispersion 
corrections has also been studied in P450 heme species which are similar to peroxidase heme 
species [316].    
A basis set is a set of functions that represent the molecular orbitals of a system of atoms. 
The basis set used in this project is the 6-31G* split valence basis with additional polarisation 
functions to non-hydrogen atoms [321].  For the heme iron, an effective core potential (ECP) 
was used to overcome the need for larger basis sets to describe the many more electrons of 
the transition metal. In an ECP the core electrons are replaced with an effective potential. In 
this project, the heme iron was treated with the LACVP basis set replacing the 1s, 2s and 2p 
orbitals and with the 3s, 3p, 3d and 4s orbitals treated explicitly [322].  
Molecular systems where the valence shell is only partially filled, and the spin of unpaired 
electrons does not equal one another, are known as open shell systems. These systems have 
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an excess of either alpha or beta spin electrons, leading to an overall spin not equal to zero. 
In DFT there are two methods to treat such systems: restricted open-shell and unrestricted 
open-shell. The restricted treatment uses doubly occupied orbitals as far as possible with the 
remainder left unpaired. The doubly occupied orbitals are treated identically regardless of 
whether the unpaired spin is alpha or beta. This fails to consider the effect of spin polarization 
on the doubly occupied orbitals as unpaired electrons will interact differently with electrons 
of different or the same spin. Unrestricted open shell methods use two distinct sets of 
molecular orbitals to describe the alpha and beta spin electrons [323]. Unrestricted open shell 
methods are  more general, as well as being more straightforward to implement 
computationally ([225] page 108). 
4.1.2 QM/MM calculations 
The protein environment plays an important role in modulating and stabilising the activity 
of reactive residues or cofactors in enzymes. Modelling the properties of cofactors containing 
transition metals can be achieved using high level QM calculations [324]. DFT or ab initio 
methods needed for these calculations are computationally laborious so the number of atoms 
that can be efficiently modelled is limited. When studying the effect of the protein 
environment, which is made up of many thousands of atoms, it is necessary to use a hybrid 
quantum mechanics/molecular mechanics (QM/MM) approach [325]. QM/MM calculations 
combine the high level electronic calculations on important atoms embedded within a MM 
calculation of the rest of the protein and solvent environment.  
Hybrid QM/MM methods aim to incorporate the benefits of both the QM electronic 
structures and the rapid molecular mechanics (MM) calculations used for many thousands of 
atoms [326]. Even a well parameterized MM force field cannot typically model reactivity 
(making or breaking bonds) and will struggle to describe the more complex electronic 
environment around transition metals and radicals in conjugated systems. In these cases, QM 
calculations are needed. For large biomolecules such as enzymes, QM/MM methods offer the 
capability to embed a QM calculation of a region of interest into the MM environment. This 
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is typically implemented to include both mechanical and electrostatic interactions across the 
QM/MM boundary [325, 327]. For biological systems, where the protein environment plays 
a large role in modulating the activity of the reactive species, having both the spatial and 
electronic context of the region of interest is clearly very important. The electrostatic and Van 
der Waals interactions of the MM force field are used to polarize the QM region. The atoms  
in the QM region are also assigned a MM type Lennard-Jones potential is used to model their 
steric contribution to the MM region [328].  
 
Figure 4.1.3 QM/MM calculation setup. The atoms treated with a QM calculation are shown in 
orange. They are embedded in a MM simulation. The two calculations are linked in this case by a “link-
atom”method (LA) to satisfy valences over the QM/MM boundary. The MM calculation is split further 
into and active an frozen region (blue and black). MM active atoms move in response to the QM region 
(blue) and are surrounded by atoms that have been frozen to set the context for the MM active 
calculation. 
 
Semi-empirical QM methods (such as AM1) can be used in QM/MM molecular dynamics 
simulations typically consisting of many thousands of steps [329]. However, such methods 
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are unable to model transition metal orbitals. Using DFT in the QM calculation is generally 
too computationally intensive for dynamic simulations. For heme reactive species discussed 
here a snapshot of an MD simulation is used in a QM/MM geometry optimization to obtain 
a total QM/MM energy. This total QM/MM energy is made up of the MM energy, QM energy 
and QM/MM interaction energy [328].  
The boundary between QM and MM regions in enzymes will often fall across a covalent 
bond. There are a few popular methods for dealing with this issue. This work uses link atoms 
to satisfy valences over the QM/MM boundary [325, 327]. Here a QM dummy atom, in this 
case hydrogen, is added to the QM region and some of the non-bonded MM interactions are 
excluded. The link atom approach could be applied over any covalent atom pair but the best 
results are achieved on carbon-carbon single bonds away from highly charged groups [328]. 
In the QM/MM software used in this chapter, ChemShell, charges close to the link atoms are 
shifted away, and point dipoles added to compensate for the shift [240].  
4.1.3 QM cluster models  
The first section of this chapter contains QM cluster models of the three-published 
neutron cryo-crystallography structures [198, 199]. These structures are the ferric (Fe3+) and 
compound I ([Fe4+]•+) species of CcP, and the compound II (Fe4+) intermediate of AXP 
(PDB id: 4CVI, 4CVJ and 5JPR) [5, 6]. The protonation state of the distal histidine (dHIS) in 
the neutron structure has dHID in the ferric and dHIP in compound I and II intermediates 
(see Figure 4.1.1 and Figure 4.1.4).  
4.1.4 Setup 
Each of the experimental structures formed the starting point for two geometry 
optimisations: one with the same dHIS protonation as in the neutron structure and a second 
with the opposite dHIS protonation. Table 4.2.1 shows the 6 structures that were used in the 
QM cluster models. The doublet and quadruplet spin states of ferric and compound I heme 
has been seen to be experimentally and computationally degenerate [330]. The choices of 
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theory level, basis sets, spin states and the size of the QM region to be studied in this work 
were all informed by previous calculations on the same or similar systems [324, 331, 332]. 
The protonation states of all ionisable residues were taken directly from the neutron structure 
of ferric CcP and applied to all equivalent residues in all other setups (PDB id: 4CVI, 4CVJ 
and 5JPR) [5, 6]. Histidine residues  6 and 175 were HID and 60,96,181 were HIP. Both 
protonation states of HIS52 were explored.   
 
 
Figure 4.1.4 Neutron structure active site conformation. The atoms displayed make up the QM 
cluster and the QM region of the QM/MM calculations (non-polar hydrogens not displayed but included). 
The coloured numbers under the black residue labels are the residue numbers for CcP (in red) and AXP (in 
blue). Orange lines represent procedurally detected hydrogen bonds. The grey name below the structures is 
the file naming index used. The Cγ carbons are fixed for all truncated amino acids except aspartate where 
the Cβ is fixed. 
4.1.5 An Engineered Ascorbate Peroxidase 
The structures investigated with QM/MM were expanded to include the three heme 
species of each enzyme CcP, AXP and APX2 with and without substrates (see Table 4.2.2). 
AXP2 is an engineered ascorbate peroxidase that incorporates N-methyl histidine as the 
proximal heme ligand. It was produced to investigate the role of the proximal hydrogen 
bonding network, conserved in heme peroxidases. The hydrogen bonding network is between 
pHIS, pASP and pTRP. The pASP-pHIS interaction in heme peroxidase is thought to give the 
pHIS partial imidazolate character [333]. The hydrogen bond between pASP-pHIS has been 
implicated in: fine tuning the redox properties of the heme, aiding O−O bond heterolysis and 
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stabilizing key oxyferryl intermediates [334–336]. Some QM computational studies have 
shown that a more imidazolate (more positive) proximal histidine causes a delocalisation of 
radical spin density to the histidine ligand [337]. However, other QM/MM studies that 
increased the hydrogen bonding strength of pASP showed little difference in spin density on 
the pHIS [330].  
Experimental results with N-methyl histidine (NMH) ligated AXP (AXP2) have shown 
that NMH appears to be a more robust ligand than HIS when it comes to peroxidase activity. 
APX2 with NMH as the proximal ligand increased the turnover number (TON) by a factor of 
5 [333]. Combining the kinetic results with the crystallographic structure, Green et al. suggest 
that the NMH is able to improve AXP2 through hyperconjugation of the electron-donating 
methyl substituent to the Nδ, allowing it to more robustly stabilise radical delocalisation to 
the proximal ligand [333].  There is particular interest in using N-methyl histidine in the de 
novo peroxidase system as it lacks the natural proximal hydrogen bonding network. 
 
Figure 4.1.5 AXP2 active site conformation. The atoms displayed make up the QM region of 
APX2 QM/MM calculations (non-polar hydrogens not displayed but included). The coloured numbers 
under the black residue labels are the residue numbers. Orange lines represent hydrogen bonds calculated 
using Chimera. The grey name below the structures is the file naming index used. dPHE label included as 
a point of reference but was not included in the QM region. 
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4.1.6 Generating MM parameters  
To run the MM portion of a QM/MM calculation requires all atoms and their interactions 
to be parameterised in the MM force field. Ferrous and ferric heme B parameters are included 
as part of the CHARMM force field. Heme B ferric and oxyferryl parameters have been 
published for cysteine ligated P450-like heme [244]. To rigorously parametrise a new residue 
or cofactor into a MM force field first requires QM calculations (e.g. in the gas phase) to 
determine the bond lengths, strengths and the charge distribution of the molecule. The point 
charges on each atom are generated by a charge fitting method that uses the three-
dimensional molecular electrostatic potential, a grid generated by QM calculation [244]. 
These parameters are then scaled for use within a particular force field. For the CHARMM 
force field, the charges are scaled to reproduce the quantum mechanically-obtained 
interaction energies between the solvent and solute [242]. The resulting parameters should 
then be tested in MD simulations to ensure they accurately model the molecule and its 
interactions [338].  
Full parameterisation of the ferryl hemes was beyond the scope of this project. Instead, 
updated parameters for histidine ligated ferric, compound I and II heme B were generated 
using the existing CHARMM27 parameters, QM cluster results and preliminary QM/MM 
results (Section 4.3.1)[331, 339]. These parameters were only used for short MD simulations 
and minimisations where the protein movements were constrained before the QM/MM 
geometry optimisation. In the QM/MM calculations the MM parameters of the atoms in the 
QM region are ignored, except for their Lennard-Jones potential which is only used by the 
MM calculation.  
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Figure 4.1.6 CHARMM atom naming convention. The heme atoms include OE which is only 
present in compound I and II and HO1, only present in compound II. The histidine tautomers are HSP 
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4.2 Materials and methods 
4.2.1 Gas-phase quantum mechanics calculations in Jaguar 
The high-resolution neutron structures of the ferric, compound I and compound II heme 
species were used as the starting coordinates (PDB: 4CVI, 4CVJ and 5JPR) [5, 6]. The atoms 
taken to perform the QM calculations are shown in Figure 4.1.4. High spin iron was chosen 
for ferric and compound I calculations as it has been seen to be preferable in previous 
calculations on the same system [324, 331]. Initially, only six Cartesian restraints were used. 
These fixed the atom nearest to the backbone of each amino acid residue to the position in 
space it was found in in the experimental structure. This was the Cγ for all residues except 
aspartate where the Cβ was fixed. Due to convergence issues, an additional dihedral 
constraint to maintain the porphyrin’s rotational orientation about the proximal histidine was 
added. The Jaguar initial guess was aided by explicitly defining the formal charges of all 
charged species.  
Index Species Protein PDB Distal HIS Charge Multiplicity 
110 Ferric CcP 4CVI HID 1 4 
120 Ferric CcP 4CVI HIP+ 2 4 
210 Cpd I CcP 4CVJ HIP+ 2 4 
220 Cpd I CcP 4CVJ HID 1 4 
310 Cpd II AxP 5JPR with bound K+ HIP+ 2 3 
320 Cpd II AxP 5JPR with bound K+ HID 1 3 
Table 4.2.1 QM cluster calculations structures. The pdb starting structure, distal histidine 
residues protonation state, charge and multiplicity are shown. The word compound has been abbreviated 
to Cpd. 
4.2.1.1 Stepwise QM cluster model setup procedure   
1. Edit protonation: For 120,220 and 320 the distal histidine (dHIS) protonation state of 
the neutron structure was edited using UCSF Chimera [340]. 
2. AMBER minimisation: A minimization of the solvent and hydrogens was performed with 
a strong restraint on all other atoms in AMBER16 using the CHARMM27 force field 
(maxcyc=600, restraint_wt=100 kcal.mole-1.Å-2)[339]. 
3. QM Atoms extracted: The QM atoms were extracted using VMD [237]. Eight hydrogen 
atoms were added to satisfy the valence remaining from breaking 8 C-C bonds. They were: 
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two Heme vinyl groups between CAA-CBA and CAD-CBD, one on the proximal aspartate 
CA-CB and five on the remaining amino acid sidechains between CB-CG. 
4. Jaguar 8.5 (Schrödinger, LLC, NY, USA) Setup: 
a. Using Maestro (Schrödinger, LLC, NY, USA) six Cartesian restraints were 
added to fix the atom that was closest to the backbone for each residue. This 
was atom CG in all cases apart from ASP where it was CB. 
b. The B3PW91-D3 functional and 6-31G* basis set was used for all atoms other 
than the heme iron which was described by the LACV3P* basis [315, 317, 319, 
320, 322].  
c. Jaguars unrestricted open shell method was implemented with the use of the 
iufh=1 keyword. 
d. Solvation modelling with a self-consistent reaction field, using the standard 
Poisson-Boltzmann solver (Isolv=2) was used. 
Three different restraint conditions were tested:  
The QM0 setup only used Cartesian restraints mentioned above. QM1-di included a dihedral 
restraint was added between the dHIS and heme to prevent the heme from freely rotating 
(pHIS:CE1- pHIS:NE2-HEM:Fe-HEM:ND). QM2-Di-B included the previous dihedral and a 
bond restraint on the proximal TRP (NE1-HE1=1). For QM2-Di-B and QM0 the solvation 
field was applied as on a single point energy calculation after geometry optimisation without 
it. For QM1-Di the results of geometry optimisation without solvation field were used as a 
starting point for geometry optimisation with the solvation. 
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4.2.2 MD and QM/MM  
 
Index Protein Species dHIS Substrate PDB Charge Mult 
120 CcP Ferric HIP+ - 4CVI 2 4 
110 CcP Ferric HID - 4CVI 1 4 
160 CcP Ferric HIP+ H2O2 4CVI 2 4 
150 CcP Ferric HID H2O2 4CVI 1 4 
210 CcP Cpd I HIP+ - 4CVJ 2 4 
220 CcP Cpd I HID - 4CVJ 1 4 
410 CcP Cpd II HIP+ - 2XJ5 2 3 
420 CcP Cpd II HID - 2XJ5 1 3 
510 AXP Ferric HIP+ - 1OAF 2 4 
520 AXP Ferric HID - 1OAF 1 4 
570 AXP Ferric HIP+ H2O2 & ASC 1OAF 2 4 
580 AXP Ferric HID H2O2 & ASC 1OAF 1 4 
610 AXP Cpd I HIP+ - 2XI6 2 4 
620 AXP Cpd I HID - 2XI6 1 4 
630 AXP Cpd I HIP+ ASC 2XI6 2 4 
640 AXP Cpd I HID ASC 2XI6 1 4 
310 AXP Cpd II HIP+ - 5JPR 2 3 
320 AXP Cpd II HID - 5JPR 1 3 
330 AXP Cpd II HIP+ ASC 5JPR 2 3 
340 AXP Cpd II HID ASC 5JPR 1 3 
710 AXP2 Ferric HIP+ - 5L86 2 4 
720 AXP2 Ferric HID - 5L86 1 4 
770 AXP2 Ferric HIP+ H2O2 & ASC 5L86 2 4 
780 AXP2 Ferric HID H2O2 & ASC 5L86 1 4 
810 AXP2 Cpd I HIP+ - 5L86 2 4 
820 AXP2 Cpd I HID - 5L86 1 4 
830 AXP2 Cpd I HIP+ ASC 5L86 2 4 
840 AXP2 Cpd I HID ASC 5L86 1 4 
910 AXP2 Cpd II HIP+ - 5L86 2 3 
920 AXP2 Cpd II HID - 5L86 1 3 
930 AXP2 Cpd II HIP+ ASC 5L86 2 3 
940 AXP2 Cpd II HID ASC 5L86 1 3 
Table 4.2.2 Structures used for MD and QM/MM geometry optimisation.  
The PDB codes is bold are the neutron cryo-crystalography structures.  
4.2.2.1 Generating parameters  
To run the MD simulation and MM portion of the QM/MM geometry optimisation the 
existing CHARMM heme B parameters needed to be modified. The initial: bond, angle and 
charge values to add the ferryl oxygen and hydroxide were taken from the QM cluster 
optimisation results. Lennard-Jones and improper terms were added using similar terms 
already in the CHARMM27 force field [339]. The bond strengths of the Fe-O were inspired 
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by AMBER heme B intermediate parameters [244]. The initial values were modified after 
QM/MM geometry optimisations of the neutron structures. These initial calculations had all 
the heavy atoms that would make up the QM region fixed (using the AMBER ibelly keyword) 
during the MM minimisation and solvent equilibration.  
Parameters for ascorbate (ASC), hydrogen peroxide (H2O2) and the proximal Nδ-methyl 
histidine (NMH) ligands were also generated. The H2O2 parameters were generated using 
literature values as inspiration but also the results of QM geometry optimisations at the same 
theory level as the QM/MM calculations [341]. Initial ascorbate parameters were generated 
using a combination of automatically produced parameters from the CHARMM general force 
field (CGenFF), using a webserver (SwissParam, www.swissparam.ch), and the AMBER Gaff 
force field using ACPYPE [247, 342]. These parameters were refined with QM geometry 
optimisations at the same theory level as used for all calculations in this section. The 
parameters for 9-methyl guanine and histidine in the CHARMM27 force field were modified 
to Nδ-methyl histidine [339]. The charges were refined after an initial QM/MM geometry 
optimisation.  
4.2.2.2 Initial calculations   
This initial setup lacked proper MM minimisation before QM/MM optimisation and was 
severely hampered by software problems. The first was a problem in the ChemShell version 
3.6 incorrectly reading or implementing AMBER input files. ChemShell then had difficulties 
interfacing with the ORCA4.0. Finally, transient MPI (Message Passing Interface) errors from 
an unknown source occurred while sharing nodes with other users on Bluecrystal phase3. The 
AMBER ibelly function keyword removes the energy of the fixed atoms and therefore is not 
an ideal option for restraining atoms in MD.  Calculations are also slow and cannot be 
parallelised. For subsequent calculations a Cartesian restraint that can be more easily fine-
tuned was used. The AMBER restraint key word “restraint wt” was used along with defining 
the “restraintmask” atoms.  
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The list of structures under investigation are the same as those shown in Table 4.2.2. 
After the modification of the dHIS protonation state was made to the crystal structure, VMD 
was used to solvate the protein and generate CHARMM parameter (.psf) and coordinate 
(.pdb) files [237]. AMBERtools16 parmed.py with chAMBER was used to convert these to 
AMBER compatible input files (parameter.prmtop and coordinate.inpcrd) [229]. The AMBER 
solvent minimization, solvent heating, system minimization, heating and pressure 
equilibration were carried out on a local Linux machine using AMBER16 PMEMD for the 
minimisation steps and PMEMD.cuda for all others. Production MD was carried out with 
PMEMD.cuda on Bluecrystal phase 3 (University of Bristol HPC, using Nivdia Tesla K20 
GPU’s).  
4.2.2.3 Stepwise QM/MM setup  
1. Edit initial structure: All atoms were changed to CHARMM atom types. When using the 
neutron structures, the distal protonation state was either edited or maintained. When 
using X-ray crystal starting coordinates the protonation for all residues with variable 
protonation states was set to match the results of the neutron structure.  Additional B 
residues were removed from the pdb file of the neutron structure. Simulations with AXP 
included potassium bound in the cation binding site. In all other simulations no other 
ions were added. The X-ray structure of APX2 did not include a cation and none was 
added. All APX experimental structures were missing two N-terminal residues. The X-ray 
structure of APX2 was missing three N-terminal residues. In both cases these residues 
are part of an unstructured loop away from the heme so were not modelled back in.  
Experimental CcP structures had either one or two N-terminal residues missing; these 
were modelled back in using Chimera’s MODELLER interface (salilab.org/modeller) to 
make all CcP structures consistent.  
2. Setup and Solvate in VMD: Using the CHARMM27 parameters and topology files for all 
amino acids and edited CHARMM27 heme b, Ferric, Compound I (c1), Compound II (c2) 
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species. VMD generated xplore-type .psf and .pdb files. No ions were added to the setup 
but ions bound in the starting coordinates were retained.  
3. Convert to AMBER inputs and minimise: Using ChAMBER in AMBERtools16 
parmed.py AMBER .prmtop and .inpcrd files can be generated. 
A standard minimisation protocol for AMBER MD was then performed which included: 
minimisation of the solvent and hydrogens with strong restraints on heavy atoms, MD 
heating of solvent with restraints on solute and a minimisation of all atoms. 
4. Equilibration and MD: MD without any restraints resulted in significant rotamer 
changes in short MD runs (<1ns). In the region around the heme these were mainly 
changes in the dHIS rotamer; rotating upwards away from the heme. Different options for 
restraining the residues around the heme were explored. The following schemes were 
used for MD equilibration; 50 ps heating of system, 200ps NPT equilibration and then 
10ns NPT MD production simulation. Using the AMBER restraints keywords, rather 
than fixing with ibelly keyword, allows the weight of the restraint to be fine-tuned and 
the calculation to run GPU parallelized.  
5. Restraints: A 30 kcal.mol-1.Å-2 restraint on all protein residues more that 15 Å from the 
heme iron was used for all structures except APX2 compound I and II. In the MD there 
were no restraints on the solvent or residues within 15 Å of the heme iron. APX2 
compound I and II MD simulations had no restraints as these structures had the ferric 
enzyme as a starting structure. For simulations with substrates H2O2 and/or ascorbate, 
weak distance restraints using an AMBER NOE RST file (Nuclear Overhauser 
Enhancement restraint) file were applied. The restraints are only active if the distance is 
greater than a cut off value. The restraint energy is calculated as well with a square bottom. 
Between the distances r2 and r3 the restraint energy is flat, with no restraint applied. The 
energy between r2 - r1 and r3 - r4 the restraint energy applied increases parabolically. 
Below r1 and above r4 there is a linear increase in the energy of the restraint. The rk2 and 
rk3 values are the force constants at the lower and upper bounds (r1 and r4). Setting rk2 
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= 0 removes the minimum distance restraint. H2O2 was weakly restrained between 2.5 
and 6 Å from the heme iron and strongly restrained after 6 Å (r1 = 1.30 Å, r2 = 1.80 Å, 
r3 = 2.50 Å, r4 = 6.00 Å, rk2 = 0 kcal.mol-1.Å-2, rk3 = 5 kcal.mol-1.Å-2,). Ascorbate was 
weakly restrained between 12 and 16 Å from the heme iron and strongly restrained after 
16 Å (r1 = 1.10 Å, r2= 1.20 Å, r3 = 12.00 Å, r4 = 16.00 Å, rk2 = 0 kcal.mol-1.Å-2, rk3=5.0 
kcal.mol-1.Å-2).  
6. Selecting a representative structure: A snapshot of the MD simulation was then 
selected to go forward to QM/MM geometry optimisation. The snapshots were not taken 
from the first 1 ns of the 10 ns MD. Snapshots with transient movements away from the 
active site conformation of the experimental structure were avoided.  The 10 ns MD 
trajectories were clustered using AMBERtools16 cpptraj [229]. Five clusters were 
produced from a fit around the heme and pHIS residue. The clustered structures were 
used as a guide for choosing the representative snapshot of the MD. The chosen snapshot 
was converted back to CHARMM atom types and residues as cpptraj only outputs AMBER 
types. 
7. Minimise: A MM minimisation of the whole system with the convergence criteria for the 
energy gradient set to 0.1 kcal.mol-1.Å-2 was performed (usually converged around 2000 
cycles, max 4000) 
8. Truncate: VMD was used to select and keep the closest 2000 waters to the protein as a 
solvent shell. Then the QM, MM active and frozen atoms for the QM/MM calculation were 
set. The QM region atoms were the same atoms as in the QM cluster calculation. The 
heme vinyl groups cut between CAA-CBA, CAD-CBD, Proximal Aspartate cut between 
CA-CB and remaining sidechains between CB-CG. The two closest water molecules to the 
heme iron or oxyferryl-O were included in the QM region. The MM Active region was 
defined as same residue as any atom within 4 Å of any QM atoms. To keep the number of 
MM active atoms consistent, between calculations of the same protein, the active residues 
for all structures were calculated and compared. A list of protein residues in the MM active 
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region was then made by amalgamating the calculated residues for each of the proteins 
together (CcP, AXP and AXP2). The active waters were then also separately defined as 
the 20 closest water molecules to any of QM region atoms. This allowed all calculations 
on the same protein to have the same number of MM active region atoms. Frozen atoms 
were defined as all other atoms not in the MM active or QM region. 
9. QM/MM geometry optimisation with ChemShell and ORCA4: These calculations 
were performed on Bluecrystal Phase 3 with ORCA4 running the QM calculation 
parallelised over eight cores. All atoms in the ChemShell geometry optimization were 
treated with their corresponding CHARMM parameters [240, 343]. The frozen regions 
atoms are fixed during the geometry optimization but they provide an electronic and steric 
context for the MM active region. The MM active region atoms run as a MM minimisation 
using ChemShell’s MM engine Dl-poly and the CHARMM force field. These atoms can 
respond to changes in the QM region of the calculation. For the QM atoms all the MM 
force field terms, except the Lennard-Jones parameters (which are only used by the MM 
calculation), are deleted. Hydrogen link atoms are added and an ORCA geometry input is 
generated with each step. For electrostatic coupling the keyword coupling=shift was used. 
The ORCA geometry optimization used the B3LYP functional and 6-31G* basis set for all 
atoms other than the heme iron which was described by the LANL2DZ basis [317, 318, 
322]. ORCA keywords convrgence=LooseSCF and dispersion _correction=B3LYP were 
also used to add dispersion correction (D3) and aid convergence [315].  
4.2.2.4 Analysis  
Structures and trajectory were analysed and visualised with VMD, using its Tcl scripting 
interface [237]. Hydrogen bonding calculations and image processing was conducted with 
Chimera (UCSF Chimera v1.1) [340]. Chimera defines hydrogen bond based on a published 
survey of crystallographic hydrogen bonds [344]. These strict criteria were relaxed by 20˚ and 
0.2 Å.  
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4.3 Results 
4.3.1 QM Cluster Model  
The dihedral restraints added to the QM1 and QM2 setups aimed to keep the heme 
orientation similar to the experimental structure and stop cycles of the heme rotation. The 
heme rotating around the proximal ligand resulted in long searches for a converged structure 
with some simulations taking over 600 cycles. The calculations with the dihedral restraint 
(QM1-Di) had limited success in this respect as the driving force for sampling different heme 
rotations proved greater than maintaining the proximal hydrogen bonding network. As a 
result, the pHIS rotates with the heme producing proximal heme geometries that do not 
resemble the neutron structure. The calculations with the dihedral constraint did succeed in 
reaching convergence in fewer cycles.  
4.3.2 Iron coordination 
The first shell coordination around the heme iron is generally in good agreement with the 
experimental neutron structure. For the ferric calculations the distance of the Fe-N (HEM:FE 
- pHSD:NE2) increase slightly from the neutron structure. The 110-ferric-HID by 0.08 Å and 
120-ferric-HIP by 0.13 Å (Table 4.3.2). This could have been driven by a larger movement of 
the heme which would not be possible in the protein environment. In the compound I and II 
calculations the heme deviates less from the position in the experimental structures. The Fe-
N distances increase by only 0.01 Å in the compound I calculations and less than 0.1 Å in 
compound II. The Fe=O and Fe-O bond lengths in compound I and II deviate from the 
experimental structure by less than 0.03 Å. These bond lengths taken from the QM1-Di setup, 
reproduced with QM0 and QM2 setups, are within the experimental error of the neutron 
structure. The Fe-O bond lengths support the experimental assignment of a non-protonated 
compound I with a short Fe=O and a protonated compound II with a longer Fe-OH bond 
[198, 199].  
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Figure 4.3.1 Structural comparison of results with QM1-Di setup including a solvation field. 
Black structures are the experimental structure [198, 199]. Red structures are the results of geometry 
optimisation with the same dHIS protonation as the experimental structure and blue are the results with 
the alternative protonation state. 
4.3.2.1 Distal Histidine protonation  
To compare the QM energy of the change in dHIS protonation of the different species the 
energy was balanced with a change in protonation of the solvent. It is not possible to 
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accurately calculate the QM energy of a proton with DFT as it has no electrons.  The equations 
5.1 to 5.3 show how the energies for each species were balanced. The H2O and H3O+ energies 
were calculates with the same theory level as the QM cluster models (with and without a 
solvent field). The grey numbers are the index for that structure.  
110[FedC]HID + HdOC 	 	
∆ôöõ
L⎯⎯N 	120[FedC]HIPC + H8O  (5.1) 
210[<AaC]•C?ùûC + ?8@	
	∆ü†°
L⎯⎯N 	220[<AaC]•C?ù¢ + ?d@C     (5.2) 
310[<AaC]?ùûC + ?8@	
∆ü†£	
L⎯⎯N 	320[<AaC]?ù¢ + ?d@C  (5.3) 
 
Species 
Difference in Energy (kcal/mol) 
Without solvent field  With solvent field 
QM0 QM1-Di QM2-Di-B QM1-Di QM2-Di-B 
ΔEnF, Ferric, D→P -41 -35 -11 -72 -75 
ΔEn1, Cpd I, P→D 40 49 70 96 125 
ΔEn2, Cpd II, P→D 40 47 60 100 111 
 
Table 4.3.1 Difference in energy between QM cluster structures. The energy differences ΔEnF, 
ΔEn1 and ΔEn2 correspond to equations 5.1, 5.2 and 5.3. 
 
The comparison of the total energy of the neutron structure dHIS protonation state 
(110[Fe3+]HID, 210[Fe4+]•+HIP+ and 310[Fe4+]HIP+) with the alternative dHIS protonation 
state, suggests that the protonation observed in the experimental structure is energetically 
favourable for compound I and compound II. However, the ferric structure also seems to 
favour dHIP which is not seen in the experimental structure.   
Table 4.3.1 shows that increasing the number of restraints (QM0 to QM1-Di to QM2-Di-
B) resulted in higher energy structures but did not change the trend of the data. Adding a 
solvation field stabilised further the positive dHIP protonation state but the trend in the 
results remained the same.  
4.3.2.2 Distal Hydrogen bonding network 
The dARG in the experimental structures can be seen in two conformations’ “in” < 5 Å 
from the heme iron and “out” > 7 Å from the heme iron (Table 4.3.2). In all ferric QM cluster 
calculations, the dARG starts in the out conformation and moves in slightly to a position 
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around 6 Å from the heme iron. The compound I dARG starts 4.3 Å from the heme iron and 
moves slightly out but remains < 5 Å. The compound II moves out from 7.7 Å much closer 
and forms a hydrogen bond with the oxygen of the oxyferryl species.  
The distal water molecule in the ferric optimisation results has moved away from the 
heme iron. The experimental structure predicted it to be ligating the heme iron at 2.65 Å 
(WAT:O-HEM:FE). In the QM geometry optimisation of the same dHIS protonation as the 
neutron structure (110-ferric-HID) the water moves out to 3.8 Å from the heme iron 
(WAT:O-HEM:FE). In both the dHID and dHIP ferric structures the water has moved to 
hydrogen bond with both the dHIS and dARG. The first row of  Figure 4.3.2 shows the 
orientation for the ferric heme structures.  
The water molecule in the compound I structure has changed orientation more subtly 
from the neutron structure. In the protonated (210-C1-HIP+) geometry optimisation result 
the water is slightly closer to the oxyferryl-O forming a hydrogen bond with it as well as the 
dHIS and dARG. The same is true for the deprotonated result (220-C1-HID) although the 
water is in a different orientation, acting as a hydrogen bond donor to the dHIS. In the 
protonated results the distance from the water to the oxyferryl-O and dHIS (HEM:OE - 
WAT:O and WAT:O - dHIS:NE2) is shorter than the deprotonated (see Table 4.3.2).  
The Compound II neutron structure had two water molecules close to the oxyferryl-O 
with only the closest retained in the QM calculation. In both 310-C2-CcP-HIP and 320-C2-
CcP-HID the dARG moves in towards the place of the second water in the neutron structure. 
The compound II result shows that in both protonation states the water has moved hydrogen 
closer to the oxyferryl-O forming a hydrogen bond. The protonated (310-C2-HIP) result forms 
a closer HEM:OE - WAT:O interaction than the deprotonated as well as a hydrogen bond with 
the dHIS (WAT:O-dHIS:NE2) which is missing in the deprotonated optimised structure.  
4.3. Results 
  183 
 
Figure 4.3.2 Distal hydration from QM1-Di minimised structures 
Black structures are the experimental structure. Red structures are the results of geometry 
optimisation with the same dHIS protonation as the experimental structure and blue are the results with 
the alternative protonation state. 
4.3.2.3 Proximal Hydrogen bonding network  
The proximal H-bonding network seen in the experimental structure was lost in all of the 
cluster geometry optimisations. In QM1-Di the rotation of the heme and pHIS was 
constrained with a dihedral restraint. The energy benefit of heme rotation seemed to outweigh 
H-bonding pHIS-pASP breaking the interaction and rotating both Heme and pHIS. In the 
QM1-Di and QM0 the proximal tryptophan hydrogen (pTRP:HE1) transfers to bond with the 
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ASP OD2 (making ASP-OOH TRP-N+). The exception was 110-ferric-HID where there was 
elongation but no transfer. In the QM2-Di-B setup this pTRP N-H bond was fixed as 
deprotonation does not occur in the protein environment. With the fixed bond the hydrogen 
bond network is better retained in some of the optimised structures (120-ferric-HID, 210-C1-
HIP). The proximal hydrogen bonding network was disrupted in most optimised results. In 
general the pHIS rotated to face the pHIS:N-H bond directly at the pTRP rather than forming 
a hydrogen bond with the pASP. 
4.3.2.4 Spin Density  
The tryptophan radical was observed with high spin density in all optimised compound I 
structures. One exception to this was in the optimised structure 220-C1-HIP with QM2-Di-
B setup where the pHIS had rotated so the pHIS:N-H bond was no longer facing with the 
pASP or the pTRP. In this structure, the unpaired spin density is found on the oxyferryl 
species not the pTRP. The deprotonation of the pTRP produced unpaired spin density on the 
pTRP in all simulations where it occurred.  
   Distance (Å) 







NS 4CVJ 210-c1-CcP-HIP 
220-c1-





Cycles 0 89 77 0 79 75 0 86 147 
HEM:FE - pHSD:NE2 2.02 2.10 2.15 2.12 2.13 2.13 1.97 2.04 2.06 
HEM:FE - dHIS:NE2 5.73 6.22 5.78 5.21 5.76 5.53 5.33 5.91 5.02 
HEM:FE - dTRP:NE1 3.72 4.34 3.61 3.15 2.92 3.07 3.26 3.02 3.67 
HEM:FE - dARG:NH2 7.16 5.79 6.29 4.33 5.00 4.81 7.67 4.97 5.34 
WAT:O - HEM:FE 2.65 3.83 3.36 3.92 3.83 3.95 4.15 3.92 4.00 
HEM:FE - HEM:OE     1.64 1.67 1.65 1.88 1.89 1.86 
HEM:OE - WAT:O     3.06 2.63 2.75 2.96 2.60 2.68 
HEM:OE - HEM:HO1             0.99 0.97 0.96 
Table 4.3.2 Distance information from QM1-Di calculations with solvation field. The 
Neutron structures (NS) are the first column of each section. The other 6 columns are distances from 
geometry optimised QM cluster calculations. The shading of data cells is scaled for each row going form 
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4.3.3 QM/MM calculations  
QM/MM geometry optimisations of the same systems studied in the QM cluster models 
were setup. This was to observe what difference including the protein environment would 
make on the optimised structures and to improve the heme and proximal residue movements 
of the QM cluster model. The number of calculations was also expanded to include each heme 
species in CcP, AXP and AXP2, as well as calculations including H2O2 and ascorbate. Each 
starting structure was set up in pairs, one with the dHIS protonated (dHIP) and another 
deprotonated (dHID).  
4.3.3.1 Generating parameters  
To run MD simulation and MM portion of the QM/MM geometry optimisation the 
existing CHARMM heme B parameters needed to be modified. The parameters generated for 
H2O2 and ascorbate were tested in short MD (5 ns) simulation with explicit TIP3P solvent 
and remained in physically realistic conformations. The changes made to the CHARMM heme 
partial charges are shown in Table 4.3.3. The bond angle between O-Fe-N was seen to be 
perpendicular to the heme in the compound I and II QM and QM/MM geometry optimisation. 
However, in the MD simulation of compound II (Fe4+-OH) the O-Fe-N angle would bend 
seemingly due to electrostatic interactions with the hydroxyferryl-O and H and the porphyrin. 
To maintain the geometry seen in QM calculation the O-Fe-N angle was strengthened.  
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Atom 
Name 
Mulliken charges averaged 
Ferric Cpd I Cpd II 
HO1   0.37 
OE  -0.47 -0.72 
FE 0.86 0.67 0.62 
NA -0.7 -0.65 -0.65 
NB -0.7 -0.65 -0.65 
NC -0.7 -0.65 -0.65 
ND -0.7 -0.65 -0.65 
C1A 0.23 0.25 0.24 
C2A 0.01 0.04 0.03 
C3A 0.01 0.04 0.03 
C4A 0.23 0.25 0.24 
C1B 0.23 0.25 0.24 
C2B 0.01 0.04 0.03 
C3B 0.01 0.04 0.03 
C4B 0.23 0.25 0.24 
C1C 0.23 0.25 0.24 
C2C 0.01 0.04 0.03 
C3C 0.01 0.04 0.03 
C4C 0.23 0.25 0.24 
C1D 0.23 0.25 0.24 
C2D 0.01 0.04 0.03 
C3D 0.01 0.04 0.03 
C4D 0.23 0.25 0.24 
CHA -0.1 -0.16 -0.18 
HA 0.1 0.18 0.15 
CHB -0.1 -0.16 -0.18 
HB 0.1 0.18 0.15 
CHC -0.1 -0.16 -0.18 
HC 0.1 0.18 0.15 
CHD -0.1 -0.16 -0.18 
HD 0.1 0.18 0.15 
Table 4.3.3 Charges on central heme atoms. Mulliken population charges were averaged 
between symmetrical atoms and two calculations of the same heme species with different dHIS 
protonation states. See Figure 4.1.6 for atom names. The averaged elementary charge quoted is in Hartree 
(atomic units). The shading of data is scaled going form the lowest value (red) to highest (blue). 
4.3.3.2 Molecular dynamics  
After editing the experimental structures to change the dHIS protonation state, a short 
MD simulation of the system was run to allow the distal site to sample new solvent 
conformations. The first round of MD was performed without any restraints. This 
unrestrained setup showed large movements of the active site residues. For example, in the 
ferric simulation the dHIS rotamer could change, flipping out of the active sites with the 
dHIS:Nε around 15 Å from the iron. The pASP and pTRP were seen to move away from the 
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heme and the pHIS rotated to find new H-bonding pairs. It was assumed that the complex 
environment around the heme was not being sufficiently captured by the MM force field 
parameters. The only setup that continued with the unrestrained MD were APX2 compound 
I and II (index 810 to 940, see Table 4.2.2). This was because the starting coordinates for 
these simulations was the ferric crystal structure and not a structure of the relevant 
intermediate. For all other structures (index: 110 to 780) a 30 kcal.mol-1.Å-2 restraint on all 
protein residues more that 15 Å from the heme iron was applied during the MM equilibration 
and production MD. No restraints were applied to solvent or residues within 15 Å of the heme 
iron. Simulations with ascorbate and H2O2 had distance restraints applied to keep the 
substrates close to the heme. In the dHIP, simulation a distance restraint applied when H2O2 
was more than 6 Å from the heme iron was not enough to ensure sampling above the heme 
iron. The restraint distance was therefore changed to 2.5 Å for all simulations with H2O2.  
 
Figure 4.3.3 MD Hydration plots. (A) Shows the number of Unique Water molecules that sampled 
the distal heme face over the course of a 10 ns MD simulations. (B) Is the mean number of water 
molecules at the distal face of the heme over the course of the MD. The distal heme face was defined as 
both 6 Å from the heme Iron and 5 Å fron the dHIS. The –SUB results are structure with the substrate 
H2O2 and/or ascorbate, see Table 4.2.2 for details. All points with error bars show the standard deviation 
and the mean.  
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Figure 4.3.4 Hydration and RMSD plots. A and D are comparison of the MD frame chosen for 
QM/MM and the result of QM/MM geometry optimisation. (A) is the of the number of hydrogen bonds 
amongst the atoms of the QM region and water within 8 Å of the iron. (B) Shows the time the closest 
water to the iron spent as the closest solvent molecule over the 10 ns MD. (C) shows the distance between 
the dARG:NE2 and HEM:FE for the MD snapshots chosen for QM/MM optimisation. The black points 
with dashed line are values from the relevant experimental structure.  (D) Is the RMSD of the heavy 
atoms of the QM region. Both the MM structure and QM/MM results are compared to the experimental 
starting structure. The –SUB results are structure with the substrate H2O2 and/or ascorbate. See Table 
4.2.2 for details. All points with error bars show the mean and the standard deviation. 
 
Figure 4.3.3 shows that on average, MD simulations with ferric heme have more water 
molecules accessing the distal site and that it is also occupied by more water on average 
(Figure 4.3.3.B). There is no significant difference between the average number of water 
molecules occupying the distal site of dHIP and dHID setups. The variance in the hydration 
results decreases going from high variation in the ferric systems to lower in compound I to II 
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systems (Figure 4.3.3). In the majority of compound I and II MD simulations the closest water 
remains the closest water to the heme iron for the entire simulation (Figure 4.3.4.B). These 
trends in hydration suggest that the solvation in the Oxy- and Hydroxy-ferryl intermediates 
is more ordered or more constrained.  Most of the RMSD of the final QM/MM result 
compared to the experimental structure is introduced during the MD simulation. Figure 
4.3.4.D shows the majority of the RMSD increase from the experimental structure occur 
during the MD simulation, with only small changes occurring during QM/MM optimisation 
(on average a 8.2% change, sd= 19.6). 
A prominent portion of the RMSD of the QM region atoms was the movement of the 
dARG. During the 10 ns MD of the ferric simulations (index; 100’s, 500’s and 700’s) the “in” 
conformation of the dARG was sampled on average 13% of the time (sd=23). The “in” 
conformation was sampled 82% and 85% of the time in the compound I and II MD 
simulations (sd=21 and 28). The “in” conformation was defined as when the dARG:NE2 was 
closer than 5 Å to the heme iron. For simulations of the ferric enzyme dARG started in the 
“out” position and on only 2 occasions moved in. The compound I simulation started and 
ended with the dARG “in” conformation, except in the AXP2 simulation where the dARG 
started out and moved in. All compound II simulations where the dARG started “out” it 
moved “in” over the course of the MD. 
4.3.3.3 Convergence  
Many of the ferric QM/MM geometry optimisations took a large number of cycles to 
converge (>400 cycles). For 3 Ferric minimisations (110, 150 and 710)  the criteria had to be 
loosened after 1000 cycles. The second row of  Figure 4.3.8 shows that some QM/MM results 
from alternative MD snapshot structures suffered convergence issues. Part of the issue seems 
to be that the hydration of the ferric heme is more varied and selecting the most appropriate 
waters for the QM region becomes more difficult.  
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4.3.3.4 Iron coordination  
The Fe=O bond in compound I is reliably reproduced in the QM/MM geometry optimised 
structures (see Figure 4.3.5.A). All the CcP and AXP results have an average Fe=O bond 
length 1.680 Å (sd=0.0025). The AXP2 bond is slightly but significantly shorter (1.665 Å, 
sd=0.0017, Pvalue= 0.0095). All these values are slightly longer (~0.3 Å) than the 
experimental structure and within the same range as the QM cluster models. The compound 
II Fe-OH bond distances are also reliably reproduced by the QM/MM result. The data follow 
a trend of decreasing Fe-OH bond length ongoing from CcP to AXP to AXP2.  
The Fe-pHIS:NE2 (Fe-N) bond lengths in the QM/MM optimised results were more 
variable than F-O bond lengths but still broadly in line with the experimental results. 
 
Figure 4.3.5 Iron oxygen and iron nitrogen bond distances. (A) shows the distance between the 
heme iron and oxygen in the ferryl intermediates. One value for AXP2-HID is from graph B. (B) shows 
the distance between the HEM:Fe and pHIS:NE2. All coloured plots are the results the QM/MM 
calculations. The black points with dashed lines are values from the neutron cryo-crystallography 
experimental structures. 
 
4.3.3.5 Distal histidine energy changes 
The same procedure of balancing final energies conducted with the QM cluster models 
was also conducted for the QM/MM energy of optimised structures. For the QM/MM results, 
equation 5.1 has been reversed, producing equation 5.4. The energy difference quoted for the 
QM/MM results is always comparing moving from dHIP to dHID. This is unlike the QM 
cluster results where the energy of the neutron structure protonation state was compared 
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with the modified protonation state.  In most cases, the difference in energy of the QM/MM 
results is much greater than expected for a simple proton affinity, by an order of magnitude 
in some cases. On average the strongest preference for dHIP is in the compound II structures 
and the lowest energy barrier in the ferric calculations. The only calculation where the pHID 
is energetically favourable is with CcP in the ferric form with H2O2 as a substrate.  
Alternative snapshots in the second row of Figure 4.3.8 show minimisation of systems 
that did not converge after >1000 cycles. These structures are all dHID starting structures 
were the distal site water or H2O2 has deprotonated over the course of the minimisation. The 
energy differences between dHIP to dHID are relatively low (shown in Figure 4.3.8, not Figure 
4.3.6) compared to the average difference of the QM/MM calculations.   
[FedC]HIPC + H8OC 	 	
∆ôöõ
L⎯⎯N	[FedC]HID + HdO   (5.4) 
 
Figure 4.3.6 QM/MM energy differences to move from dHIP to dHID. All points with error bars 
show the mean and the standard deviation. 
4.3.3.6 Distal Hydrogen bonding  
Significantly more hydrogen bonds were detected in the QM/MM results compared to 
the MD input snapshot. The average detected hydrogen bonds from MD input snapshot was 
7.63 and QM/MM results average was 9.88 (sd = 1.91 and 1.83 Pvalue = <0.005). Figure 
4.3.4.A shows that compound I QM/MM results have on average the most hydrogen bonds, 
then compound II, finally ferric structures. dARG can be seen to form at least one hydrogen 
bond with compound I oxyferryl-O in all QM/MM optimised structures. This is also the case 
in over half the compound II structures. Figure 4.3.7.A shows that for all compound I and 
most of the compound II QM/MM structures the dARD is in the “in” partition. The QM/MM 
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Fe-dARG distances are all slightly longer (~0.5) than the MD input structure and are more 
in line with the experimental results. 
The distal dHIS-Fe distances are very similar for all QM/MM results. The nature of the 
hydrogen bond that dHIS makes with solvent in the distal site varies depending on the 
protonation state it is in. The closest water to the ferryl-O in Compound I and II is highly 
ordered in the QM/MM optimised results. In all dHIP calculations, this distal water donates 
a hydrogen bond to the ferryl-O and accepts a hydrogen bond from the dHIP. In all dHID 
calculations the water donates a hydrogen bond to both the ferryl-O and the dHID.  
The hydrogen bonding of dTRP to the ferryl-O of both compound I and II is observed 
in all CcP and AXP calculations. The dTRP-Fe distance is shorter on average in the compound 
I and II calculations than the ferric. The compound I calculations show very little variation 
from each other and the experimental neutron structure (Figure 4.3.7.C).  
 
Figure 4.3.7 QM/MM result distance measures. (A) shows the distance between HEM:Fe and 
dARG:NH2. (B) shows the distance between HEM:Fe and dHIS:NE2. (C) shows the distance between 
HEM:Fe and dTRP:NE1. APX2 has a dPHE rather than dTRP. The results in the yellow shaded circle are 
the distance to the dPHE. (D) shows the distance between HEM:Fe and WAT:O. All coloured points are 
the results the QM/MM calculations. The black points with dashed lines are values from the neutron cryo-
crystallography experimental structures. 
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Figure 4.3.8 CcP QM/MM optimised structures. Only the heavy atoms (and polar hydrogens) of the 
QM region are displayed. QM/MM geometry optimisation results are in colour and are displayed with 
experimental starting structures in black. Structures in the second row have not converged. dHIP results 
are in Orange and dHID are in blue. The thin purple lines are the calculated hydrogen bonding 
interactions. The numbers above arrows, going between dHIP to dHID pairs, are the balanced QM/MM 
energy differences (kcal/mol). The structure titles are coloured to match the graphs in this section.  
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Figure 4.3.9 AXP QM/MM optimised structures. Only the heavy atoms (and polar hydrogens) of 
the QM region are displayed. QM/MM geometry optimisation results are in colour and are displayed with 
experimental starting structures in black. dHIP results are in Orange and dHID are in blue. The thin 
purple lines are the calculated hydrogen bonding interactions. The numbers above arrows, going between 
dHIP to dHID pairs, are the balanced QM/MM energy differences (kcal/mol). The structure titles are 
coloured to match the graphs in this section. 
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Figure 4.3.10 AXP2 QM/MM optimised structures. Only the heavy atoms (and polar hydrogens) of 
the QM region are displayed. QM/MM geometry optimisation results are in colour and are displayed with 
experimental starting structures in black. dHIP results are in Orange and dHID are in blue. The thin 
purple lines are the calculated hydrogen bonding interactions. The numbers above arrows, going between 
dHIP to dHID pairs, are the balanced QM/MM energy differences (kcal/mol). The structure titles are 
coloured to match the graphs in this section. 
4.3.3.7 Proximal hydrogen Bonding 
The proximal hydrogen bonding network is generally well maintained by the QM/MM 
calculation compared to the neutron structure. The pASP-pTRP hydrogen bond is detected in 
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all but one of the CcP results and all but two of the AXP results. Rotation of the pHIS in the 
QM cluster calculation is seen to a lesser extent in the QM/MM calculations. In all CcP 
compound I and II calculations, the pHIS rotates to donate a hydrogen bond on to the same 
pASP-O that is accepting the pTRP hydrogen bond. This behaviour is not seen in the AXP 
and AXP2 calculation. Where movements of the pHIS in AXP and AXP2 calculations occur 
they have been introduced during the MD equilibration before the QM/MM optimisation. In 
the QM/MM results where the pHIS-pASP hydrogen bond is not detected, the pASP is 
forming a hydrogen bond with a water molecule. The water molecule in this position near the 
pASP and pHIS is seen in the experimental structures and QM/MM results.  
4.3.3.8 Spin Density 
No difference was seen between the spin density on pHIS of CcP and AXP and the 
pNMH of AXP2 in compound I calculations. In all ferric calculations, the pHID or pNMH has 
a small amount of spin density (0.1 au). In compound I and II calculations the only notable 
spin on the proximal ligand is very small negative spin (- 0.01 au) on the iron ligating 
nitrogen, NE2. Figure 4.3.12.B-D shows that in AXP2 there is a significant reduction of spin 
density on the compound I iron and an increase on the oxyferryl-O. 
Figure 4.3.11 shows that the QM/MM experiments can reproduce the experimental 
result of a pTRP radical seen in CcP compound I. The radical compound I signal on the pTRP 
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Figure 4.3.11 Spin density on heme and pTRP. The plotted vales are the sum of the magnitude 
of spin density on the pTRP (A) and heme (B), it is therefore possible for the value to be greater that the 
total spin of the system. All points with error bars show the mean and the standard deviation. 
 
A Mulliken population analysis was performed to calculate atomic charges for the QM 
region atoms. The iron charges in the compound I and II intermediates are more negative 
when compared to AXP and CcP (Figure 4.3.12). The oxyferryl-O charges are more positive 
than the oxygen charge in CcP and AXP.  There is no significant difference in the positive 
charge of the pNMH residue when compared to the pHIS. 
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Figure 4.3.12 Atomic charges and spin density on heme Fe and oxyferryl-O. Charges and 
spin densities are calculated from Mulliken population analysis and are displayed atomic units (au). Error 




  199 
4.4 Discussion  
4.4.1 QM Cluster Models  
The aim of the QM cluster model geometry optimisations was to attempt to reproduce 
the important interactions of the protein active site. The bond distances in the first 
coordination sphere around the iron are in good agreement with the experimental structures. 
They support the assignment of non-protonated Fe=O compound I in CcP and a protonated 
Fe-OH compound II in APX. The experimentally observed compound I radical was also 
reproduced by the cluster model, supporting the assignment of pTRP•+ radical cation in CcP 
[156].  
In many of the cluster models, large movements of the heme during the minimisation 
highlighted the significance of the protein environment on constraining the porphyrin. 
Adding a dihedral constraint to minimise heme rotation was not sufficient to stop movement 
that is not possible in the natural system. In future, for cluster models of this type it may be 
beneficial to run calculations with a Cartesian restraint on the edge of the truncated 
propionates, rather than the dihedral constraint at the proximal ligation site. Expanding the 
calculation to a QM/MM hybrid model should also avoid these problems as these include the 
protein environment. 
The rotation of the heme and pHIS disrupted the proximal hydrogen bonding network in 
almost all the optimised structures. The erroneous pHIS and heme rotations did raise the 
question of whether the orientation of the pHIS can control pTRP radical formation in CcP 
compound I. Tryptophan radicals were seen in all calculations where the pHIS N-H bond was 
interacting with the pASP or facing the pTRP.  However,  a pTRP radical was not observed in 
one calculation where the pHIS was rotated in the opposite direction.  
In the ferric experimental structure the nearest water molecule is situated very close to 
the heme iron. This geometry was not favoured by either dHIP or dHID protonation cluster 
model. The water moves out into the distal pocket by just over 1 Å in the ferric dHID 
calculation and just under 1 Å in the ferric dHIP calculation. The nearest water to the oxyferryl 
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species in the neutron cryo-crystallography structure of compound I was assigned in an 
orientation that favoured interacting with the dHIS and not the oxyferryl-O. This orientation 
was then assumed to preclude the water-mediated mechanism of compound I reduction. The 
water molecule of the cluster model moves slightly to form hydrogen bonds with both the 
dHIS and oxyferryl-O. This challenges the mechanistic assumption, made by authors of the 
experimental structure, as it seems to be in an acceptable orientation for water mediated 
proton transfer to the oxyferryl-O. 
The cluster models show a significant movement of dARG to the “in” position where it is 
“out” in the AXP experimental structure. This change may be the result of only one crystal 
water being included in the cluster model of each intermediate. The APX compound II 
experimental structure has two water molecules in the distal site of the heme. Further work 
to improve the cluster model could include additional Cartesian restraints on the heme and 
testing the effect of additional water molecules on the hydrogen bonding of the distal site and 
dARG prosition. Calculations with H2O2 in place of water in the distal site may show the 
protonation state on the ferric neutron structure (110-ferric-HID) to be able to better 
accommodate peroxide activation.  
4.4.2 QM/MM calculations 
The QM/MM calculations were used to expand the number of starting structure used 
in the QM cluster models as well as address some of their limitations. In the QM/MM 
optimisation, the MM protein environment provides steric and electrostatic context for the 
calculation to ameliorate unrealistic heme conformations. The calculations were performed 
with two QM solvent molecules and structures were set up that included substrates. Including 
a short MD simulation before the QM/MM geometry optimisation allowed the solvent of the 
distal site to fully adjust to the modified dHIS protonation and/or inclusion of substrate. The 
starting structure used in the calculation will bias the results to structures that are similar to 
it. Running MD simulations aimed to reduce this bias by broadening the conformations 
sampled but does not remove it.  
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QM/MM and QM cluster Fe=O bond length results for protonated compound I are in 
line with the neutron structure and resonance Raman measurements in CcP [223].  Xray 
structures of AXP compound I and CcP compound II are difficult to isolate. An APX 
compound I species can be formed through photoreduction of the ferrous-oxy intermediate 
(Fe2+-O=O) which shows a Fe=O bond length of 1.73 Å [301]. This bond length is in line 
with a slightly impure Fe=O rather than a Fe-OH. The same authors used a similar method 
to generate a CcP compound II which reported a F-O bond length (1.82 Å) in line with a 
protonated hydroxyferryl (Fe4+-OH) structure. 
The proximity of dTRP to the heme iron and hydrogen bonds it forms with the 
oxyferryl-O was conserved across all compound I QM/MM calculations. It is clearly an 
important stabilising interaction of the oxyferryl species. The dARG was seen to prefer the 
‘”in” conformation in both compound I and II precursor MD simulations. The MD input 
structures for QM/MM had the dARG closer to oxyferryl-O than after the QM/MM geometry 
optimisation. This may mean that the electrostatic parameters of the ferryl intermediate need 
to be better scaled to interact with the positive protein sidechains. In this project, this could 
have caused oversampling of the dARG “in” position for compound II calculations.  However, 
experimental structures of AXP and CcP compound II show both the dARG “in” and “out” 
positions. Additionally, movement of the dARG “in” was also seen in the compound II cluster 
models. For further work the MM parameters for connecting each intermediate to the pHIS 
should be modified to reflect the average pHIS:NE2-Fe bond length for each intermediate. 
The results in this work all used the same CHARMM patch to attach the pHIS to the heme. 
As a result, the MD NE2-Fe bond was the same in all MD simulations.  
The closest water to the oxy- and hydroxyferryl-O was seen to be highly ordered in all 
three enzymes. In all dHIP calculations it took up a position accepting a hydrogen bond from 
the dHIP and donation a hydrogen bond to the oxyferryl-O. In all dHID calculations it was in 
a similar position but donating a hydrogen bond to both the dHID and oxyferryl-O. As 
previously mentioned for the cluster models, this puts the water molecule, especially in the 
pHIP structures, in an acceptable position for water-mediated proton transfer to reduce 
compound I and II. The QM/MM calculations also produced increased hydrogen bonding of 
the dARG and solvent molecules around the dARG. As a result, protons coming for either the 
dARG or solvent coordinated by the dHIS are both plausible routes.  
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The ferric dHIS QM/MM calculations took the longest to converge and had the highest 
failure rate. This could be because both compound I and II have a more constrained structure. 
The ferric dHID structures were the most dynamic in terms of solvent exchange for the distal 
site. This could have made choosing the two most appropriate water molecules to include in 
the QM region of the QM/MM calculation more difficult. Work to investigate how the number 
of active site waters affects geometry optimisation convergence would be beneficial for future 
calculations. 
These calculations do not support the hypotheses that the pNMH in AXP2 improves the 
resilience of the enzyme by delocalising the radical on to the proximal ligand [333]. No change 
in spin density of the proximal ligand was observed. The Fe-O bond in APX2 compound I and 
II is slightly shorter than in the AXP2. There is also a notable shift in the charge and spin 
density between the Compound I iron and oxyferryl-O. In APX2 compound I the iron is 
assigned more negative charge and less spin density whilst the opposite is true for the 
oxyferryl-O. Cation binding in a site close to pTRP in AXP has been seen to be important in 
producing porphyrin, rather than tryptophan, radicals. The pNMH ligand in AXP2 achieves 
this without a cation bound. 
MD simulations were set up where H2O2 was constrained to near the heme iron, weakly 
between 2.5 and 6 Å and then more forcibly at distances greater than 6 Å. The aim of these 
calculations was to understand more about how the dHIS protonation state might better 
accommodate peroxide activation. QM/MM optimised structures show the pHID structures 
were better able to bind H2O2 with it forming hydrogen bonds between the dHID, dARG and 
water molecule. In some QM/MM geometry optimisations direct deprotonation of H2O2 by 
the dHID occurred. These results seem to support a “dry” mechanism for the generation of 
the peroxyferric intermediate (compound 0) [5, 196].  
Comparing QM/MM energies of structures that have undergone separate MD 
equilibration does not appear to be a particularly robust method to detect subtle changes in 
protonation state. Input structures had the same number of frozen and active atoms and the 
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QM region atoms and total atoms only differed by a single proton. However, when the final 
energies were balanced and compared they were more varied than anticipated and often 
differed by much more than is to be expected in a proton affinity calculation. The general 
trend of the calculations show that there is a preference for dHIP in the compound I and II 
species and less of a preference for dHIP in the ferric calculations. The calculations are then 
broadly in line with the protonation states reported in the neutron cryo-crystallography 
structures [5, 6].  
 
Figure 4.4.1 Suggested peroxidase mechanism. Structures with the dashed line around them are 
based on the geometry optimisation of the neutron cryo-crystallography structures. The compound 0 
structure was not modelled in this project. In structure (B) the deprotonation of H2O2 is proposed to occur 
before the formation of the peroxyferric intermediate (compound 0). In structure (E) and alternative 
protonation route via the dARG is shown in grey.  
 
A potentially interesting approach to further understand the role of the distal protonation 
could be to run the optimisation forward and backward. That is, starting with one dHIS 
4.4. Discussion 
  204 
protonation, running a geometry optimisation, editing it to the alternative dHIS protonation, 
and re-running the geometry optimisation. Then a comparison could be made between the 
energetic and structural changes of forward and reverse optimisations.  To improve the 
QM/MM calculations on peroxidase systems in the future it may be useful to constrain further 
the MD minimisations to decrease the variation it generates. This could allow specific 
interactions to be tested without their effect being lost in the variation generated by MD. 
Alternatively, increasing the number of QM/MM optimised results from different starting 
inputs and averaging the results could also lead to more reliable results and make it easier to 
unpick the effect of subtle variation on these electronically complex systems.  
The results from this project support a reaction scheme such as shown in Figure 4.4.1. 
The wet mechanism for compound 0 formation in HRP was supported by Vidossich et al. with 
a combined MD and QM/MM analysis in 2010 [199]. They showed a lower energy barrier for 
water mediated deprotonation of H2O2 in a system were the H2O2 was already bonded to the 
heme iron. The Fe-O bond in the compound 0 intermediate used (Fe3+-OHOH) was around 
2.1 Å. Preliminary calculations in this project suggest that deprotonation of H2O2 by the pHID 
may occur directly at Fe-O distances near to 2.9 Å.  The hydrogen bonding in the distal site 
of calculation of compound I and II, along with the preference for dHIS to remain protonated, 
would suggest a water mediated mechanism for compound I and II protonation. However, the 
dARG position in compound I and some of the compound II results suggest it also could play 
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Chapter 5 
5 Discussion and conclusions 
This project has focused on understanding the structural components necessary to 
produce peroxidase activity in a de novo protein. This was primarily achieved using the 
bottom-up maquette design approach. Computational modelling conducted on natural 
peroxidases was also performed to further our understanding of the peroxidase reactive 
mechanism and to lay the foundation for the same modelling techniques to be used in 
the de novo system in the future. The first two results chapters described the design and 
characterisation of a de novo peroxidase. Incorporating a c-type heme cofactor in the de 
novo four-helix bundle allowed the protein to be expressed as a holoenzyme in vivo [111]. 
The last design step for producing C45, the maquette peroxidase, was to remove the 
distal ligating histidine, leaving the final iron coordination site accessible to water. The 
inspiration for this change came from natural peroxidases that have a penta-coordinate 
heme ligation [145, 147–149]. This modification transformed an unreactive parent 
protein to a highly catalytically efficient thermostable de novo enzyme.  
Tailor-made synthetic proteins that can mimic the highly specific and efficient 
catalysis of natural proteins are key to realising the goal of robust and sustainable 
catalysts for industrial biotechnology [1]. Maquettes have been designed to incorporate 
many natural cofactors including: heme, chlorins, flavins and quinones  [54–58]. They 
have been used to study allosteric and charge activated conformational switching, 
cofactor binding, electron transfer and oxygen binding [59–62]. These results, taken 
with the results of this work, demonstrate the potential value the de novo 
oxidoreductases maquettes might have in bespoke synthetic pathways. 
5.1 Catalysis  
The covalent incorporation of c-type heme into the 4-helix bundle produced a 
protein robust enough to tolerate the removal of the distal histidine binding site. The 
mono-histidine maquette produced on its removal (C45), shows characteristic UV-
visible spectroscopic changes associated with water bound to the distal face in the 
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resting state [257]. On mixing with a known electron-donating substrate, ABTS, and 
H2O2 the maquette shows impressive peroxidase activity (Figure 2.3.11). In terms of 
catalytic efficiency (kcat/KM), some substrates can match activity of HRP and even 
outperform DHP with its natural substrate (HRP activity with guaiacol and DHP activity 
with TBP see Table 2.3.3). C45 demonstrates that the conserved active site residues of 
natural peroxidase are not required to produce promiscuous peroxidase activity. 
Efficient peroxidase activity seems to be predominantly dependent on: creating a mono-
histidine heme ligation in a protein environment that allows for the binding and 
activation of H2O2, and a heme edge that is solvent exposed to allow electron transfer 
from electron donating substrates.  
Peroxidases generally function optimally at acidic pH’s [152]. pH dependent profile 
of kcat in C45 fits to a double pKa curve with an optimum at pH 8.6. The difference in 
pH optimum is likely to be a result of not having a distal histidine residue conserved in 
natural peroxidases. As C45 lacks this feature at pH values under the first pKa (pH 8), 
it is likely that the rate of compound 0 deprotonation is rate limiting. This inference is 
chiefly made by analogy to peroxygenase activity studies with a thermophilic P450 
[292]. The decrease in activity above pH 8.6 points to a residue with a pKa of 9.1 being 
involved in the reactive cycle. The most likely candidate is K52. In MD simulations of 
C45, K52 can be seen to hydrogen bond with heme propionates and is within 6.5 of the 
heme edge. To probe the mechanism of the C45 in greater detail mutation studies of 
residues that could stabilise the reactive intermediates of C45 would be interesting. K52 
and Q45 should be the first residues explored as they close the heme distal site and are 
able to stabilise the negative charge produced during the formation of compound 0.  
Similar to natural peroxidases, C45 is able to oxidase a broad range of electron-
donating substrates. Many natural peroxidases do not have a single well-defined binding 
site for small molecule peroxidase substrates. CcP, LiP, VP, DypB and DHP have at least 
two small molecule binding sites, with one normally situated near the heme edge [163, 
165, 166, 172, 184]. A computational binding study suggests that the same is true for 
C45. The most frequently sampled substrate binding site was close to the heme above 
L22, but the closest binding site to the heme sampled was at the heme edge. Further 
work to validate the binding site above L22 is needed to better understand which 
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binding sites are kinetically important.  A first step would be to mutate L22 to perturb 
the binding of substrate at this site. The redox potential of the substrate, rather than a 
positive result in the computational binding screen, was seen to be the best indicator to 
predict substrate reactivity with C45. By testing a range of substrates, it was possible to 
infer that the redox potential of C45 compound I is close to that of 4-aminobenzoic acid 
(~1000 mV vs NHE). 
5.2 Structure 
The CD spectroscopy of the c-type maquette shows it is highly helical and 
thermostable (Figure 2.3.4). The long flexible loop regions and the lack of ordered core 
packing has rendered attempts at crystallisation futile. These factors combined with a 
highly repetitive sequence also make NMR structural assignment problematic. The 
inherent conformation flexibility that C45 exhibits likely aids incorporation of c-type 
heme by the Cytochrome c biogenesis system I (Ccm) [69]. The Rosetta folding and 
MD simulations of C45 suggest that it is a stable four-helical bundle but that flexibility 
in the second and fourth helices is likely to play an important role in binding and 
activating H2O2. Further simulation of water or H2O2 bound heme species could be a 
straight-forward method of probing what interactions may be important in allowing this 
flexibility.  
Future work to better understand how the flexibility of the maquette effects 
peroxidase activity and heme incorporation will be extremely important. Appendix E 
shows work already underway to produce c-type heme maquettes with increased 
structural stability. C-type maquettes with an additional heptad repeat and a coiled-coil-
C45 chimera have been designed. Extending the heptad, on the far end of the helix from 
the heme, could help force a homogeneous bundle conformation without any large 
changes to heme binding site. The coiled-coil-C45 chimera protein is made up of an 
idealised anti-parallel coiled-coil with the C45 heme binding portion added to each helix 
at one end of the bundle. Preliminary work with the extended heptad version of C45 
(CXH) shows that it expresses in E. coli, incorporates heme and oxidises ABTS. Future 
work on expressing protein for NMR and crystallisation trials could produce atomistic 
structural information of the c-type maquettes.  
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5.3 Radical  
The UV-visible intermediate observed on mixing C45 and H2O2 could be the 
maquette compound I intermediate as observed in Electron Paramagnetic Resonance 
(EPR) spectroscopy to produce a radical signal. Like natural peroxidases, C45 and its 
dW mutants can function with or without tryptophan radicals [172, 295]. One possible 
explanation of the results of Chapter 3 could be that, in the absence of electron-donating 
substrates, all three tryptophan residues on C45 are capable of producing tryptophan 
radicals that are observable by EPR spectroscopy (Figure 3.2.17). However, it may be 
the case that C45 acts in a similar way to the peroxidase activity of Cyt c, forming a non-
specific array of protein radicals. Further work in developing the radical scavenging 
assay described in Section 3.3.12, needs to be explored to be able to conclusively assign 
the radical species [302].  
Experiments with an electron-donating substrate suggest the more distant 
tryptophan residues are not as kinetically relevant as the closest tryptophan residue. 
With ABTS as an electron donor, which is predicted to primarily bind at the heme edge, 
having redox-active residues producing alternative radical sites reduced the efficiency 
of oxidation. This trend has been observed in CcP when the sequential removal of seven 
redox-active residues resulted in increased catalytic efficiency towards a small molecule 
substrate [295]. Tryptophan residues in C45 may make the enzyme more resilient 
(increased TON), though more work is required to develop a reliable assay for this 
measure. For further work, an assay with glucose oxidase and superoxide dismutase 
producing a steady supply of H2O2 without any other oxygen radicals could be the best 
way of testing the total turnover number in peroxidase maquettes. Reactions of glucose 
and glucose oxidase quickly become limited by the diffusion of oxygen into solution. 
With the right optimisation, mixing could then be used as a method of controlling H2O2 
production. 
5.4 QM calculations of natural peroxidases 
The aim of the QM and QM/MM calculation on the natural peroxidase was to better 
understand how the protonation state of the distal histidine effects the distal site of 
natural peroxidase. These calculations were also run with a view to use that same type 
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of calculation on the de novo peroxidases in the future. Neutron cryo-crystallography 
structures of compound I and II, in CcP and AXP respectively, challenged the existing 
mechanism of proton delivery in the peroxidase mechanism [5, 6]. In these structures 
both the compound I and II species have the distal histidine (dHIS) doubly protonated 
(dHIP), which in turn means an additional proton is required in the formation on 
compound I. Calculations were setup for each species in pairs, one with the distal 
histidine singly protonated (dHID) and the other with the dHIP species. A comparison 
between the energies of the system and the distal hydrogen bonding networks was made 
to rationalise the difference between the species. 
Comparing the QM cluster and QM/MM calculations energies of the dHID and dHIP 
calculations shows a stronger preference for dHIP in the compound I and II species. 
This supports the results of the neuron structures. Comparing QM/MM energies of 
structures that have undergone separate MD equilibration does not appear to be a 
particularly robust method to detect subtle changes in protonation state. When the final 
energies were balanced and compared they were more varied than anticipated. Further 
work is need to understand what part of the calculation has larger than expected energy 
differences. Performing QM energy calculations on the atoms of the QM region of the 
QM/MM calculation without geometry optimisation should be the first step in further 
validating these calculations. With these calculations it would then be possible to 
compare the structure without the energy contribution of the MM calculations, which 
is likely to be the source of the larger than expected energy differences.  
Another approach to further validate the results of the QM/MM calculations could 
be to run the optimisation forwards and then backwards. That is, starting with one dHIS 
protonation, running a geometry optimisation, editing it to the alternative dHIS 
protonation, and re-running the geometry optimisation. Then a comparison could be 
made between the energetic and structural changes of forward and reverse 
optimisations.  
The calculations show the ferric species is the most conformationally dynamic, 
making it the most difficult to model, with many of the QM/MM calculations struggling 
with a high number of cycles to reach the convergence criteria. In contrast, the 
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compound I and II species were more restrained by interactions with the oxyferryl-O. 
The closest distal water in both dHID and dHIP calculations formed hydrogen bonds 
with the oxyferryl species and the dHIS. The orientation of these interactions support a 
water-mediated mechanism of compound I and II deprotonation [198, 199]. Preliminary 
calculations in this project suggest that deprotonation of H2O2 by the pHID may occur 
directly at Fe-O distances near to 2.9 Å. Calculations on the energy of compound I 
formation performed by Vidossich et al., showed a lower energy barrier for water 
mediated deprotonation of H2O2 in a system were the H2O2 was already bound to the 
heme (Fe-O = 2.1 Å) [199]. Further work to reproduce the energy calculation 
performed by Vidossich et al., with peroxide starting at a geometry further from the 
heme (Fe-O = 2.9 Å), could produce significant insight in to compound 0 formation if 
this is found to be a lower energy pathway.  
This project has shown the success of many years of iterative rational design to 
produce a in vivo expressed de novo peroxidase maquette. This flexible scaffold is 
extremely catalytically efficient for a de novo enzyme but its dynamic nature has made 
atomistic structural determination difficult. This project has reviewed the increasing 
accuracy of protein structure prediction software as well as displaying the increasing 
utility of existing MD and QM/MM computational methods. For flexible maquette 
proteins of the future, advances in computational modelling may make the need for 
experimental structures less pressing. These robust and highly tuneable redox proteins 
could be designed and folded in silico.  Substrate binding site could be identified using 
MD binding simulations and the regio- and stereoselectivity of their reactions 
rationalised though QM/MM calculations. These functional components could then 
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A. Chapter 1 
These are no appendices for Chapter 1. 
B. Chapter 2 




























jump_def: 114 139 138 138 
aa: CYZ HEM 
cst_atoms: SG CB CA CAB C3B C4B 







B.2 Amber input files  
----- RES.dis ------ 
&rst 
  ixpk= 0, nxpk= 0, iat= 851,4638, r1= 1.30, r2= 
1.80, r3= 5.70, r4= 6.10,  
      rk2=0.0, rk3=10.0, 
 &end 
 &rst 
  ixpk= 0, nxpk= 0, iat= 3662,2727, r1= 1.10, r2= 1.20, r3= 2.50, r4= 3.50,  
      rk2=0.0, rk3=5.0, 
 &end 
 &rst 
  ixpk= 0, nxpk= 0, iat= 3663,2967, r1= 1.10, r2= 1.20, r3= 2.50, r4= 3.50,  
      rk2=0.0, rk3=5.0, 
 &end 
----- minsolv.i ----- 
Minimization of solvent+Hs with 
restraints for protein heavy atoms 
&cntrl 
 imin=1, maxcyc=50, ntmin=1,  
 ntpr=10, 
 cut=12.0, 
 ntr=1, restraint_wt=100.0, 




----- mdsolv.i ----- 
MD heating of solvent with 
restraints for solute  
&cntrl 
 imin=0, irest=0, ntx=1, 
 nstlim=25000, dt=0.002, 
 ntpr=500, ntwx=5000, ioutfm=1, 
 ntb=2, cut=12.0,  
 ntc=2, ntf=2, 
 ntt=1, tautp=1.0, tempi=50.0, 
temp0=300.0, 
 ntp=1, taup=1.0, pres0=1.0,   







----- min.i ----- 
Minimization of system  
&cntrl 





----- heat.i ----- 
MD quick heating of system  
&cntrl 
 imin=0, irest=0, ntx=1, ig=-1, 
 nstlim=10000, dt=0.002, 
 ntpr=100, ntwx=5000, ioutfm=1, 
iwrap=0, 
 ntb=1, cut=12.0, 
 ntc=2, ntf=2, 





----- eq_ntp.i ----- 
200ps NPT MD equilibration of 
system 
&cntrl 
 imin=0, irest=1, ntx=5, 
 nstlim=100000, dt=0.002, 
 ntpr=1000, ntwx=50000, ioutfm=1, 
iwrap=0, 
 ntc=2, ntf=2, 
 ntb=2, cut=12.0, 
 ntp=1, pres0=1.0, taup=1.0, 
 ntt=1, tempi=300.0, tautp=1.0,  
/ 
 
----- md.i ----- 
10ns NPT MD production simulation 
&cntrl 
 imin=0, irest=1, ntx=5, 
 nstlim=5000000, dt=0.002, 
 ntpr=10000, ntwx=50000, 
ioutfm=1, iwrap=1, 
 ntc=2, ntf=2, 
 ntb=2, cut=12.0, 
 ntp=1, pres0=1.0, taup=1.0, 





B.3 ChemShell input script example 
# QM/MM calculation of ferric_CcP from amber MD cluster 
# JJ 12.03.17 
# Using dl-find  
# getting $molname 
source ./molname_vmd.dat 
# getting $qmatoms 
source ./qm_atoms.dat 
# getting $active amd $frozen atoms 
source ./frozen_atoms.dat 
source ./active_atoms.dat 
set file_name "$molname-qmmm3C" 
puts stdout "starting $file_name" 
set Nproc "4" 
set resxyz "vmd-out"   
puts stdout "---- This script is for calculatons without the propionates ----" 
set charge1 [ expr $Charge + 2 ]  
puts stdout "charge changed from $Charge to $charge1" 
set Charge $charge1  
puts stdout "mult: $Mult charge: $Charge" 





read_xplor_psf atom_types= types atom_charges= charges atom_masses= mass file= 
$file_name.psf 
# save data 
set fp [ open save.chm w] 
puts $fp "set types   [ list $types ]" 
puts $fp "set charges [ list $charges]" 
# Read starting coordinates from PDB file 
puts stdout "readining in coordinates from $file_name.pdb..." 
read_pdb coords=start.c file=$file_name.pdb 
read_pdb coords=start-org.c file=$file_name.pdb 
puts stdout "done" 
#### Read starting coordinates from VMD xyz file 
puts stdout "readining in coordinates from $resxyz.xyz..." 
read_xyz coords=start.c file=$resxyz.xyz 
puts stdout "done" 
# Obtain residue information (for dl-find) from PDB file 
puts stdout "setting pdb_residues..." 
set pdb_residues [ pdb_to_res "$file_name.pdb"  ] 
puts stdout "done" 
# Sourcing the new ORCA interface 
source  /panfs/panasas01/chem/jj1134/SOFTWARE/orca-chemsh.tcl 
# ORCA block settings are specified here. 
set orcasimpleinput "! B3LYP 6-31G Opt LooseSCF D3" 
set orcablocks " 
%basis 
  # Dummy basis, will be overridden 
  NewGTO fe \"LANL2DZ\" end 




Print\[ P_Basis \] 2 















  HFTyp uhf 
  MaxIter 400 
end 
" 
set fp [ open pes.txt w ] 
# Loop over the potential energy surface 
set rc "$file_name" 
# Geometry Optimization 
dl-find coords=start.c \ 
     coordinates= hdlc \ 
     residues= $pdb_residues \ 
     frozen= $frozen \ 
     active_atoms= $active \ 
     optimiser=lbfgs \ 
     maxcycle= 500 \ 
     dump = 10 \ 
     theory=hybrid : [ list \ 
       coupling=shift \ 
       atom_charges= $charges \ 
       qm_theory=orca : [ list  \ 
          executable=/panfs/panasas01/chem/jj1134/SOFTWARE/orca_4_0_0_2_linux_
x86-64/orca \ 
          orcasimpleinput= $orcasimpleinput \ 
          orcablocks= $orcablocks \ 
          nproc=$Nproc \ 
          charge=$Charge \ 
          mult=$Mult ] \ 
       qm_region= $qmatoms \ 
       mm_theory=dl_poly : [ list \ 
          mxexcl=176 \ 
          conn=start-org.c \ 
          exact_srf=yes \ 
          use_pairlist=no \ 
          cutoff=1000 \ 
          scale14 = { 1.0 1.0 } \ 
          atom_types= $types \ 
          atom_charges= $charges \ 
          use_charmm_psf=yes \ 
          charmm_psf_file=$file_name.psf \ 
          charmm_parameter_file=$par \ 
          charmm_mass_file=$top ] ] \ 
     list_option=full \ 
     result= result.c 
 
set final_energy [ get_matrix_element matrix=dl-find.energy indices= {0 0 } ] 
puts "Reaction coordinate: $rc Energy: $final_energy" 
puts $fp "$rc $final_energy" 
set tcl_precision 12 
# Write trajectory 
write_xyz file=tmp.xyz coords=result.c 
exec cat tmp.xyz >> pes.xyz 
# Write pdb for this step 







C. Chapter 3 
 
Figure C.1 Experimental (black) and simulated (red) results for EPR radical signals. The g-
tensor value and spin-Hamiltonian parameters used to model the EPR signal is also given as an 
inset in each figure. The naming convention between the experimental samples of the dW2.1-3 




D. Chapter 4 































Cycles 0 89 77 0 79 75 0 86 147 
HEM:FE - pHSD:NE2 2.02 2.10 2.15 2.12 2.13 2.13 1.97 2.04 2.06 
pASP:OD2 - pHSD:HD1 2.06 1.73 2.11 2.11 2.51 3.44 2.32 3.46 2.63 
pASP:OD2 - pTRP:NE1 2.65 2.80 2.70 2.69 2.71 2.72 2.73 2.71 2.70 
pTRP:HE1 - pTRP:NE1 0.87 1.04 1.70 0.86 1.72 1.72 0.86 1.71 1.70 
HEM:FE - dHIS:NE2 5.73 6.22 5.78 5.21 5.76 5.53 5.33 5.91 5.02 
HEM:FE - dTRP:NE1 3.72 4.34 3.61 3.15 2.92 3.07 3.26 3.02 3.67 
HEM:FE - dARG:NH2 7.16 5.79 6.29 4.33 5.00 4.81 7.67 4.97 5.34 
WAT:O - HEM:FE 2.65 3.83 3.36 3.92 3.83 3.95 4.15 3.92 4.00 
WAT:O - dHSD:NE2 3.10 2.67 3.03 2.63 2.77 2.81 2.81 2.75 3.84 
WAT:O - dTRP:NE1 2.32 2.87 3.51 2.68 3.70 3.81 2.75 3.42 4.11 
WAT:O - dARG:NH2 5.06 2.87 4.09 3.44 2.88 2.73 6.65 2.90 2.83 
HEM:FE - HEM:OE    1.64 1.67 1.65 1.88 1.89 1.86 
HEM:OE - WAT:O    3.06 2.63 2.75 2.96 2.60 2.68 
HEM:OE - HEM:HO1       0.99 0.97 0.96 
Table D.1 QM cluster model distance information for QM1-Di result with solvation field. 
 
Species 










ΔEnF, Ferric, P→D 252 -57 254 527 533 394 
ΔEn1, Cpd I, P→D 631  389 508 180 328 
ΔEn2, Cpd II, P→D 788  655 289 750 403 





E. Structural mutants 
This appendix contains preliminary data on structural mutants of c-type maquettes. 
CXH is a c-type maquette that is an extended version of C45. It has an additional heptad 
on each helix (Figure E.1). CCC is a coiled-coil-C45 chimera the helices at the c-type 
heme binding end of the bundle are the same sequence as C45. The remaining sequence 
comes from an anti-parallel coiled-coil. Genes were designed and optimised before being 
produced (Eurofins, UK). They were then cloned into the same expression vector as 
C45 (Section 2.3.1).  
 
Figure E.1 Protein sequences of new structural mutants.  
E.1 CXH cloning expression purification 
Only CXH was expressed and purified. The expression and purification of CXH was 
conducted using the same method as C45 (seen in Section 2.2.2). Figure E.2 shows the 
size exclusion chromatography (SEC) trace and SDS-PAGE results for the purification 
of CXH. The SEC trace shows that CXH is not in a homogeneous conformation at pH 
8.6. There is a secondary band seen in the SDS-PAGE results close to the same weight 




Figure E.2 SEC and SDS-PAGE results for CXH. 
The 280 nm SEC trace is shown with the x-axis showing the accumulated volume (ml). Below the SEC 
trace is the SDS-PAGE results of the purification. The bands (not including the ladder) start with “Ni2 
FT” lane which is the elution from the first nickel affinity column after the cleavage of the his-tag. The 
remaining bands are fractions from the SEC purification of the flow-through from the second nickel 
column. 
 
E.2 UV-visible Spectroscopy 
The ratio of protein (280 nm) to Soret λmax is reduced in CXH. It is 1:2 rather than 
1:3 seen in C45. This is likely a result of a population of holoenzyme in the CXH sample 




Figure E.3 UV-visible spectra of CXH in the ferric and ferrous form.  
E.3 CD 
CD spectrum of CXH shows the typical absorbance’s for α-helical proteins. These 
are negative bands at 222 nm and 208 nm and a positive band at 193 nm. The melting 
temperature has increased in comparison to C45. CXH has a Tm of 88 ˚C where as C45 
has a Tm of 84 ˚C . 
 
Figure E.4 CD results for CXH. (A) CD spectrum for CXH. Scans of melts for 5-95˚C are displayed as 
solid lines going from red to yellow. Scans of cooling experiments from 95-5˚C are displayed as dashed 





E.4 Electrochemistry  
Optically transparent thin-layer electrochemistry (OTTLE) was performed by the 
same method seen in Section 3.2.7. CXH has a EM only 6 mV more negative that C45 
(CXH = 180.2 C45 = 174 mV vs NHE). 
 
Figure E.5 OTTLE results. The fraction of reduced protein has been fitted to a single electron Nernst 
equation. The midpoint potentials (EM) are shown on each graph. The values taken during the reduction 
are shown in circles and the subsequent oxidation values are shown as squares.  
 
E.5 Kinetic assays  
The concentration of CXH was estimated using the c-type Soret λmax extinction 
coefficient determined for C45. This will have led to and underestimate in the 
concentration of total protein used in all the preliminary assays. However, it may be a 
good estimate of the amount of protein with c-type heme incorporated, as the 
concentration measurements was determined using the heme absorbance (Soret λmax).   
The same methodology for steady state kinetics with ABTS was used as described in 
Section 2.2.12. CXH has very similar steady-state kinetic properties to C45. Table E.5.1 






Figure E.6 Steady-state kinetics of CXH with ABTS. The error bars are the standard deviation. 
 
 
Enzyme Substrate kcat* (s-1) KM (µM) kcat/KM (M-1s-1) Condition 
C45 WT ABTS 2.0* ± 0.028 3.1 ± 0.21 6.4 ± 0.43 x10 5 pH 8.6 
CXH ABTS 0.67* ± 0.0002 2.7 ± 0.38 2.5 ± 0.36 x10 5 pH 8.6 
Table E.5.1 Steady-state kinetics curve fitting values. kcat* values are displayed as the results 
are a rate limiting H2O2 concentration (100 µM). 
 
 
 
